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Harnessing Yarrowia lipolytica’s Potential as a Lipid and Alkane 
Production Platform 
 
John James Blazeck, Ph.D. 
The University of Texas at Austin, 2013 
 
Supervisor:  Hal S. Alper 
 
Engineering cellular phenotype can enable the in vivo synthesis of renewable 
fuels, industrial precursors, and pharmaceuticals.  Achieving economic viability requires 
the use of a cellular platform that generates high titers independent of fermentation 
condition, through either native or imported biosynthetic metabolism.  While lacking 
fully developed genetic tools, the oleaginous yeast Yarrowia lipolytica has the native 
capacity to produce large titers of lipids and citric acid cycle intermediates.  However, 
unlocking this biosynthetic capacity requires complete rewiring of native metabolism.  To 
this end, this work focuses on the development and engineering of the yeast Y. lipolytica 
to rewire native metabolism and enable the production of lipids, alkanes, and itaconic 
acid. 
Precise control of gene expression is a requisite to enable metabolic and pathway 
engineering applications for any host organism.  However, Y. lipolytica lacks promoter 
elements strong enough to manipulate intracellular metabolism.  Thus, we utilized a 
hybrid promoter engineering approach to produce libraries of high-expressing, tunable 
promoters, seven-fold stronger than promoters previously characterized in Y. lipolytica 
 ix 
1,2
.  We successfully applied this approach to Saccharomyces cerevisiae, expanding 
transcriptional capacity of the strongest constitutive to highlight our hybrid approach as a 
generalizable method to increase expression capacity in eukaryotic organisms 
3
.   
We utilized our novel Y. lipolytica hybrid promoters to drive intracellular 
metabolism towards lipid production and to overexpress heterologous enzymes that 
enable alkane and itaconic acid production.  Specifically, we implemented a global 
rewiring of Y. lipolytica’s native metabolism to increase lipogenesis more than sixty fold 
to 25.3g/L (the highest lipid production ever reported) and generated cells nearly 90% 
lipid content.  We further expressed a lipoxygenase enzyme to catalyze the novel 
microbial production of the short-chain n-alkane, pentane.  Finally, we exploited Y. 
lipolytica’s capacity to accumulate citric acid cycle intermediates by expressing a 
heterologous cis-aconitic acid decarboxylase enzyme to produce itaconic acid.  
Increasing substrate availability through media optimization and genomic engineering 
increased pentane and itaconic acid production threefold and eightfold, respectively 
4
.  
Collectively, these studies have facilitated the utilization of Y. lipolytica as an industrially 
relevant microbial platform, and represent a generic approach towards enabling 
biosynthetic control in microbial hosts will ill-defined gene expression technology. 
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Chapter 1:  Introduction and Background 
1.1 METABOLIC ENGINEERING OF MICROBIAL HOSTS 
Metabolic engineering utilizes the expression of recombinant DNA to divert 
metabolic flux towards a desired product.  In this manner, metabolic engineering has 
enabled large-scale, cell-based production of pharmaceuticals, fuels, and chemicals from 
renewable resources.  Traditionally, model microbial hosts such as Escherichia coli or 
Saccharomyces cerevisiae have been utilized for many metabolic engineering 
applications.  However, recent widespread advances in recombinant technologies have 
enabled basic engineering of a much wider variety of microorganisms.  These organisms 
often have unique biosynthetic capacities not found in standard E. coli and S. cerevisiae 
hosts.  Genetic tools have been developed for organisms able to accumulate organic acids 
5
, amino acids 
6
, butanol 
7
, and many other valuable compounds.  However, these genetic 
tools are often limited, especially in their ability to enable precise control of metabolic 
pathways.  In particular, the non-conventional yeast, Yarrowia lipolytica, has the innate 
ability to produce large quantities of lipid content 
8
 and citric acid 
9
, but has rudimentary 
gene expression technologies.   
Manipulating metabolic flux requires the capacity to precisely control 
recombinant gene expression level, a capacity that is often non-existent or severely 
limited in non-conventional microbial hosts.  Thus, a question is often raised before 
undertaking metabolic engineering endeavors – will it be easier to maximize yields in a 
non-conventional host with innate, beneficial metabolic abilities, or in a conventional E. 
 2 
coli or S. cerevisiae host 
10
?  This dissertation demonstrates a reproducible methodology 
towards harnessing biosynthetic capacity in non-conventional hosts, by first developing a 
generalizable promoter engineering approach to permit precise gene expression control 
(Chapters 2,3, and 4), and then by using this gene expression control to manipulate Y. 
lipolytica’s metabolism for alkane (Chapter 5), lipid (Chapter 6), and itaconic acid 
production (Chapter 7).  Chapter 8 provides a brief review of our major findings and 
recommendations for future studies, and Chapter 9 contains comprehensive materials and 
methods descriptions. 
1.2 CONTROLLING GENE EXPRESSION WITH PROMOTER ENGINEERING 
Intracellular metabolic flux is regulated by a series of distinct yet interwoven 
levels of regulatory control—occurring at the transcriptional, translational, and protein 
levels 
11
.  Achieving flux control on the metabolomic level requires a concurrent capacity 
to directly manipulate gene expression.  Gene expression is controlled at its most 
fundamental level by promoter elements that drive transcription.  Hence, metabolic 
engineering applications have long relied on endogenous promoter discovery and use to 
control gene expression.  However, these promoters are limited in that they do not permit 
tunable transcriptional control (without differential regulation), and they do not maximize 
the transcription levels achievable within an organism.  To address this issue, the field of 
promoter engineering attempts to modulate promoter transcriptional capacity by 
mutating, enhancing, or otherwise altering promoter DNA sequence.  In doing so, 
promoter engineering can help generate the dynamic range necessary to enable fine-tuned 
gene expression to maximize production formation for metabolic engineering 
 3 
applications.  What follows is a brief overview of eukaryotic promoter structure and 
function and of previous promoter engineering attempts to enable transcriptional control.  
As yeast microbial hosts are utilized for all experiments performed in this dissertation, 
yeast promoters are specifically highlighted. 
1.2.1 Overview of eukaryotic/yeast promoter structure and function 
Figure 1.1: Overview of promoter structure 
 
A schematic of yeast promoter architecture. Yeast promoters have very few conserved motifs.  Instead, it is more 
applicable to view them as modular enhancer and core elements. 
 
Eukaryotic transcription initiation is complex; requiring DNA sequence-specific 
transcription factors to bind within a promoter element and interact with transcriptional 
coactivators that help localize the basic transcriptional machinery 
12
.  Routinely, 
eukaryotic promoters are thought to contain two distinct regions:  (1) a core element and 
(2) an upstream enhancer element.  Transcriptional direction and start site are determined 
by the core promoter element while the upstream enhancer element helps determine 
transcriptional frequency, or promoter strength.  The core promoter is the minimal 
promoter region required to allow formation of the pre-initiation complex (PIC) and to 
initiate transcription 
12-14
, and is typically a succinct stretch of less than 80 nucleotides 
extending roughly 35 bp upstream or downstream from the transcriptional start site (TSS) 
 4 
14,15
.  In yeast, little is known about potential core promoter consensus motifs and only 
~20% of genes contain a TATA-box (Figure 1.1) 
16.  As the core promoter’s function is 
to enable basal transcription, a suitable TSS and the capacity to recruit PIC components 
are equally essential.   
Eukaryotic upstream enhancer elements localize trans-acting regulatory elements 
(transcription factors) as a means of controlling transcriptional frequency or imparting 
regulation to a core promoter.  Within the enhancer element, concise and specific DNA 
sequences serve as transcription factor binding sites or ―docking points‖ for 
transcriptional activators or repressors 
17-22
.  Promoter-bound transcription factors interact 
with one another locally and with the basal transcriptional machinery to establish 
promoter regulation and promoter strength, i.e., frequency of PIC formation and 
subsequent transcription initiation 
23-25
.  DNA regions prone to increase transcriptional 
frequency of a core promoter are commonly referred to as upstream activating sequences 
(UAS).  Similarly, an upstream repressive sequence localizes transcription factors that 
reduce transcription rate 
12
.  Promoter regulation (induction or repression dependent on 
environmental conditions) is also a result of transcription factor mediated interactions in 
the enhancer element 
26-29
.  Promoter engineering techniques alter both core and enhancer 
elements to modulate overall promoter expression capacity. 
1.2.2 Promoter engineering strategies 
Promoter engineering has become an enabling technology for metabolic 
engineering purposes by facilitating the creation of novel gene expression control 
elements.  The basis for much of this engineering is related to promoter architecture.  
 5 
Visualizing eukaryotic promoters as a core-enhancer fusion facilitates engineering hybrid 
promoters, in which modular enhancer and core combinations can determine promoter 
regulation and transcriptional capacity.  At the more basic level, both enhancer and core 
elements possess specific transcription factor binding sites that determine overall 
promoter function.  Randomized promoter mutagenesis through error-prone PCR alters 
transcription factor binding sites thus altering promoter strength.  Since binding site 
mutations are far more likely to reduce transcription factor interactions, these random 
mutagenesis approaches often produce promoter variants with lower strengths than the 
template sequence.  In fact, the majority of promoter engineering methods, while 
successful at producing libraries with large ranges in gene expression, have been unable 
to drastically increase promoter strength.   
  
 6 
Figure 1.2: Promoter engineering strategies 
 
 
(A) Ep-PCR introduces random mutations (depicted as red stars) into a wildtype promoter element that alter promoter 
sequence, adapted from 30.  Large-scale characterization of mutated promoters facilitates isolation of a promoter library 
that retains endogenous regulation but spans large expression ranges.  (B) Hybrid promoter engineering utilizes tandem 
upstream activations sequences to modulate core promoter expression to construct synthetic hybrid promoters with 
novel strength or regulation, adapted from 3.   
1.2.2.1 Error-prone PCR 
Error-prone PCR (ep-PCR) introduces random mutations into a DNA sequence of 
choice (Figure 1.2a).  When applied to an entire promoter region, mutations occur 
throughout the consensus and spacer regions and lead to disparate function.  This 
approach is guaranteed to yield novel promoter variants (with sufficient library sizes) and 
proper selection techniques allow the isolation of promoters driving a wide variation in 
gene expression.  For example, mutagenesis of the bacteriophage-derived PL-λ 
 7 
constitutive E. coli promoter yielded a library of engineered promoters of varying 
strengths spanning a 196-fold range with identical regulation 
30
.  Ep-PCR of the strong 
constitutive S. cerevisiae TEF1 promoter generated a similarly diversified promoter 
library spanning a 15-fold range 
30,31
.  Finally, random mutagenesis of the oxygen-
responsive S. cerevisiae DAN1 promoter enabled isolation of two mutants induced under 
less-stringent anaerobiosis than the wild-type promoter 
32
.  
1.2.2.2 Hybrid promoter engineering 
A hybrid promoter engineering approach entails the assembly of enhancer 
element-core promoter fusions to rationally enhance basal core transcriptional capacity or 
enable novel promoter regulation (Figure 1.2b).  Basic hybrid promoter work in E. coli 
led to the formation of many commonly utilized promoters, including the tac promoter (a 
fusion derived from the trp and lac promoters) 
33
, and the rhaPBAD, a tightly regulated 
arabinose and rhamnose promoter fusion 
34
.  In yeast, hybrid promoters have traditionally 
been utilized to dissect promoter function and regulation 
33,35-40
.   In this light, essential 
DNA sequences are identified in part due to the modularity of hybrid promoter core and 
enhancer elements.  Upstream enhancer elements contain transcription factor binding 
sites that enable native regulation and expression activation or repression to be 
maintained independent of core promoter region.  Minimal regions of these DNA regions 
can identify specific regions essential for transcriptional activation or induction control 
(i.e., upstream activation sequences).  Constructing hybrid promoters composed of 
tandem repeating UAS elements can theoretically greatly increase core promoter 
expression capacity, as each additional UAS increases overall hybrid promoter strength.  
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Chapters 2 – 4 of this dissertation are devoted towards the development of the hybrid 
promoter engineering approach as a unique tool to increase promoter expression capacity, 
especially in nonconventional organisms that lack the capacity for strong, tunable gene 
expression. 
 
1.3 YARROWIA LIPOLYTICA AS A METABOLIC ENGINEERING HOST 
Yarrowia lipolytica is a widely studied dimorphic yeast with many intriguing 
metabolic capabilities 
41-44
, and is a unique host for biochemical production and 
heterologous protein excretion due to its ability to secrete native and heterologous 
proteins at high levels 
45-47
.  Lipase, leucine amino peptidase, hydroperoxide lyase, 
glucoamylase, alpha-amylase, galactanase, polygalacturonase, cellulase, xylanase, 
laccase, prochymosin, urokinase-type plasminogen activator, anti-RAS single chain 
variable fragment, and many other fungal, plant, and mammalian proteins have been 
successfully expressed and secreted from Y. lipolytica 
45,47-53
.  Y. lipolytica’s genome 
consists of six chromosomes, totaling 20.5 million base pairs in length with an average 
GC content of 49% 
54
.  Y. lipolytica is also very uncommon in its ability utilize 
hydrophobic and waste carbon sources 
55-57
.  In particular, Y. lipolytica is well-known for 
its ability to grow robustly on pure and crude glycerol.  Y. lipolytica is also an industrial 
producer of the TCA cycle intermediate, citric acid 
58
, and this tendency to produce citric 
acid is directly linked to its ability to accumulate lipids 
59
.   
Yarrowia lipolytica is an oleaginous organism, meaning that it can accumulate 
high levels of lipid content, exceeding 40-70% dry cell weight when cultivated in fatty 
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acid containing media 
60-65
.  The lipid accumulation phenotype is induced by nitrogen 
starvation conditions that slow cell growth and production.  However, the availability of 
Y. lipolytica’s genome sequence 66 along with basic genetic tools such as transformation 
methods 
67,68
, gene knockouts 
69
, and both episomal 
70-73
 and integrative expression 
cassettes 
74-76
 largely enables metabolic engineering approaches.  As the only oleaginous 
organism with developed genetic tools, Y. lipolytica represents an ideal host in which to 
optimize metabolism to enable lipid accumulation across multiple environmental 
conditions and regardless of carbon source.  In vivo conversion of lipid content could 
permit production of oleo-chemicals such as fatty acid methyl esters and alkanes 
77-80
.  In 
fact, Y. lipolytica’s lipid reserves have proven amenable to further in vivo manipulation, 
making the implementation of previously characterized alkane production pathways more 
promising 
77,79,81,82
.  Additionally, Y. lipolytica’s citric acid pool can be exploited for the 
production of non-native organic acids, namely itaconic acid 
83
.  However, as stated 
above, assuming this control of cellular metabolism requires precise control of key gene 
expression, an area in which Y. genetic toolbox is severely underdeveloped 
56
.   
 
1.4 FATTY ACID AND LIPID METABOLISM IN Y. LIPOLYTICA  
Lipid accumulation in Y. lipolytica can be induced by nitrogen starvation and has 
been associated with the activity of four enzymes: AMP Deaminase (AMPDp), ATP-
Citrate Lyase (ACLp), Malic Enzyme (MAEp) and Acetyl-CoA Carboxylase (ACCp) 
59,61
 (Figure 1.3).  AMPDp is activated in oleaginous organisms during nitrogen 
starvation and cleaves AMP into inosine 5’-monophosphate and NH4
+
 to replenish 
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intracellular nitrogen levels; Low levels of AMP inhibit the isocitrate dehydrogenase 
enzyme in the citric acid cycle, causing a buildup of isocitrate.  Aconitase reversible 
interconverts isocitric acid and citric acid, but equilibrium concentrations favor high citric 
acid levels.  This citric acid is shuttled out of the mitochondria by the citrate/malate 
shunt
59,84,85
, where ACLp cleaves it into oxaloacetate and acetyl-CoA.  Finally, ACCp is 
activated by high cellular citrate levels 
59
 and carboxylates acetyl-CoA into malonyl-CoA 
fatty acid building blocks 
86
.  Fatty acid synthesis is further encouraged by a MEAp-
mediated increase in NADPH levels 
59
.   
Figure 1.3: Lipid metabolism in Yarrowia lipolytica 
 
The mechanism for lipid accumulation is diagrammed summarily.  In brief, AMPD activity inhibits citric acid cycle 
under nitrogen starvation condition, causing a buildup of citric acid.  Citric acid is cleaved by ACL to form acetyl-CoA, 
which is further carboxylated by ACC to produce malonyl-CoA fatty acid building blocks.  Fatty acids are incorporated 
in lipids following the Kennedy Pathway in which three acyl-CoA molecules are bound to a single glycerol molecule.  
Fatty acids are degraded peroxisomally through the four step β-oxidation pathway to replenish acetyl-CoA pools. 
 11 
Fatty acids can be directly stored in intracellular lipid bodies, though they are 
typically incorporated into triacylglycerides (lipids) before storage 
63
.  Lipid synthesis 
follows the Kennedy Pathway to fuse three fatty acids to a glycerol-3-phosphate (G3P) 
backbone 
87
.  The ultimate step of lipid synthesis is catalyzed by the DGA1 or DGA2 
acyl-CoA:diacylglycerol acyltransferases 
59,88
.  G3P backbone is synthesized from 
dihydroxyacetone phosphate (DHAP) by the cytosolic, NAD
+
-dependent glycerol-3-
phosphate dehydrogenase (GPD1) and recycled into glycolysis by the mitochondrial, 
FAD
+
-dependent glycerol-3-phosphate dehydrogenase isoform (GUT2) 
61
.  Y. lipolytica 
also efficiently incorporates extracellular fatty acids, oils and triglycerides by hydrolysis 
of the hydrophobic substance, transport into the cell, and assembly into triglycerides 
59
.  
A small fraction of free fatty acids are shunted into production of steryl esters, by 
acylation of a sterol 
88
.  Lipids, free fatty acids, and steryl-esters accumulate in lipid 
bodies, where they are stored as energy sources 
63
.   
Lipid hydrolysis mobilizes free fatty acids for peroxisomal degradation through 
the four step β–oxidation cycle 89 - oxidation by one of six acyl-CoA oxidases (POX1-6), 
hydration and dehydrogenation by the multifunctional enzyme (MFE1), and thiolysis by a 
3-ketoacyl-CoA-thiolase (POT1 or PAT1) 
59
.  In comparison, S. cerevisiae contains only 
one POX homolog, as it is not known for its ability to accumulate hydrophobic 
compounds.  The PEX10p transcription factor has been implicated in peroxisomal 
biogenesis and Δpex10 mutants display increased lipid content 4,90,91.   
Genomic modifications to Y. lipolytica’s fatty acid, lipid, and central carbon 
metabolism have shown promise towards increasing lipid accumulation capacity. 
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Deletion of the six POX genes increased ex novo incorporation of oleic acid in Y. 
lipolytica, while deletion of the single MFE1 gene had a similar effect 
61,63
.  Increasing 
G3P backbone levels by combining GUT2p deletion and GPD1p overexpression in these 
β–oxidation deficient backgrounds further increased ex novo lipid accumulation to 65-
75% lipid content 
61
.   Overexpression of DGA1p increased de novo lipid accumulation 
fourfold over control levels to 33.8% lipid content, and co-overexpression of ACC1p 
further increased lipid accumulation slightly to a final yield of 41% lipid content 
92
.  To 
date, no study has attempted to completely redirect metabolic flux towards lipid 
accumulation, by simultaneously manipulating fatty acid, lipid and central metabolism.  
Furthermore, no study has attempted to utilize Y. lipolytica lipid pools for the production 
of value-added hydrophobic chemicals, like alkanes.  Chapters 5 and 6 of this dissertation 
are devoted to enabling Y. lipolytica as an alkane and lipid production platform.  Finally, 
Chapter 7 utilizes Y. lipolytica’s fatty acid precursor pool to produce itaconic acid. 
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Chapter 2:  Hybrid Promoter Engineering in Yarrowia lipolytica 
2.1 CHAPTER SUMMARY 
In poorly characterized or nonconventional hosts, a common limitation preventing 
metabolic engineering applications is a lack of strong, tunable promoter elements to 
efficiently control gene expression.  In particular, Yarrowia lipolytica is an intriguing 
oleaginous organism with developed recombinant DNA technology that is limited in its 
applications by an inability to manipulate and overexpress enzymatic pathways.  Here, 
we have utilized a hybrid promoter approach to produce libraries of high-expressing, 
tunable promoters in Y. lipolytica.  These synthetic promoters are comprised of two 
modular components—the enhancer element and the core promoter element.  By 
exploiting this basic promoter architecture, we have overcome native expression 
limitations and provided a strategy for both increasing native promoter capacity and 
producing libraries for tunable gene expression.  In doing so, we have created the 
strongest promoters ever reported in Y. lipolytica.  These promoters exhibited a range of 
more than 400 fold in terms of mRNA levels, and up to eight-fold higher fluorescence 
levels compared with typically used endogenous promoters.  These promoter libraries 
represent an enabling technology for metabolic engineering applications in Y. lipolytica, 
and we have illustrated that tandem copies of upstream activating regions can serve as 
synthetic transcriptional amplifiers that may be generically used to increase the 
expression level of promoters.  Thus, we have opened the possibility that the hybrid 
promoter engineering approach is a generalizable approach applicable to other organisms. 
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2.2 INTRODUCTION 
Developing and establishing a comprehensive suite of promoter elements in 
organisms with poorly defined genetic tools is essential for enabling metabolic and 
pathway engineering applications.  To this end, the oleaginous yeast Yarrowia lipolytica 
has received attention as a potential biofuels producing host, yet lacks genetic tools for 
tunable and high level gene expression.  In other organisms, prior attempts of promoter 
engineering relied on modifying the expression range of endogenous promoters through 
point mutations.  As an example, error-prone PCR of the native Saccharomyces 
cerevisiae TEF promoter yielded a library of mutant promoters with a nearly seventeen-
fold range in relative expression strength 
31
. A similar approach in E. coli led to a nearly 
eighteen-fold range in relative expression strength based on the heterologous Pl-lambda 
promoter 
30
.    An alternative strategy aimed at tuning intergenic regions in heterologous 
Escherichia coli operons enabled a seven-fold improvement in pathway throughput and 
was used to prevent the accumulation of a toxic intermediate 
93
.  While successful, these 
methods and applications are quite limited by: (1) their reliance on a strong, well-defined 
starting core promoter and (2) the tendency of alterations to result in expression levels 
lower than these baselines.  These limitations present a challenge for creating a dynamic 
range of promoters with similar regulation in a novel organism without highly 
characterized strong promoter elements. 
Beyond point mutations, the generation of hybrid promoters has been previously 
successful in significantly augmenting promoter architecture and function 
33,94,95
.  Most of 
these approaches attempt to create synthetic hybrid promoters by fusing an upstream 
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activating sequence (UAS) to a separate (often minimal) core promoter region.  The 
result is a functional UAS-core promoter chimera.  In this construct, the UAS regulatory 
site enhances gene expression by localizing trans-acting regulatory elements 
(transcription factors). As a result, this approach raises the possibility to uniquely 
engineer promoters as two independent, synthetic parts—activating regions and core 
regions.  We developed a generalizable approach of hybrid promoter engineering for the 
construction of both very high-strength promoters and tunable promoter libraries in the 
non-conventional, oleaginous yeast host Y. lipolytica. 
Y. lipolytica is a unique host for biochemical production and heterologous protein 
excretion 
47,62
 that largely enable metabolic engineering approaches 
54,69,72,74
.  However, it 
lacks the defined promoter elements to enable high strength enzyme overexpressions 
56
.  
One of the strongest promoters in Y. lipolytica, the XPR2 promoter has complex 
requirements for induction that hinders its industrial applications 
53
.  Nevertheless, this 
promoter has been functionally analyzed to reveal a 105 basepair distal UAS fragment 
named UAS1B 
96,97
.  Previously, between one to four tandem UAS1B copies were fused 
to a core minimal LEU2 promoter to create four increasingly strong hybrid chimera 
promoters, named hp1d through hp4d 
53
.  As a result, the hp4d promoter has become a 
commonly used tool for heterologous protein expression in Y. lipolytica.  A further re-
analysis of these four promoters revealed a linear increase of promoter strength as a 
function of number of tandem UAS1B elements which strongly raises the possibility of 
further improvements.   
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2.3 RESULTS AND DISCUSSION 
2.3.1 Characterization of endogenous promoters at the single-cell level 
Prior studies of promoter strength in Y. lipolytica have relied on assaying whole 
cultures for protein expression level (using reporters such as β-galactosidase) 45,53.   It is 
commonly known that these methods can mask potential bimodal ―on/off‖ distributions 
within bacterial populations.  Thus, to avoid this complication, we sought to utilize a 
fluorescence-based assay using the Y. lipolytica plasmid pSl16-Cen1-1(227) 
98
.  All 
results generated in this study, except where indicated, employed derivatives of this 
replicative, ARS-CEN based plasmid.  Since codon biases are known to limit translation 
in Y. lipolytica 
99
 and no fluorescent reporter protein has been previously used in Y. 
lipolytica to gauge promoter strength, we initially evaluated several available fluorescent 
reporter proteins. The TEF promoter was coupled to four different fluorescence genes 
including yECitrine, EGFP, hrGFP and mStrawberry and flow cytometry was performed 
to determine reporter functionality.  Of these variants, only hrGFP imparted detectable 
fluorescence (Figure 2.1a).  This gene, optimized for expression in mammalian cells, has 
the highest Codon Adaptation Index for Y. lipolytica of the four fluorescence genes, 
100
 
indicating the closest compatibility with codon usage frequencies for this organism.  
As a result, the hrGFP reporter gene was used to evaluate the promoter strength of 
seven previously identified endogenous Y. lipolytica promoters—TEF, EXP, FBA, 
GPAT, GPD, YAT, and XPR2 (Table 2.1, Figure 2.1b) 
45,101,102
.  Based on this analysis, 
the relative ordering of promoters strengths is EXP > TEF > GPD > GPAT > YAT > 
XPR2 > FBA.  The low mean fluorescence values of even the strongest of these native 
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promoters, EXP and TEF, highlight that even strong endogenous promoters in Y. 
lipolytica may be too low for metabolic engineering purposes.  When each of these 
promoters was used in a plasmid-based construct, a bimodal fluorescence distribution 
was seen.  These results strongly suggest an ―on/off‖ switch mechanism resulting from 
the low copy CEN-based plasmid used in the study.  It is interesting to note that this 
bimodal distribution was absent when using an integrated expression cassette instead.  As 
a result, this work highlights an important consideration for using plasmids in a Y. 
lipolytica system.  Based on prior reports to further improve the expression strength, a 
consensus four nucleotide ―caca‖ sequence 5’ of the +1 ATG codon was included 99,103-
105
; however, this inclusion was found to be detrimental to expression levels in most cases 
(data not shown).  The differential regulation patterns and small dynamic range of these 
endogenous promoters require a novel approach to enable metabolic engineering 
applications in this organism. 
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Figure 2.1: A fluorescence based assay for endogenous promoter characterization 
 
 
(A) The relative fluorescence levels of yECitrine, mStraw, EGFP and hrGFP driven by the TEF promoter in Yarrowia 
lipolytica were tested with flow cytometry and mean fluorescence from different fluorescent protein were presented for 
comparison.  These results indicate that hrGFP was the only functional fluorescent protein for this system.  (B)  
Endogenous promoters including EXP, TEF, GPD, GPAT, YAT, XPR2, and FBA were used to drive the expression of 
hrGFP.  The mean fluorescence data was collected with flow cytometry analysis for comparison at a timepoint of 48 
hours in minimal medium.  Error bars represent standard deviation from biological replicates.  The control for these 
experiments was Y. lipolytica strain Po1f transformed with blank, replicative pMCSCen1 plasmid.  The EXP and TEF 
promoters were identified as the strongest among this tested set. 
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Table 2.1: Elements utilized in initial hybrid promoter development 
Promoter 
element 
name 
Open reading frame regulated YALI number Basepair 
range 
Reference 
number 
EXP1 Export protein YALI0C12034p -999 to -1 
102
 
GPAT Glycerol-3-phosphate dehydrogenase YALI0C00209p -1130 to -1 
102
 
GPD Glyceraldehyde-3-phosphate 
dehydrogenase 
YALI0C06369p -931 to -1 
102
 
TEF Translation elongation factor EF-1α YALI0C09141p -406 to -1 
102
 
YAT1 Ammonium transporter YALI0E27203p -775 to -1 
102
 
FBA Fructose-bisphosphate aldolase YALI0E26004p -830 to +171 
102
 
XPR2 Alkaline extracellular protease YALI0E26719p -947 to -1 
53
 
TEF(136) Translation elongation factor EF-1α YALI0C09141p -136 to -1 This study 
TEF(203) Translation elongation factor EF-1α YALI0C09141p -203 to -1 This study 
TEF(272) Translation elongation factor EF-1α YALI0C09141p -272 to -1 This study 
TEF(504) Translation elongation factor EF-1α YALI0C09141p -504 to -1 This study 
TEF(604) Translation elongation factor EF-1α YALI0C09141p -604 to -1 This study 
TEF(804) Translation elongation factor EF-1α YALI0C09141p -804 to -1 This study 
TEF(1004) Translation elongation factor EF-1α YALI0C09141p -1004 to -1 This study 
Leum β-isopropylmalate dehydrogenase YALI0C00407p -92 to +25 
53
 
UAS1B Alkaline extracellular protease YALI0E26719p -805 to -701 
53
 
The elements used in this study are listed with their names, open reading frame regulated, YALI accession number and 
basepair range. 
 
2.3.2 Creating and characterizing a hybrid promoter series using the UAS1B 
element and minimal leucine core promoter 
To bypass the limitations of endogenous promoters in Y. lipolytica, we evaluated 
the generalizable nature of hybrid promoters comprised of fused upstream activating 
sequences with a minimal core promoter.  In prior work, a nearly perfect positive linear 
correlation was previously detected between the number of tandem UAS1B sequences 
and promoter outputs in the hp1d to hp4d promoter series 
53
.  This observation led to our 
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hypothesis that these minimal core promoters and potentially other Y. lipolytica full-
length, native promoters are enhancer limited.  To address this limitation, we created an 
expanded series of hybrid promoters by fusing between one and thirty two tandem 
UAS1B enhancer sequences to the leucine minimal promoter (Leum) to form promoters 
UAS1B1-Leum through UAS1B32-Leum (Figure 2.2a). The newly constructed UAS1B-
Leum promoter series was tested with hrGFP based flow cytometry analysis after ~9 
doublings to help insure promoter stability.  The fluorescence data displayed several 
domains for correlation between output fluorescence and the number of upstream UAS 
elements.  Initially, an exponential increase in fluorescence was seen as UAS1B sequence 
count increased from one to eight.  This trend became linear through nineteen tandem 
repeats (a total of 1995 bp of upstream activating sequences upstream of the core 
promoter).  Finally, the output fluorescence seemed to be saturated through 32 tandem 
UAS1B repeats (Figure 2.2b).  This data strongly conformed to a Hill Cooperative 
Binding model (correlation coefficient of 0.95) and exhibited a high Hill Constant (3.889) 
which indicates a strong amount of binding cooperativity of the enhancer elements 
(Figure 2.2b).  Specifically, this data was fit to the equation: 
 
 
with the resulting coefficients of  a= 0.794, Hill Coefficient= 3.889, and c= 10.146.  As 
with the prior tests using endogenous promoters, these plasmid-based expression 
cassettes showed a bimodal distribution of fluorescence levels that was independent of 
the promoter being evaluated.  However, when these cassettes were integrated into the 
tCoefficien HilltCoefficien Hill
tCoefficien Hill
 UASof # 
 UASof #
  a  FL)mean min  - FLmean (max   FLmean min   FLMean 
c
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genome, these promoters gave a singular, high expression peak which indicates that the 
bimodal nature was conceivably due to an episomal expression issue related to this 
organism.  These integrative expression cassettes generated roughly two-fold higher 
fluorescence values than their corresponding replicative-based cassettes, and the lack of 
bimodal distribution was seen for all promoters tested and was not dependent on UAS1B 
copy number (data not shown). 
Figure 2.2: Developing and characterizing a UAS1B-Leum hybrid promoter set. 
 
(A) A schematic diagram for UAS-enabled hybrid promoter engineering illustrates that these promoters were created 
from two distinct parts—the core promoter and upstream activation sequence (UAS) elements. By inserting tandem 
copies of UAS upstream to the core promoter, fine-tuned promoter sets with the strongest expression levels seen in Y. 
lipolytica were created.   
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Figure 2.2 continued 
 
 
(B) The tandem insertion of 1 to 32 copies of UAS1B sequences upstream of a minimal LEU promoter enabled 
construction of the UAS1B1-Leum to UAS1B32-Leum promoters. Error bars represent standard deviation from 
biological triplicates. The relative promoter strengths of UAS1B-Leum promoters were fit to a Hill equation, 
resulting in a= 0.794, Hill Coefficient= 3.889, c= 10.146 and r2= 0.9495 using Polymath Software (Willimantic, CT).  
(C) Transcriptional profiling of select promoter constructs was used to calculate mRNA levels relative to the minimal 
Leum promoter.  Expression profiles matched fluorescence data.  Error bars represent standard deviation from technical 
triplicates.   
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Figure 2.2 continued 
 
(D) Promoter driven expression of a β-galactosidase gene yielded similar results to hrGFP.  Lysed cultures were 
pelleted down prior to absorbance measurements.  Error bars represent standard deviation from biological triplicates. 
 
2.3.3 Transcriptional analysis of the UAS1B-leum hybrid promoter series 
A transcriptional analysis was performed to confirm that the observed effect in 
fluorescence was indeed manifested at the transcriptional level.  To do so, qRT-PCR 
analysis was employed using the hrGFP mRNA of select promoter constructs (Leum, 
UAS1B4-Leum, UAS1B8-Leum, UAS1B16-Leum, UAS1B24-Leum, and UAS1B32-Leum) 
(Figure 2.2c).  Expression values were normalized to the mRNA level seen with only the 
minimal leucine promoter used to drive hrGFP.  Indeed, the increase in mean 
fluorescence levels was strongly correlated with the increase in relative mRNA levels.  
 24 
The relative mRNA levels increased and likewise plateaued for constructs with a high 
number of UAS1B repeats.  Moreover, these results demonstrate an extraordinary range 
of promoter strength in this series with more than a 400 fold dynamic range of transcript 
level between the minimal promoter and strongest promoters in this set.  
2.3.4 Utility and stability of the UAS1B-leum hybrid promoter series 
To ensure that the observed effect was independent of reporter gene, we sought to 
provide a further characterization of the UAS1B-Leum promoter series with a separate 
reporter gene, the β-galactosidase gene encoded by E. coli lacZ.  Select promoter 
constructs (including the endogenous TEF, EXP, and XPR2 promoters as well as hybrid 
UAS1B-leum constructs containing 1, 2, 3, 4, 6, 8, 12, 16, 20, 24, 28, and 32 UAS1B 
copies) were used to construct expression cassettes with lacZ in place of hrGFP.  β-
galactosidase assays were performed as described previously 
106,107
 with a maximum 
value of 1198 miller units generated by the UAS1B28-leum construct (Figure 2.2d).  
Promoter strength increased with increasing UAS1B copy number up through 32 UAS1B 
repeats unlike in the HrGFP assay.  However, the β-galactosidase assay results matched 
well with the hrGFP analysis and the data showed a strong positive statistical correlation 
(r
2
=0.85).  The strongest UAS1B-Leum hybrid promoter exhibited a more than eight fold 
increase in promoter strength in terms of Miller units compared to the strong endogenous 
promoters tested in this study.  These results demonstrate that the UAS1B-leum hybrid 
promoter series developed here is a generic tool for obtaining tuned gene expression in Y. 
lipolytica.  It should be noted that the expression of the UAS1B4-Leum reported here 
were substantially lower than previously reported.  These comparisons are difficult due to 
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the slight differences in restriction sites used to create these hybrid promoters, the use of 
rich media in prior reports, and the use of replicative plasmids here compared with 
integrated plasmids in other studies.  Even with these difference and discrepancies, this 
work still presents up to a fourfold increase in performance compared with the best 
reported endogenous promoters or previously constructed hybrid promoters 
53,108
.  This 
illustrates that multiple tandem repeats of the UAS1B enhancer element activate 
transcription to levels far stronger than those previously described and that this enhancer 
activation can occur at regions more than 2000 nucleotides upstream of the start codon 
(for UAS1B16-32-Leum).     
 These hybrid promoters rely on a high number of tandem repeats, thus, genetic 
stability was evaluated.  To accomplish this, selected promoter constructs (with 12 or 16 
repeated UAS1B elements) were tested on the basis of sequence fidelity after non-
selective serial subculturing.  These strains were subcultured for a total of 36 generations.  
After this process, cells were harvested and plasmids were isolated and sequenced to 
assess gene construct stability.  In total, 20 separate plasmids containing the UAS1B12-
Leum and 20 containing the UAS1B16-Leum promoters were evaluated.  17 out of 20 
UAS1B12-Leum and 20 out of 20 UAS1B16-Leum promoters were positively sequence 
and restriction enzyme digest confirmed after 36 doublings.  Only 3 out of 20 UAS1B12-
Leum promoters were unstable through 36 generations as they were truncated down to 
UAS1B3-Leum.  Thus, these promoters are suitably stable in Y. lipolytica for long-term 
expression and use.   Collectively, this data suggests that the expression output from 
hybrid promoters can be altered by changing the number of activating regions with a 
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given core promoter region.  Next, we sought to address the ability to alter the core 
promote region of this construct. 
2.3.5 Generalizing the hybrid promoter approach by switching the core promoter 
region 
 As discussed above, a hybrid promoter has two potential independent elements—
activating regions and core promoter region.  The data above suggests that tandem UAS 
elements may serve as movable, synthetic expression amplifiers for a given promoter.  
Next, we sought to test the hypothesis that even native promoters in Y. lipolytica are 
enhancer limited and can be strengthened by adding additional UAS elements.  To do so, 
we constructed new hybrid promoters containing either eight tandem UAS1B sequences 
(UAS1B8) or sixteen tandem UAS1B sequences (UAS1B16) inserted 5’ upstream of a 
series of different TEF-based core promoters.  Specifically, we amplified eight different 
regions of the TEF promoter spanning 136 bp and 1004 bp upstream of the ATG starting 
site from PO1f 
53
 genomic DNA (Table 2.1).  Included in this set is the consensus 404 bp 
TEF promoter for Y. lipolytica as well as lengthened and truncated versions of this 
promoter.  These eight core TEF promoters and their corresponding UAS1B8 and 
UAS1B16 hybrid promoters were tested and compared with the Leum, UAS1B8-Leum 
and UAS1B16-Leum constructs. 
 This new series of hybrid promoters was assayed via hrGFP fluorescence by flow 
cytometry.  In the absence of UAS elements, it can be seen that the fluorescence value 
decreases for truncated promoters below the consensus TEF size as expected.  Moreover, 
the full length (and larger) TEF promoters have more strength than the minimal leucine 
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promoter (Figure 2.3a).  The UAS1B8 and UAS1B16 enhancer fragments in isolation do 
not confer any promoter activity (data not shown).  When these enhancer fragments were 
fused with the TEF promoter elements, a substantial increase in the net promoter strength 
was seen regardless of the TEF variant utilized.  The enhancement provided by UAS1B8 
was roughly half the value obtained by using UAS1B16.  Moreover, these enhancements 
were seen for both more minimal and full length TEF promoter elements, even with the 
existence of naturally occurring UAS elements in the consensus and longer TEF 
promoters.  Thus, this data suggests shows that even strong endogenous promoters like 
TEF are enhancer limited in Y. lipolytica and their expression capacity can be increased 
through additional UAS elements.  Furthermore, we demonstrated that the ability of a 
UAS1B element to amplify expression is independent of the core promoter element. 
 The amplification of expression imparted by the UAS1B8 and UAS1B16 enhancer 
elements was not even for all promoters.  The fold increase of the constructs relative to 
the UAS-free TEF core promoters is plotted in (Figure 2.3b).  In general, the largest 
improvement is obtained when the UAS elements are placed most closely 5’ of a core 
promoter region.  This fold improvement trend is rationalized in terms of a mechanism of 
proximity and localization of enhancer elements.  However, it is interesting to note that 
the total promoter size (with 16 activating sequences and a core region) totals upwards of 
three thousand basepairs for many of these promoters—a region that is quite large for 
typical yeast constructs.  In addition, many of these larger constructs were the best 
performing promoters.  Specifically, nearly all of these promoters proved to be stronger 
than the corresponding UAS1B8-Leum and UAS1B16-Leum promoters, demonstrating 
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the fitness of the TEF-based core promoter regions for strong hybrid promoter 
engineering.  Thus, both the choice of tandem enhancer element and core promoter 
element contribute to the collective strength of hybrid promoters.  In this regard, this 
work demonstrates that tandem UAS elements serve to synthetically amplify the 
expression level imparted by the core promoter element chosen.  In this regard, 
transcription factor binding is posited to serve as a major rate limiting step for 
transcription at promoter sites with addition of upstream activating sites alleviating this 
limitation.  Thus, it is possible for us to control transcriptional activity by indirectly 
modulating transcription factor localization or affinity through the choice of enhancer and 
core elements in a hybrid promoter.  This observation raises the possibility of rationally 
designing hybrid promoters with specified expression strength.  The drastic increase in 
expression levels by both of the UAS1B8 and UAS1B16 elements across this series 
demonstrates that these genetic elements are portable, modular components that can 
generically alleviate native enhancer-limitation without disrupting endogenous 
regulation.  The modularity of the UAS1B insert and the strength of the UAS1B-Leum 
and UAS1B-TEF series advocate the use of hybrid promoter engineering as generic 
approach towards building stronger, fine-tuned promoter libraries with interchangeable, 
modular components. 
A promoter-less plasmid was utilized as a negative control for the majority of 
these experiments.  True controls would consist of 105 basepair DNA segments that lack 
promoter function fused in tandem, to mimic each UAS1Bn-Core promoter construct.  
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Unfortunately, lack of an acceptable characterized DNA sequence and time constraints 
prevented construction of these controls. 
Figure 2.3: Expanding the hybrid promoter approach by altering core promoter element. 
 
 
(A)  The characterization of relative promoter strengths for the core TEF promoters (blue), UAS1B8-TEF promoters 
(red) and UAS1B16-TEF promoters (green) using flow cytometry.  This data was compared with the UAS1B8-Leum 
and UAS1B16-Leum promoters.  (B) The tuning ability of UAS1B8 and UAS1B16 decreases as a function of core 
promoter length.  
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2.4 SUMMARY AND CONCLUSIONS 
Collectively, these results give credence to the theory that Y. lipolytica promoters 
are enhancer-limited, and we have shown that this limitation can be effectively overcome 
through hybrid promoter engineering.  We observed that both the choice of tandem 
enhancer element and core promoter element contribute to the collective strength of 
hybrid promoters, and that tandem UAS elements help bypass the enhancer limited nature 
of promoters by serving as transcriptional amplifiers.  The generic approach of hybrid 
promoter engineering described here is an important, generic synthetic biology tool 
enabling the construction of high-level and fine-tuned promoters with interchangeable 
promoter parts.  This approach is one of the first to rationally amplify the expression 
output of a given promoter element.  By utilizing this approach, we have expanded the 
metabolic engineering toolbox in Y. lipolytica and developed several novel promoter 
series - UAS1B1-32-Leum, UAS1B8-TEF, and UAS1B16-TEF.  In doing so, we created the 
strongest characterized promoters in Y. lipolytica and the first ever reported capacity for 
tunable gene expression in this organism.   
Heterologous protein expression requires strong promoters to obtain high protein 
expression level, while metabolic pathway engineering necessitates strictly controlled, 
fine-tuned promoters set to optimize pathways.  The generic hybrid promoter approach 
described here accomplished both of these tasks.  Moreover, this work establishes 
synthetic hybrid promoter construction as an approach to expand and enhance the 
strength of engineered promoters in a manner not accessible through traditional promoter 
engineering applications.    
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Chapter 3:  De Novo Hybrid Promoter Development 
3.1 CHAPTER SUMMARY 
Hybrid promoter construction entails two main tasks, first isolating and 
characterizing core promoter and upstream activating sequence (UAS) elements, and then 
utilizing these parts to build functional, high strength promoters.  The majority of hybrid 
promoter engineering work - done with the intent to maximize and control gene 
expression - has been performed in Y. lipolytica and have all utilized the same upstream 
activating sequence, UAS1B, as the sole UAS element.  Therefore, the full flexibility of 
hybrid promoter generation has been limited by reliance on well-established upstream 
activating regions that are unlikely to be characterized in nonconventional hosts.  To 
circumvent this limitation, we describe here the methodology for the isolation, 
characterization, and incorporation of novel UAS elements into strong, tunable hybrid 
promoter libraries in Y. lipolytica.   
As a test case, the native TEF promoter in Yarrowia lipolytica was examined to 
identify putative UAS elements that serve as modular synthetic transcriptional activators.  
Resulting synthetic promoters containing a core promoter region activated by between 
one and twelve tandem repeats of the newly isolated, 230 nucleotide UASTEF#2 element 
showed promoter strengths 3 to 4.5-fold times the native TEF promoter.  Further analysis 
through transcription factor binding site abrogation revealed the GCR1p binding site to 
be necessary for complete UASTEF#2 function.  These various promoters were tested for 
function in a variety of carbon sources.  Finally, by combining disparate UAS elements 
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(in this case, UASTEF and UAS1B), we developed a high-strength promoter with for Y. 
lipolytica with an expression level of nearly seven-fold higher than that of the strong, 
constitutive TEF promoter.  Thus, the general strategy described here enables the 
efficient, de novo construction of synthetic hybrid promoters to both increase native 
expression capacity and to produce libraries for tunable gene expression.  Without the 
prerequisite of a previously characterized UAS element, the hybrid promoter engineering 
approach is even more useful for nonconventional hosts. 
 
3.2 INTRODUCTION 
Synthetic hybrid promoters consist of a core promoter region fused to a single 
upstream activating sequence (UAS) or multiple tandem UAS repeats that augment and 
modulate promoter function 
2,33,53,94,95
, and hybrid promoter engineering has been 
demonstrated to be the only effective approach to increase expression capacity in an 
organism 
109
.  All prior hybrid promoter engineering efforts designed to increase overall 
promoter strength have been performed in the oleaginous yeast Y. lipolytica and have 
utilized the same 105 basepair upstream activating sequence, named UAS1B, as the sole 
UAS element.  UAS1B was originally isolated through a functional dissection of the 
strong, tightly regulated XPR2 native promoter and showed promising constitutive 
transcriptional activation abilities 
53,96,110
.  Previously, we showed that multiple tandem 
repeats of this UAS element adjacent to a core minimal LEU2 promoter or core TEF-
based promoters resulted in significant transcriptional activation 
2,53
.   
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However, fully characterized UAS regions are not likely to be found in 
nonconventional organisms.  Thus, we sought to develop a de novo approach, 
encapsulating UAS isolation and hybrid promoter construction, to enable the application 
of the hybrid approach into any nonconventional host.  
 
3.3 RESULTS AND DISCUSSION 
3.3.1 Isolation of a Y. lipolytica TEF promoter region UAS 
Prior analysis of the 406 basepair full length TEF promoter revealed that the 136 
basepair proximal to the ATG start codon, dubbed TEF(136), was unable to drive the 
expression of an hrGFP reporter gene 
2
.  However, when this core promoter fragment was 
used in conjunction with a known UAS element, resulting TEF(136)-based hybrid 
promoters generated high fluorescence levels.  These results established TEF(136) as a 
functional, low-strength core promoter that had been apparently stripped of its native 
UAS elements 
2
.  Analysis of the TEF promoter revealed that a drastic change in GC 
content coincided with the end of all putative TATA elements at 149 basepairs upstream 
of the ATG start codon.  Consequently, we postulated that a strong upstream activating 
sequence responsible for the majority of the TEF promoter’s transcriptional activation 
ability must be located further upstream in the remaining 257 basepairs.  We tested this 
hypothesis by constructing two distinct series of hybrid promoters in which between one 
and three tandem repeats of a putative 257 basepair TEF upstream activating sequence, 
dubbed UASTEF, were fused to a core promoter.  Hybrid promoter series UASTEF(n)-TEF 
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employed the 406 basepair native TEF promoter (TEF) as a core promoter, while series 
UASTEF(n)-Leum employed a minimal core LEU2 promoter (Leum).  Flow cytometry 
analysis of the UASTEF(n)-TEF and UASTEF(n)-Leum hybrid promoters revealed strong 
expression enhancement by tandem UASTEF elements (Figure 3.1).  Therefore, we 
validated the existence of a strong UAS element upstream of the minimal core TEF(136) 
sequence, and demonstrated its capacity as a synthetic amplifier when fused to either the 
minimal leucine promoter or the full native TEF promoter.  The enhancement of 
fluorescence levels were strongly linearly correlated to the number of UASTEF copies (r
2
 
= .9899 for TEF core and r
2
 = .9983 for Leum core; r
2
 values calculated using a linear 
regression in Microsoft Excel), demonstrating the modularity and functional additivity of 
this novel UAS.  This linear relationship is in contrast to the Hill-curve dynamics seen 
with the UAS1B enhancement 
2
.  This difference suggests that UAS elements have 
distinct transfer functions of activity.  Net promoter strength strongly depended on core 
promoter choice, as hybrid promoters employing the TEF core were more than three-fold 
stronger than Leum-based counterparts.  The maximum expression amplification 
imparted to each core promoter differed as well.  In this vain, three UASTEF tandem 
repeats generated a 6.45-fold amplification of expression when fused to the Leum core 
promoter (compared to basal Leum), while only a 3.44-fold increase emerged in the 
corresponding TEF-based constructs.  These results echo our previous findings that 
amplification levels were highest with more minimal core promoter constructs.  
Moreover, both UAS enhancer element and core promoter elements contribute to overall 
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hybrid promoter strength in a logical manner, raising the possibility of rationally 
designing synthetic hybrid promoters. 
Figure 3.1: Functional testing of the novel UASTEF element 
 
Relative fluorescence values indicate that the UASTEF element functions as a strong modular upstream activating 
sequence, linearly increasing expression capacity of both the TEF native promoter (r2 = .9899) and the Leum minimal 
promoter (r2 = .9983).  Three tandem repeats of the UASTEF element elevated protein expression to more than three-
fold base levels for the TEF promoter and six-fold for the Leum promoter.  Final expression capacity of the UASTEF(3)-
TEF promoter approached UAS1B16-TEF and UAS1B16-Leum levels, two of the strongest previously characterized 
hybrid promoter in Y. lipolytica.  Error bars represent the standard deviation of measurements between biological 
triplicates 
3.3.2 Investigating the effect of incorporating disparate UAS sequences 
We next investigated the impact of combining disparate UAS elements.  The 
UASTEF element proximal to the core promoter in promoter UASTEF(3)-TEF was replaced 
by an UAS1B8 fragment 
2
 to form hybrid promoter UASTEF(2)-UAS1B8-TEF.  The mean 
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fluorescence levels generated by UASTEF(2)-UAS1B8-TEF are at least as high as the 
strongest promoters yet described in Y. lipolytica 
2
, advocating future work assessing 
potential benefits of incorporating multiple, distinct UAS elements into hybrid promoters 
(Figure 3.2).   
Figure 3.2: Combining the novel UASTEF with the UAS1B element 
 
Relative fluorescence values indicate that the UASTEF(2)-UAS1B8-TEF promoter surpasses in strength the previously 
characterized UAS1B16-TEF and UAS1B32-Leum promoters, the strongest promoters constructed in Y. lipolytica.  Error 
bars represent the standard deviation of measurements between biological triplicates.  P-value comparing UASTEF(2)-
UAS1B8-TEF to UAS1B32-Leum  = 0.17. 
 
As described above, all prior hybrid promoter attempts in Y. lipolytica have been 
limited to only one UAS element.  But by combining disparate UAS elements, we 
obtained surprisingly high levels of gene expression in a much shorter total promoter size 
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(1850bp vs. up to 3700bp).  We hypothesize that the distinct UAS elements localize 
different transcription activating factors with unexpected cooperative effects and thus 
more efficiently enhance transcription.  Prior evidence has demonstrated that the 
combination of GCR1 and RAP1 regulatory sequences constitute one of the strongest 
activating sequences known in S. cerevisiae 
111
.  The UAS1B sequence was initially 
identified through a deletion analysis of the XPR2 promoter and was shown to be 
necessary for XPR2 promoter function 
110
.  The UAS1B sequence contains a TUF/RAP1 
transcription factor binding site that by itself rescues native promoter activity when 
inserted to replace a UAS1B deletion 
110
.  Our transcription factor deletion analysis 
(described below) confirmed the importance of a consensus GCR1 binding site found in 
the UASTEF sequence towards transcriptional activation.  Hence, the unison of GCR1 and 
RAP1 transcription factor binding sites within the same promoter could drastically 
increase transcriptional capacity, and it is likely that the localization of these regulatory 
sequences serves as the mechanism behind the synergy seen when combining the 
disparate UASTEF and UAS1B8 elements to form hybrid promoters.  These types of 
synergies will form the basis of developing predictive models for designing de novo 
promoters.  
3.3.3 Functional dissection analysis of the UASTEF element through promoter 
truncation and transcription factor binding site removal 
With the 257 bp UASTEF established as a modular, synthetic transcriptional 
amplifier, we sought to dissect its genetic sequence in search of a more minimal, compact 
UAS element.  Twenty-two unique but overlapping fragments spanning the UASTEF 
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sequence were PCR amplified to create a UASTEF-based truncation library (Figure 3.3a).  
Putative UAS library elements were individually fused to the minimal TEF(136) core 
promoter to form promoters UASTEF#1-TEF(136) through UASTEF#22-TEF(136).  The 
minimal TEF(136) core promoter was selected for hybrid promoter construction to allow 
for the highest sensitivity in measuring UAS activity.  The newly constructed hybrid 
promoter series was tested with hrGFP based flow cytometry analysis.  The fluorescence 
data reveal that the majority of truncated UASTEF fragments continue to retain at least 
modest UAS activity (Figure 3.3a,b).  This result suggests that nearly all of these 
fragments can serve to create functional, synthetic hybrid promoters.  However, hybrid 
promoter strength showed a pronounced correlation to UASTEF fragment length, 
providing evidence that the majority of the original 257 bp UASTEF sequence is required 
for full activity (Figure 3.3b).  UASTEF#2 displayed the highest activating capacity of the 
UASTEF truncations tested, elevating the strength of the TEF(136) core promoter to levels 
1.5-fold times the native TEF promoter (Figure 3.3a).  Thus, we selected UASTEF#2 for 
further hybrid promoter library construction and for a more rigorous examination. 
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Figure 3.3: Dissection of the UASTEF element.   
 
(A) Twenty-two overlapping fragments spanning the UASTEF sequence were inserted upstream of a TEF(136)-hrGFP 
expression cassette and tested for transcriptional amplification activity.  Relative fluorescence values are shown.  Error 
bars represent the standard deviation of measurements between biological triplicates.   
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Figure 3.3 continued 
 
 
(B) Relative fluorescence values are plotted as a function of putative UAS length, with a noticeable correlation between 
decreasing putative UAS strength and decreasing UAS length.  (C)  A simplified schematic picture is provided 
detailing the location of specific consensus transcription factor binding sites within the UASTEF#2 element and the TEF 
native promoter.  Error bars represent the standard deviation of measurements between biological triplicates. 
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Figure 3.3 continued 
 
(D)  Three putative transcription factor binding sites (NDT80p, MCM1p, and GCR1p) were removed individually and 
combinatorially from the UASTEF#2 element within a UASTEF#2(1)-TEF(136)-hrGFP expression cassette.  Relative 
fluorescence values are shown.  Error bars represent the standard deviation of measurements between biological 
triplicates. 
 
The majority of the UASTEF#2 element is necessary for full UAS activity, 
precluding a more thorough characterization through truncation analyses.  We 
characterized UASTEF#2 through the systematic removal of three putative consensus 
transcription factor binding sites predicted within this sequence.  In our truncation 
analysis, we observed that removing twenty seven basepair at the 5’ end of UASTEF (-406 
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to -386 deletion) tended to decrease UAS strength, but further truncation had little effect.  
We also observed that the removal of twenty seven basepairs from the 3’ end of the 
original UASTEF (-149 to -176 deletion) often increased UAS strength, but further 3’ 
truncation (-176 to -196/-216/-236 deletion) always decreased UAS strength (Figure 
3.3a,c).  Thus, we concluded the existence of an upstream repressive element (URS) 
between basepairs -149 to -176 and enhancing UAS elements in the remaining truncated 
regions (-406 to -386  and -176 to -196/-216/-236 deletion).   
An analysis of the native TEF and the UASTEF#2-TEF(136) promoters at the 
sequence level in the yeast promoter database (SCPD) 
21
 revealed that consensus binding 
sites for yeast transcription factors MCM1p and PUT3p are lost in the twenty seven 
basepair truncation.  Further sequence analysis of the UASTEF#2 element also highlighted 
consensus binding sites for transcription factors NDT80p at position -386, for GCR1p at 
position -186, and for a separate MCM1p at position -257 (Figure 3.3c).  We 
hypothesized that the GCR1p and NDT80p binding sites grant UAS activity, while this 
second native MCM1p binding site reduces UAS activity.  To test this hypothesis, we 
employed site-directed mutagenesis to delete the NDT80p, GCR1p, and MCM1p binding 
sites from the UASTEF#2-TEF(136) promoter (Figure 3.3c), and tested and compared 
binding site deletion mutants with hrGFP based flow cytometry.  This deletion analysis of 
putative revealed that MCM1p binding sites have no effect on TEF promoter activity 
(Figure 3.3d), implicating the PUT3p binding site as a repressive element within the 
27bp 3’ fragment of UASTEF.  As expected, removal of the NDT80p and GCR1p bindings 
sites reduced UASTEF#2-TEF(136) promoter strength, by 15 and 31% respectively 
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(Figure 3.3d).  Combinatorial deletion of NDT80p and GCR1p binding sites only 
slightly further decreased promoter strength, revealing the GCR1p binding site as the 
predominate site responsible for UASTEF#2 function.  Thus, the GCR1p binding site 
motif is essential for UAS capability, while URS activity is most likely conferred by the 
PUT3p binding site.  By combining a truncation analysis with targeted binding site 
mutagenesis, we were able to propose transcription factors localized by the TEFUAS 
region that both activate and repress transcription and attain a greater understanding of Y. 
lipolytica native promoters.  Knowledge of these specific transcription factors allowed us 
to explain unexpected interactions resulting from combining disparate UAS elements in a 
single hybrid promoter. 
3.3.4 Constructing hybrid promoters with the novel UAS 
Above, we have demonstrated how UAS elements can be deduced and 
mechanistically studied through promoter truncation and mutagenesis analyses.  To 
complete the generic hybrid promoter construction process, we utilized one, two, three, 
four, five, six, nine or twelve tandem repeats of the newly isolated UASTEF#2 sequence to 
enhance expression of the minimal TEF(136) core promoter.  These new UASTEF#2 
based promoters were tested and compared to the native TEF promoter, amongst other 
controls, via hrGFP fluorescence by flow cytometry.  Multiple copies of UASTEF#2 
increased hybrid promoter strength for up to six tandem repeats, at which point 
expression enhancement from added UASTEF#2 elements had been saturated (Figure 
3.4a).  Ultimately, UASTEF#2-TEF(136) hybrids yielded expression levels 3.5-fold higher 
than the native, full length TEF promoter starting point (Figure 3.4a).  Expression 
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cassettes containing tandem UASTEF#2 copies without the TEF(136) promoter generated 
no expression above background levels.  To further demonstrate the utility of the 
UASTEF#2-TEF(136) series, we utilized the β-galactosidase gene as alternate reporter 
protein.  Once again, UASTEF#2-mediated enhancement increased promoter activity, 
producing a final expression enhancement to nearly twice that of the native TEF using 
this marker (Figure 3.4b).   Thus, UAS elements isolated from native promoters can be 
utilized to increase available promoter strength within an organism. 
Figure 3.4: Functional testing of the novel UASTEF#2 element to complete de novo hybrid 
promoter construction 
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Figure 3.4 continued 
 
(A) Relative fluorescence values indicate that the UASTEF#2 element functions as an upstream activating sequence, 
increasing expression capacity of the TEF(136) promoter to levels 3.5-fold higher than the native TEF promoter.  Final 
UASTEF#2-based promoter strength remained below UASTEF-based and previously characterized promoters, UAS1B32-
Leum and UAS1B16-TEF.  (B) Hybrid promoters were tested with a β-galactosidase reporter gene, yielding similar 
results to the hrGFP assay.  Error bars represent the standard deviation of measurements between biological triplicates.  
P-value comparing UASTEF#2(6)-TEF(136) to UASTEF#2(1)-TEF(136) = 0.06. 
3.3.5 Kinetic analysis of hybrid promoters and effect of media formulation 
Previous analysis of the UAS1B element (the only other known upstream 
activating sequence in Y. lipolytica) revealed expression profiles dependent on both time 
course and media formulation 
47,53
.  Thus, we sought to further characterize our novel 
UASTEF-based promoters and compare them to several previously constructed hybrid 
promoters utilizing a thorough time course kinetic analysis, and analyzing the effects of 
alternate carbon sources on promoter activity.   
We analyzed the UASTEF#2(n)-TEF(136) series, several high expression UASTEF-
truncation hybrids, the novel UASTEF(2)-UAS1B8-TEF promoter, and our previously 
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constructed strong hybrids promoters UAS1B8-TEF(406), UAS1B16-TEF(406), 
UAS1B16-Leum, and UAS1B32-Leum 
2
 via hrGFP flow cytometry after one, two, three, 
and four days of growth to discern effects of cell phase on promoter activity.  UASTEF#2-
TEF(136) promoters demonstrated fairly constitutive activity, peaking in expression 
levels after two days before decreasing (Figure 3.5a).  Interestingly, the UASTEF#2(6)-
TEF(136) and UASTEF#2(12)-TEF(136)  promoter attain nearly identical peak expression 
level, but the UASTEF#2(12)-TEF(136) promoter retains full activity much longer.  As the 
UASTEF#2(12)-TEF(136) promoter retained full activity much longer than other library 
members, increasing UASTEF#2 copy number may serve to delay the onset of reduced 
promoter activity.  Hybrid promoters based on the UASTEF truncations displayed similar 
constitutive expression profiles, with the UASTEF#2-TEF(136) promoting the highest 
expression levels (Figure 3.5b).  While stronger than the UASTEF-based hybrids, the 
UAS1B16-Leum and UAS1B32-Leum promoters were not highly activated until the third 
day of growth, confirming prior observation that the UAS1B element is most active in 
early stationary phase 
53,96
.  The addition of a TEFUAS element in the form of a TEF core 
promoter (UAS1B8-TEF and UAS1B16-TEF) shortened this lag period and facilitated 
quicker promoter activation as the UAS1B8-TEF(406) and UAS1B16-TEF(406) 
promoters displayed very high fluorescence levels and were fully expressed after only 
two days.  The UASTEF(2)-UAS1B8-TEF promoter reached maximal expression capacity 
quicker than any other tested promoter, further demonstrating the benefit of incorporating 
multiple, distinct UAS elements into the same hybrid promoter (Figure 3.5c). 
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Figure 3.5: Kinetic analysis of hybrid promoters 
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Figure 3.5 continued 
 
(A)  Relative fluorescence values indicate that tandem copies of UASTEF#2 showed progressive increased in 
transcription capacity.  (B) Various UASTEF truncation hybrid promoters (from those described in Figure 3a) displayed 
similar expression profiles, with the UASTEF#2-TEF(136) promoting the highest expression levels.  (C) UAS1B16-
Leum and UAS1B32-Leum promoters were not highly activated until the third day of growth.  UAS1B8-TEF(406) and 
UAS1B16-TEF(406) promoters displayed very high fluorescence levels and were fully expressed after only two days, 
and the UASTEF(2)-UAS1B8-TEF promoter exhibited the high expression capacity quicker than any other tested 
promoter.  Error bars represent the standard deviation of measurements between biological triplicates. 
 
To analyze the effects of media on promoter expression capacity, we tested many 
of the hybrid constructs for protein expression when grown in media utilizing glucose, 
sucrose, glycerol, or oleic acid as the sole carbon source.  UASTEF#2-TEF(136) promoters 
were minimally impacted by carbon source, with sucrose enabling the highest expression, 
and glycerol the lowest expression capacity (Figure 3.6a).  Thus, UASTEF#2-based 
hybrid promoters retained the constitutive expression properties found in the native TEF 
promoter and exhibited consistent expression levels regardless of media formulation or 
cell phase.  In contrast, promoters containing UAS1B elements were very strongly 
dependent on media composition, with highest expression on sucrose or oleic acid 
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(Figure 3.6b).  Thus, hybrid promoters constructed with the newly isolated TEF UAS 
were more constitutive than previous Y. lipolytica hybrid promoters.   
Sucrose-activated UAS1B hybrid promoters yielded surprisingly high expression 
values compared to glucose, presenting it as an alternative carbon source for protein 
expression.  However, maximum cell density was significantly decreased in sucrose-
grown cultures.  As sucrose is a disaccharide comprised of glucose and fructose, fructose-
grown cultures were also analyzed for protein expression capability, but generated less 
expression than glucose-grown cultures.  Thus, further research is necessary to determine 
the mechanism for such high heterologous protein expression in sucrose-grown cultures. 
Figure 3.6: Effect of media formulation on hybrid promoter expression 
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Figure 3.6 continued 
 
(A) Hybrid constructs were tested in medium containing glucose, sucrose, glycerol, or oleic acid as the sole carbon 
source.  UASTEF#2-TEF(136) promoters did not significantly vary with carbon source.  (B) UAS1B promoters were 
further activated when grown on sucrose or oleic acid, and had lower levels when grown on glycerol.  Error bars 
represent the standard deviation of measurements between biological triplicates. 
 
3.4 SUMMARY AND CONCLUSION 
Collectively, these results illustrate a detailed example of hybrid promoter library 
construction to increase promoter strength in an organism.  The basic architecture of 
hybrid promoters informs the need for both upstream activation sequences and core 
promoter regions.  Dissection analyses of native promoters can mediate the efficient 
isolation of novel UAS elements, and UAS elements isolated from native promoters can 
be utilized to increase available promoter strength within an organism.  Tandem UAS 
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elements help bypass the enhancer limited nature of promoters by serving as 
transcriptional amplifiers, and fusion of UAS repeats to native promoters elevates their 
basal strength, and therefore cell-wide transcriptional capacity.  We have demonstrated 
that this amplification is generic for all promoters (regardless of length) and thus not 
restricted to minimal promoters.  Nevertheless, minimal promoters can be isolated 
through a general truncation and UAS replacement analysis.  Minimal promoters increase 
the ultimate dynamic range of the hybrid promoter approach and allow for fine-tuned 
gene expression starting at a lower level.  Exploitation of both native and minimal 
promoters under the control of tandem UAS elements permits an otherwise unattainable 
range of gene expression.  Moreover, combining unrelated UAS sequences offers 
tantalizing potential for ever higher levels of gene expression and controllable regulation.  
In conclusion, the generic approach for hybrid promoter engineering advanced here is an 
important synthetic biology method enabling the construction of high-level and fine-
tuned promoters, and it represents a unique method to enable high-level overexpression 
in organisms with ill-defined promoter elements. 
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Chapter 4:  Applying the Hybrid Approach to Saccharomyces cerevisiae 
4.1 CHAPTER SUMMARY 
Hybrid promoter engineering can enable enhancement of promoter strength in Y. 
lipolytica 
1,2
.  We sought to establish this approach as a versatile metabolic engineering 
tool to increase cellular expression capacity by applying it to another host organism.  
Thus, we applied the synthetic hybrid promoter approach to the model yeast, 
Saccharomyces cerevisiae, for the creation of strong promoter libraries.  We demonstrate 
the utility of this approach with three main case studies.  First, we establish a dynamic 
range of constitutive promoters and in doing so expand transcriptional capacity of the 
strongest constitutive yeast promoter, PGPD, by 2.5-fold in terms of mRNA levels.  
Second, we demonstrate the capacity to impart synthetic regulation through adding 
galactose activation and removing glucose repression.  Third, we establish a collection of 
galactose-inducible hybrid promoters that span a nearly 50-fold dynamic range of 
galactose-induced expression levels and increase the transcriptional capacity of the Gal1 
promoter by 15% (P-value = 0.027).  These results demonstrate that promoters in S. 
cerevisiae, and potentially all eukaryotes, are enhancer limited and a synthetic hybrid 
promoter approach can expand, enhance, and control promoter activity.  These results 
firmly establish hybrid promoter engineering as a novel tool to enhance promoter strength 
in microbial hosts. 
 
 53 
4.2 INTRODUCTION 
Well-characterized promoters are essential for pathway engineering and synthetic 
biology efforts in the model eukaryotic yeast Saccharomyces cerevisiae.  Specifically, 
two main types of promoter elements are required: (1) a series of constitutive promoters 
exhibiting a dynamic range of expression capacities and (2) well-controlled inducible 
systems with defined expression outputs.  This capacity has largely been amassed 
through the isolation and characterization of numerous native promoters 
26,38,112-121
.  More 
recently, synthetic promoter libraries have been developed for fine-tuned transcriptional 
control in constitutive 
30,31
 and inducible manners 
27,32,122-124
.  However, these techniques 
are limited by their propensity to generate promoters weaker than the starting promoter 
sequence.  In all of these cases, transcriptional capacity remains ultimately bounded by 
the transcriptional potency of the strongest endogenous promoters: in yeast, the 
constitutive glyceraldehyde-3-phosphate dehydrogenase promoter (PGPD) and the 
galactose-inducible PGAL promoter 
125
.  We seek to remove these limitations in S. 
cerevisiae for both constitutive and inducible promoters by with the promoter approach 
that we have recently demonstrated in the yeast Yarrowia lipolytica 
1,2
.   
Many native promoters have been well characterized in yeast.  Constitutive 
promoters offer fairly constant gene expression levels at the single-cell level without the 
need for specific inducers or media formulations 
125
.   Several well-established and 
commonly used variants, in order of strength, include the strongest constitutive promoter 
in yeast, PGPD (also known as PTDH3) 
125
, the promoter for translation elongation factor, 
PTEF 
117
, and the fairly weak partial promoter region of iso-1-cytochrome C, PCYC 
126,127
.  
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Inducible promoters offer a complementary method for controlling gene expression 
typically through the use of small molecule inducers.  The most widely employed 
inducible promoters for pathway engineering and protein expression applications are the 
GAL promoters 
113,125,128-130
.  Galactose inducible promoters, including PGAL, collectively 
exhibit tight control with 1000-fold induction ratios between galactose-induced and 
glucose-repressed expression 
131
.  To avoid strict on/off states with this promoter, 
genomic knockouts enabled a galactose dose dependent induction response of the PGAL 
promoter 
132
.  Collectively, these core promoters are among the most commonly used in 
yeast. 
Our hybrid promoter engineering approach entails combining core promoters with 
UAS elements to enable fine-tuned control and amplification of gene expression.  Several 
upstream promoter sequences have previously been identified as transcriptional 
enhancing elements in S. cerevisiae, including a 240 basepair sequence 5’ of the mitotic 
cyclin CLB2 gene 
133, a 275 bp sequence 5’ of the mitochondrial citrate synthase CIT1 
gene 
134
, and a galactose-controlled 309 bp sequence 5’ of the GAL1 gene, 29 referred to 
henceforth as UASCLB, UASCIT, and UASGAL, respectively (Table 4.1).  These elements 
serve as the starting point for this study. 
As described above, the field is limited in techniques to both amplify promoter 
activity and modulate the degree of inducibility of promoters.  These limitations 
ultimately prevent the development of comprehensive libraries of both constitutive and 
inducible promoters.  Based on our previous efforts in Y. lipolytica 
2
, we hypothesize that 
the expression capacities of even PGPD and PGAL can be enhanced.  Hybrid promoters 
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have been previously used as a promoter dissection tool in S. cerevisiae 
33,35-40
.   Here, we 
advance the synthetic hybrid promoter approach to the yeast S. cerevisiae by creating 
several synthetic promoter libraries to increase overall cellular promoter strength. 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Creating hybrid promoters in S. cerevisiae 
As a first proof-of-concept demonstration of synthetic hybrid promoter 
engineering in S. cerevisiae, several of the identified upstream activating sequences were 
fused to a minimal core promoter echoing our previous trials in Y. lipolytica 
2
.  To do so, 
a 125 nucleotide truncation of the LEU2 promoter, called PLEUM, was selected as a 
starting point due to its low constitutive expression levels and lack of observed 
catabolite-repression 
37,38
.  While increasing tandem UAS copy number to upwards of 
twenty was successful in Y. lipolytica 
2
, the highly efficient native homologous 
recombination machinery makes similarly-sized libraries in S. cerevisiae impossible.  As 
a result, a series of PLEUM-based hybrid promoters were created by fusing between one 
and three UASCLB or UASCIT elements to the minimal core promoter (Figure 4.1 and 
Table 4.1).  To assess possible synergies resulting from combining distinct UAS 
elements, a UASCLB element was added to the UASCIT(3x)-Leum hybrid promoter, creating 
a promoter contain four  UAS elements.  Likewise, a UASCIT was added to the 
UASCLB(3x)-Leum hybrid promoter construct.  This collection of synthetic UAS-Leum 
hybrid promoters was tested for yECitrine fluorescence via flow cytometry analysis 
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(Figure 4.2a).  A linear increase in fluorescence was seen with increasing numbers of 
UAS elements.  Moreover, both promoter constructs containing four UAS elements 
linked to the PLEUM achieved promoter strengths comparable to the highest endogenous 
yeast constitutive promoter, PGPD.   
Figure 4.1: Construction of S. cerevisiae hybrid promoters 
 
A simplified schematic is provided detailing the construction of hybrid promoter-based fluorescence cassettes within 
the p416-MCS-yECitrine plasmid backbone.  A table of hybrid constructs includes a generalizable hybrid naming 
pattern (top row) along with key hybrid promoters discussed in this paper highlighted.   
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Table 4.1: List of upstream activation sequences used in S. cerevisiae. 
Upstream 
Activating Sequence 
Gene (s) 
Activated 
Inclusive Basepairs (5' 
of Start Codon) 
Length 
(Basepairs) Citation 
UASCLB CLB2 -867 to -627 240  
133
 
UASCIT CIT1 -548 to -273 275  
134
 
UASGAL 
GAL1/ 
GAL10 -457 to -148 (of GAL1) 309  
29
 
UASTEF TEF1 -401 to -198 203  This work 
The UAS elements used in this study are listed with their names, open reading frame regulated, basepair range, size, 
and reference. 
 
A second promoter library was created utilizing a minimal core promoter derived 
from the PCYC native promoter, truncated to 158 basepairs in length and dubbed PCYC158.  
This library exhibited nearly identical characteristics as the PLEUM-based hybrid library, 
with a nearly linear trend in fluorescence levels culminating in promoter strength akin to 
PGPD (Figure 4.2b).  Interestingly, the addition of a third UASCLB element to UASCLB(2x)-
PCYC158 did not enhance observed fluorescence levels.  In both the PLEUM and PCYC158 
based hybrid promoters, the UASCLB element appeared to amplify transcription slightly 
better than UASCIT (Table 4.2).  Nevertheless, these elements functioned together in 
tandem, raising the possibility that they may serve as movable, synthetic transcriptional 
enhancers independent of a core promoter choice.  As a result, it would be possible to 
isolate and incorporate novel, comparable UAS elements to enhance transcriptional 
capacity without introducing homologous DNA regions.  To this end, we isolated 203 
basepair from the 5’ section of the native PTEF from S. cerevisiae (created by excluding 
the AT rich, TATA-box containing region), and fused this element, termed UASTEF 
(Table 4.1), to the PLEUM promoter and confirmed the capacity of this element to amplify 
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expression (Figure 4.2c).  These results demonstrate that UASCLB, UASCIT, and UASTEF 
elements can act as modular, synthetic amplifiers of transcription. 
Figure 4.2: Developing UAS-Leum hybrid promoters and isolating a novel UAS element 
 
(A) Between one and three copies of UASCLB or UASCIT sequences were fused upstream of the minimal PLEUM and 
resulted in linearly increasing fluorescence values.  Further insertion of 1 UASCLB element upstream of the UASCIT(3x)-
PLEUM promoter or one UASCIT element upstream of the UASCLB(3x)-PLEUM promoter enabled expression levels on par 
with the strong endogenous PGPD promoter.  A more than 10-fold range in fluorescence levels is observed between the 
PLEUM core promoter and PLEUM-based hybrid promoters.  Error bars represent standard deviation from biological 
triplicates. 
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Figure 4.2 continued 
 
 
(B) Similar results are obtained utilizing PCYC158 as a core promoter, including the 10-fold range in fluorescence levels, 
and final promoter strength comparable to PGPD.  (C) The insertion of the novel UASTEF element upstream of the PLEUM 
core promoter resulted in more than a 3-fold increase in fluorescence levels.  The promoter-less plasmid, p416-MCS-
yECitrine was included as a negative control (Control).  Error bars represent standard deviation from biological 
triplicates. 
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4.3.2 Increasing transcriptional capacity of native promoters using a synthetic 
hybrid approach 
Next, we sought to test the hypothesis that even the strongest native promoters in 
S. cerevisiae are limited by a deficiency of UAS enhancer elements.  To do so, we fused 
three UASCLB or UASCIT tandem repeats to the PGPD, PCYC, and PTEF native promoters 
(Figure 4.1), and tested for yECitrine fluorescence (Figure 4.3a).  Hybrid promoter 
fluorescence output was roughly doubled compared to basal promoter strength for PGPD 
and PTEF and more than quadrupled for PCYC (Table 4.2).  Interestingly, UASCLB seemed 
to amplify the PGPD promoter the most whereas UASCIT elements were more effective 
with PTEF.  Both one and two tandem UASCLB elements were fused to PGPD to enable a 
linear promoter range proportional to the number of synthetic UAS elements (Figure 
4.3a).  Finally, in an attempt to further saturate the transcriptional capacity in yeast, we 
fused six UASCLB activating sequences to PGPD, despite the inherent instability of this 
repetitious sequence.  As an alternative, we also fused single copies of the UASCLB, 
UASCIT, and UASTEF elements in tandem to the PLEUM and PGPD core promoters (Figure 
4.1).  This entire UASCLB-UASCIT-UASTEF fragment was also duplicated to construct 
hybrid promoters comprised of two sets of UASCLB-UASCIT-UASTEF enhancer elements 
activating the PLEUM and PGPD cores.  Flow cytometry characterization of promoter 
strength (Figure 4.3b) depicted an evident trend towards saturation of PGPD through 
UAS-based hybrid promoters.  Moreover, the UASCLB-UASCIT-UASTEF-PGPD hybrid 
promoter, containing no regions of homology, exhibited fluorescence levels on par with 
the strongest promoters constructed here.   
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Figure 4.3: Expanding the transcriptional capacity of S. cerevisiae 
 
(A) Insertion of three tandem repeats of either UASCLB or UASCIT upstream of endogenous promoters PCYC, PTEF, or 
PGPD greatly increases expression capability.  Higher and tunable expression is enabled by fusing one to three UASCLB 
elements to the PGPD.  (A) PGPD capacity is enhanced and eventually saturated by three or more UASCLB elements, or by 
a UASTEF-UASCIT-UASCLB combination.  PGPD-based hybrid promoters represent the strongest characterized promoters 
in yeast, a 1.4-fold improvement.  As a note, an irreversible instrument recalibration at the core facility results in the 
higher than previously observed fluorescence levels.  Error bars represent standard deviation from biological triplicates. 
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Figure 4.3 continued 
 
 
 
(C) Transcriptional profiling of select promoter constructs was used to calculate mRNA levels relative to the p416-
MCS-yECitrine plasmid.  Expression profiles matched well with fluorescence data and the UASCLB(3x)-PGPD and 
UASTEF-UASCIT-UASCLB-PGPD promoters exhibited a 2.5-fold increase in mRNA levels compared to the endogenous 
PGPD promoter, and outperformed an induced GAL1 promoter.  (D) Fluorescence levels correlate linearly with relative 
mRNA transcript levels with an R² = 0.7955.  Error bars represent standard deviation from technical triplicates. 
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Figure 4.3 continued 
 
 
(E) Endogenous and hybrid promoters were tested with a β-galactosidase reporter gene. (F) Endogenous and hybrid 
promoters were tested with the yECitrine reporter gene in an industrial Sake yeast to validate that enhancer elements 
function in different genetic backgrounds.  Results agree well with prior tests with the exception of the UASCLB(3x)-PTEF 
promoter performing as the strongest hybrid promoter.  The promoter-less plasmid, p416-MCS-yECitrine was included 
as a negative control (Control).  Error bars represent standard deviation from biological triplicates. 
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Table 4.2: Fold fluorescence increase upon addition of an enhancer element 
  Enhancer Elements         
Core 
Promoter UASCLB UASCLB(2x) UASCLB(3x) UASCIT UASCIT(2x) UASCIT(3x) 
PLEUM 4.38 7.43 10.02 2.27 5.25 7.66 
PCYC158 4.07 8.09 8.45 2.57 4.01 6.92 
PCYC     4.15     4.79 
PTEF     1.63     2.09 
PGPD 1.30 1.49 1.80     1.48 
Fold fluorescence improvement between basal core strength and enhancer-activated hybrid promoter strength is given 
for various constitutive hybrid promoters created in this study. Ratios correlate to fluorescence levels seen in Figures 
4.2a,b and 4.3a.  Gray boxes signify potential hybrid promoters not constructed in this work. 
 
A transcriptional analysis was performed to confirm that the impact of the tandem 
UAS elements was indeed manifested at the transcriptional level.  To do so, qRT-PCR 
analysis was employed using the yECitrine mRNA of select promoter constructs (PLEUM, 
UASCLB(3x)-PLEUM, PTEF, UASCLB(3x)-PTEF, PGPD, UASCLB(3x)-PGPD, UASCIT(3x)-PGPD, 
UASTEF-UASCIT-UASCLB-PGPD) (Figure 4.3c).  Expression values were normalized to the 
mRNA level seen from a plasmid containing the yECitrine gene and no promoter (labeled 
control).  Indeed, mean fluorescence levels were strongly correlated with relative mRNA 
levels (Figure 4.3d), and a 10 fold dynamic range of transcript level between the minimal 
promoter and strongest promoters was observed in this set.  Moreover, UAS 
augmentation of PGDP increased its transcriptional capacity 2.5 fold, and PGDP-based 
hybrid promoters generated more mRNA transcripts than a fully induced GAL1 
promoter.  
Select promoter constructs, including the endogenous PLEUM and PTEF and their 
corresponding hybrid constructs (activated by three tandem UASCLB elements) were used 
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to construct expression cassettes with lacZ gene in place of yECitrine.  The strong PGPD 
promoter was similarly tested for basal strength and when activated by one, two, or three 
UASCLB elements, or the UASCLB-UASCIT-UASTEF fragment.  β-galactosidase assays 
were performed as described previously 
2,106
 with a maximum value of 1368 miller units 
generated by the UASCLB-UASCIT-UASTEF enhanced PGPD hybrid construct (Figure 4.3e).  
LacZ expression appeared saturated for promoters stronger that PGPD unlike in the 
yECitrine assay.  However, UASCLB markedly increased β-galactosidase activity for the 
PLEUM and PTEF core promoters, demonstrating UAS-mediated expression enhancement to 
be a generic tool for increasing gene expression in S. cerevisiae.   
Finally, to evaluate the generalized utility of these synthetic hybrid promoters, 
seventeen expression cassettes were transformed into the industrial Kyokai 7 diploid 
Sake yeast and tested for fluorescence via flow cytometry (Figure 4.3f).  In each of these 
cases, increasing the number of tandem UAS elements can improve transcriptional 
activity.  Interestingly, the PTEF native promoter generated higher fluorescence values 
than PGPD in this genetic background.  However, PTEF hybrid promoters still exhibited a 
large increase in strength compared to the basal promoter, validating the hybrid promoter 
approach as an effective tool across genetic backgrounds. 
Collectively, these data establish that even the strongest constitutive promoters in 
S. cerevisiae are enhancer limited and that yeast transcriptional capacity can be increased 
through additional UAS elements.  The magnitude of transcriptional enhancement 
depends on both UAS element and core promoter, as seen previously in Y. lipolytica 
2
.  
Regardless, all core promoters tested could be amplified through hybrid promoter 
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engineering.  A hybrid approach amplified the strength of the strongest characterized 
constitutive promoter, PGPD, by nearly 2.5 fold on the basis of transcript level (Figure 
4.3c).  These levels are higher than that achieved for the induced PGAL promoter.  
Moreover, this enhanced PGPD hybrid construct was created using three distinct UAS 
elements which preclude the potential for homologous recombination-mediated promoter 
degradation.  We postulate that these tandem UAS elements alleviate enhancer limitation 
through the localization of transcription factors, removing a major rate limiting step for 
transcription initiation.  In this context, it is unsurprising that UAS-mediated 
enhancement differed between individual core promoters, as synergy (or lack thereof) 
between specific UAS-core hybrids could promote transcription with higher (or lower) 
efficacy.  In each of these cases, total transcription factor availability is not seemingly a 
limiting factor as cells containing the strongest hybrid promoters exhibited no growth 
defects, making it unlikely that these novel, synthetic promoters will deplete or starve 
cells of transcription factors.   
4.3.3 UAS-mediated derepression of the GAL1 promoter and UAS-mediated 
regulation of constitutive promoters 
After demonstrating the utility of the synthetic hybrid promoter approach for 
controlling constitutive gene expression, we sought to apply our approach to control 
promoter regulation.  By fusing UASCLB or UASCIT elements to the PGAL promoter, we 
removed the strict on/off phenotype observed in native galactose controlled promoters.  
Subsequent tandem copies of UASCLB elements stimulated a linear trend derepressing the 
PGAL promoter under glucose-repressive conditions (Figure 4.4a,b).  In this manner, the 
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tandem UAS sites served to localize expression enhancing transcription factors upstream 
of the glucose-repressed GAL1 promoter and effectively created leaky hybrid promoters 
that allow low expressions levels even when grown on glucose.  Alternatively, fusion of 
the GAL1-derived UASGAL element to PGAL further repressed gene expression levels by 
7% in glucose conditions.  Moreover, this promoter exhibited a nearly 15% increase in 
transcript level compared to the basal PGAL promoter, validating the capacity of UAS 
elements to synthetically amplify transcriptional capacity (Figure 4.4c).   
Figure 4.4: Engineering promoter regulation in S. cerevisiae 
 
(A)  Characterization of promoter PGAL-based hybrid promoter strength shown for both galactose-induced and glucose-
repressed conditions.   Error bars represent standard deviation from biological triplicates.  P-value comparing UASGAL-
PGAL to PGAL = 0.054. 
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Figure 4.4 continued 
 
 
 
(B) Characterization of promoter PGAL-based hybrid promoter strength shown only for glucose-repressed conditions.  
Fusing enhancing UAS elements to the PGAL promoter causes leaky expression on glucose, while fusing the UASGAL 
element to PGAL further represses expression. (C) Transcriptional profiling of select promoter constructs was used to 
calculate mRNA levels relative to the p416-MCS-yECitrine plasmid.  Expression profiles matched well with 
fluorescence data.  The UASGAL-PGAL and UASCLB(3x)-PGAL hybrid  promoters were more highly expressed that the 
basal PGAL.  Error bars represent standard deviation from biological triplicates in (B) and technical replicates in (C).  P-
value comparing UASGAL-PGAL to PGAL = 0.027.  
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Figure 4.4 continued 
 
(D) Galactose-induced and glucose-repressed fluorescence levels are shown for various constitutive hybrid promoters, 
with high expression similarity across carbon sources.  UASGAL fusions to the endogenous promoters PCYC and PLEUM 
created hybrids strongly induced galactose and fully repressed by glucose.   UASGAL fusions to the endogenous 
promoters PTEF and PGPD created hybrids strongly induced galactose and unrepressed by glucose.  The promoter-less 
plasmid, p416-MCS-yECitrine was included as a negative control (Control).  Error bars represent standard deviation 
from biological triplicates. 
 
We next sought to evaluate whether inclusion of a galactose-inducible UAS 
element can impart synthetic regulation to standard, constitutive core promoters.  To do 
so, the UASGAL element was fused 5’ of various constitutive promoters including PTEF, 
PGPD, PCYC, and PLEUM and resulting fluorescence was tested under both glucose-
repressive and galactose-activating conditions (Figure 4.4d).  Additionally, several 
constitutive hybrid promoters were also tested in the same flow cytometry run to enable 
comparisons in these two conditions (Figure 4.4d).  As expected, these constitutive 
hybrid promoters performed similarly across the two carbon sources.  In contrast, the 
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UASGAL was able to impart galactose-induced activation to core promoters.  Interestingly, 
the UASGAL-PLEUM hybrid promoter appears quite similar to the native PGAL, potentially 
owing to relative activation of PLEUM by galactose.  By fusing the UASGAL element to 
PTEF and PGPD core regions, we created hybrid promoters that were quite active when 
grown on glucose and further induced by galactose.  We hypothesize that transcriptional 
repressors normally recruited by the UASGAL element were incapable of stymieing 
constitutive expression, potentially due to in vivo occupation of nearby binding regions 
by other transcription factors.  This effect has been observed in the context of the 
UASCLB element, in which binding by the essential transcription factor Reb1p prohibited 
Gal4p binding and subsequent transcriptional activation 
133
.  The result is a galactose-
inducible promoter without pure on/off functionality.   
In general, a synthetic hybrid promoter approach can be used to impart novel 
promoter traits of regulation.  The UASGAL synthetic element could efficiently introduce 
novel regulation to constitutive promoters, while glucose-repressed expression from the 
native GAL1 promoter could be enhanced or reduced by incorporating synthetic UAS 
elements.  Thus, hybrid promoter regulation and potency can be controlled through the 
choice of enhancer element or core promoter.   
4.3.4 Construction of a tunable galactose-inducible promoter library 
As a final demonstration of hybrid promoter engineering in S. cerevisiae, we 
sought to create a continuum of galactose-induced expression to change the magnitude of 
the ―on‖ state for this promoter.  Modifications described above instilled galactose 
control, but gene expression was still limited to discreet points of either very high or very 
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low expression.  Of the galactose-controlled hybrid promoters described above, only the 
UASGAL-PCYC fusion exhibited reduced galactose induction.  Thus, we sought to control 
this induction level by constructing two partial dissections of the 5’ region of the PCYC 
promoter (named CU1 and CU2) to reduce UASGAL activation of a PLEUM core promoter 
(Figure 4.5a).  These upstream regions of the CYC1 promoter tempered galactose-
induced expression, beginning to fill in gaps in the expression continuum (Figure 4.5b).   
The remainder of the continuum seen in Figure 4.5b was enabled through the 
construction of PLEUM-based hybrid promoters fused to portions of Gal4p binding sites.  
Previously, a 54 nucleotide fragment was confirmed as adequate and essential to impart 
the galactose-induced phenotype associated with the GAL1 promoter 
29
.  Here, we 
dissected this region by examining four putative Gal4p binding site DNA motifs (hereby 
named G4BS1-4) identified through a transcription factor motif search using the 
Promoter Database of Saccharomyces cerevisiae 
21
.  Putative Gal4p binding sites were 
fused individually or in combination to the PLEUM core promoter (Figure 4.5a), 
generating a library of synthetic hybrid promoters differing in expression when activated 
by galactose (Figure 4.5b).  The capacity of these Gal4p binding sites to mediate 
effective galactose induction was as follows: G4BS2 < G4BS1 < G4BS3 = G4BS4.  
Employing single or multiple Gal4p binding sites as hybrid enhancer elements enabled 
differential levels of expression, and produced a library of promoters that fully sampled 
the range of galactose induction.  Only the inclusion of all Gal4p binding sites permitted 
full galactose induction, implying that these sites are bound in vivo by separate tandem 
Gal4 proteins.  Collectively, this collection of hybrid galactose inducible promoters spans 
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a relative yECitrine expression range of nearly 50-fold without the need for any genetic 
changes to the strain.  This complete coverage of intermediate expression levels by our 
hybrid promoter library fully enables fine-tuned inducible expression, and will facilitate 
pathway engineering and applications in yeast.  
Figure 4.5: Engineering precise control of galactose-induced expression 
 
  
 73 
Figure 4.5 continued 
 
(A) A simplified schematic picture is provided, demonstrating the construction of hybrid promoters utilizing the CU1 
or CU2 regions to inhibit UASGAL activation of a PLEUM core promoter (Top).  The figure also details the dissection of a 
key 54bp sequence that confers galactose induction (Middle) and shows the construction of Gal4p binding site 
controlled hybrid promoters (Bottom).  (B) The characterization of a library of hybrid promoters that enable a 50-fold 
range of controlled galactose-induced expression is shown.  This novel library includes Gal4pBS-PLEUM hybrid 
promoters, endogenous promoters controlled by the UASGAL element, and hybrid promoters containing DNA inserted 
between a UASGAL element and a PLEUM core to decrease galactose induction.  Fluorescence levels observed from 
cultures grown on galactose are shown in red, and glucose in blue.  The promoter-less plasmid, p416-MCS-yECitrine 
was included as a negative control (Control).  Error bars represent standard deviation from biological triplicates.   
 
 
4.4 SUMMARY AND CONCLUSIONS 
Here, we have advanced a generic synthetic hybrid promoter engineering 
approach into S. cerevisiae, and in the process demonstrated that native yeast promoters 
are enhancer limited.  Obtaining high heterologous protein expression levels necessitates 
strong promoters, while pathway engineering applications demand precise control of 
gene expression levels to optimize pathway throughput.  By augmenting native promoters 
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with modular transcriptional amplifiers, we have produced the strongest promoters yet 
characterized in yeast and have also created a range of expression capacities.  We further 
enabled fine-tuned galactose-induced expression by fusing Gal4p binding sites to a 
minimal core promoter.  Given the results of this chapter and the prior two chapters 
constructing and studying Y. lipolytica hybrid promoters 
1,2
, it is conceivable that 
transcriptional capacity is enhancer limited in all eukaryotes, and the hybrid promoter 
approach could facilitate removal of this limitation.  In particular, the hybrid promoter 
approach is an ideal methodology to enable strong expression in organisms lacking well 
characterized, high strength promoters.   
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Chapter 5:  Heterologous Production of Pentane in Yarrowia lipolytica  
5.1 CHAPTER SUMMARY 
The complete biosynthetic replacement of petroleum transportation fuels requires 
metabolic pathways capable of producing alkanes.  Microbial production of long-chain 
alkanes has recently been described, but current biofuel technology lacks a 
complementary pathway to produce short-chain n-alkanes 
77
.  Yarrowia lipolytica is an 
ideal organism for oleo-chemical production due to its capacity to accumulate 
hydrophobic carbon content.  Having developed high strength-promoters designed to 
control metabolic flux in Y. lipolytica, we attempted to redirect lipid synthesis flux 
towards short-chain alkane production.  Here, we report and characterize a proof-of-
concept pathway that enables production of the C5 n-alkane, pentane, in Y. lipolytica. 
This pathway utilizes a soybean lipoxygenase enzyme to cleave linoleic acid to pentane 
and a tridecadienoic acid byproduct.  Initial expression of the soybean lipoxygenase 
enzyme within a Yarrowia lipolytica host yielded 1.56 mg/L pentane.   Efforts to improve 
pentane yield by increasing substrate availability and strongly overexpressing the 
lipoxygenase enzyme successfully increased pentane production three-fold to 4.98 mg/L.  
This represents the first-ever microbial production of pentane and demonstrates that short 
chain n-alkane synthesis is conceivable in microbial hosts.  In this regard, we 
demonstrate the potential pliability of Y. lipolytica towards the biosynthetic production of 
value-added molecules from its generous fatty acid reserves.   
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5.2 INTRODUCTION 
The complete replacement of petroleum-derived liquid transportation fuels can be 
achieved in one of two means: by using an alternative, drop-in fuel molecule (such as an 
alcohol) or by recreating the major constituents of gasoline in a renewable manner.  
Gasoline and jet fuel are complex, variable mixtures of hydrocarbons and other additives 
that contain large quantities of short and long-chain n-alkanes 
135-140
.  To this end, 
biosynthetic hydrocarbon production in engineered cellular hosts has received great 
attention recently.  In Escherichia coli and Saccharomyces cerevisiae, heterologous 
pathway expression has enabled the production of isoprenoids 
141-144
, but their abundance 
of carbon-carbon double bonds results in only the alkene fraction of fuels.  Biosynthetic 
production of long chain n-alkanes has been achieved through the reduction and 
decarbonylation of fatty acids to their aliphatic backbones 
77,80,145,146
.  In particular, this 
pathway enabled synthesis of tridecane, pentadecene, pentadecane, and heptadecane in E. 
coli 
77
.  Despite these advances, current biofuel technology is limited by a lack of 
pathways to produce short-chain n-alkanes.  Here, we present a proof-of-concept pathway 
demonstrating that it is possible to produce such short alkanes via a lipoxygenase-
mediated reaction in Yarrowia lipolytica.  Specifically, we demonstrate the first microbial 
production of pentane by importing a lipoxygenase-based pathway found in soybeans. 
Lipoxygenase enzymes convert polyunsaturated fatty acids into an unsaturated 
fatty acid hydroperoxide by adding a molecular oxygen to a (Z,Z)-1,4-pentadiene 
structural unit located within the fatty acid 
147,148
.  Pentane production by means of this 
pathway has been previously demonstrated in both soybeans and peanuts 
79,82
.  In 
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particular, soybean (Glycine max) lipoxygenases I and II and peanut (Arachis hypogaea) 
lipoxygenase convert linoleic acid (C18:2) into a 13-hydroperoxy linoleic acid 
intermediate (13-HPOD).  Further catalysis via a homolytic-β-scission reaction and 
hydride abstraction converts 13-HPOD into pentane and 13-oxo-cis-9-trans-11-
tridecadienoic acid, or into n-hexanal and 12-oxo-cis-9-dodecenoic acid 
82,149-151
.  Since 
no lipoxygenase pathway for short-chain alkane synthesis has been synthetically 
imported into a microbial system, there is discrepancy as to the enzymes required for this 
pathway.  In particular, while it is clear that lipoxygenase enzymes mediate at least the 
first step to pentane (Figure 5.1), hydroperoxide lyase enzymes have been implicated in 
n-hexanal formation from 13-HPOD degradation 
149,152-154
.  Thus, it is unclear if the 
conversion of 13-HPOD to pentane product occurs spontaneously, is mediated by the 
lipoxygenase, or requires a hydroperoxide lyase enzyme.  In vitro analysis has 
demonstrated that soybean lipoxygenase I 
155
, henceforth referred to as Gmlox1, is highly 
active under a broad range of conditions, can produce pentane from linoleic acid 
substrate, and does not produce n-hexanal - making it promising for short-chain alkane 
production 
150,156
.   
Biosynthetic pentane production requires a host system capable of producing 
linoleic acid substrate.  Thus, the oleaginous yeast Yarrowia lipolytica was chosen for 
this study based on reports that linoleic acid can account for up to 47% of total lipid 
extract 
63.  Gene deletion analyses of β-oxidation enzymes and other key fatty acid 
enzymes in Y. lipolytica have established mechanisms to further increase lipid 
accumulation 
63,88,157-159
.  Y. lipolytica possesses a developed genetic toolbox 
8,69,72,75
, and 
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our work generating hybrid promoters has significantly increased Y. lipolytica’s 
transcriptional capacity.  These promoters enable high-level genetic overexpressions 
necessary for heterologous enzymes such as the lipoxygenase utilized here 
1,2,160
. 
Figure 5.1: Lipoxygenase-mediated conversion of linoleic acid to pentane 
 
 
Soybean lipoxygenase I, Gmlox1, catalyzes the addition of molecular oxygen to the cis double bond within linoleic 
acid to form 13-hydroperoxylinoleic acid.  Scission of this intermediate to pentane and a byproduct can proceed either 
spontaneously or through further Gmlox1 catalysis, and evidence suggests that a hydroperoxide lyase enzyme may 
assist this reaction. 
 
 
5.3 RESULTS AND DISCUSSION 
5.3.1 Enabling the novel heterologous production of a short-chain alkane 
To enable synthesis of the short-chain alkane pentane in Y. lipolytica, Glycine 
max lipoxygenase isozyme 1, Gmlox1, was codon optimized and inserted into plasmid-
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borne expression cassettes driven by the well-characterized TEF, EXP, and UAS1B16-
Leum promoters 
2
.  We had previously found that the strength of these promoters varied 
such that TEF < EXP << UAS1B16-Leum.  Y. lipolytica strains harboring episomal 
Gmlox1 expression cassettes were cultured in standard minimal media for eight days and 
assayed for pentane production by sampling the headspace and injecting into GC.  In 
each of these cases, heterologous overexpression of the Gmlox1 enzyme enabled the 
novel microbial production of a short-chain alkane, pentane, as determined by GC 
(Figure 5.2a).  The highest level expression of Gmlox1, by the UAS1B16-Leum 
promoter, resulted in 3.28mg/L pentane.  Yet expression of Gmlox1 by the far weaker 
TEF promoter (by nearly seven fold) yielded a value of nearly half, 1.56mg/L (Figure 
5.2b).  Based on this experiment, it was evident that transcription of Gmlox1 was not the 
only rate limiting step for pentane production in an unoptimized, episomal expression 
system.  Therefore, we determined that the UAS1B16-Leum promoter sufficiently 
overexpressed the heterologous Gmlox1 enzyme, translational issues being outside the 
scope of this study. More importantly, these results demonstrated that the lipoxygenase 
enzyme alone was necessary and sufficient to produce pentane.   
Our initial experimentation utilized an eight-day culturing period to permit Y. 
lipolytica ample time to accumulate lipid content and linoleic acid substrate for the 
lipoxygenase enzyme.  To confirm this eight-day culturing period maximized pentane 
output, we performed a time course of pentane production with a Y. lipolytica strain 
harboring the UAS1B16-Leum-Gmlox1 expression cassette.  Pentane production was 
analyzed after two, four, six, eight, and ten days of growth, with a maximum yield of 
 80 
3.28mg/L after eight days, confirming that the eight-day growth period maximizes 
pentane production (Figure 5.3). 
Figure 5.2: Enabling short chain n-alkane production in Y. lipolytica 
 
 
(A) Top left - A chromatogram illustrating the peak at 3.34 minutes representing pentane. Bottom left – Negative 
Control - A chromatogram illustrating the lack of the peak at 3.34 minutes in a strain not expressing the Gmlox1 gene.  
Right – Positive Control - A chromatogram illustrating the peak at 3.34 minutes in a culture supplemented with 100 
mg/L pentane. (b) A codon optimized soybean lipoxygenase gene (Gmlox1) was expressed in Y. lipolytica by three 
different promoters, the endogenous TEF and EXP promoters, and the high strength UAS1B16-Leum synthetic hybrid 
promoter.  This Gmlox1 expression enabled the first reported microbial production of a short chain n-alkane.  
Expression of Gmlox1 by the UAS1B16-Leum promoter produced 3.28mg/L pentane.  Error bars represent standard 
deviation from biological triplicates. 
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Figure 5.3: Time-course of pentane production 
 
To determine the cultivation time required to maximize pentane yield, pentane production was analyzed from strains 
harboring an episomal UAS1B16-Leum-Gmlox1 expression cassette after two, four, six, eight, and ten days of growth.    
An eight day growth period yielded the highest titer of 3.28mg/L pentane, with an insignificant reduction after ten days. 
Error bars represent standard deviation from biological triplicates. 
5.3.2 Increasing linoleic acid substrate availability by supporting lipid accumulation 
To increase linoleic acid content in our host cells, we utilized two distinct 
attempts to increase overall fatty acid and lipid accumulation.  First, we altered the 
carbon and nitrogen supply in our media to shunt carbon flux directly into lipid and fatty 
acid synthesis.  Secondly, we reduced intracellular fatty acid and lipid catabolism with 
two genetic knockouts. 
5.3.2.1 Optimizing media formulation 
The impetus for lipid accumulation in Y. lipolytica is nitrogen starvation that 
triggers the shuttling of carbon directly into fatty acid synthesis 
161,162
.  Depending on the 
ratio of carbon flux versus nitrogen flux into the cell, Y. lipolytica can alter its metabolic 
state to degrade or accumulate intracellular lipid content 
62,89
.  Increasing carbon to 
 82 
nitrogen ratio in the growth media shifts carbon metabolism towards lipid accumulation 
until a threshold is reached, after which citric acid is accumulated 
9,59,163
.  Optimization of 
media for fatty acid accumulation is dependent on culturing condition (batch, fed-batch, 
continuous) and strain genotype.  Here we chose to select two conditions for comparison.  
First, we used the standard, minimal media formulation containing 20 g glucose and ~5 g 
ammonium sulfate per liter.  Second, we selected a 160g glucose and 0.2g ammonium 
sulfate per liter formulation, dubbed High C:N media, to induce lipid accumulation.   
Cultivation in High C:N media increased lipid % dry cell weight (DCW) by 67% for Y. 
lipolytica PO1f, from 9.5% lipid DCW to 15.9% lipid DCW (Figure 5.4a). This increase 
in lipid accumulation was not accompanied by an increase in organic production, as the 
concentration of citric acid in the supernatant decreased from 109.1 mg/L in minimal 
media to 82.3 mg/L in High C:N media.  Media formulation altered the overall fatty acid 
profile for PO1f slightly, and relative linoleic acid substrate accumulation decreased from 
1.39% to 1.12% (Table 5.1).  However, total linoleic acid content per cell increased 
when utilizing High C:N media as a result of higher overall lipid weight per cell.   
Table 5.1: Fatty acid profile analysis 
  Fatty acid accumulation (%) 
Strain (Media) C16:0 C16:1 C18:0 C18:1 C18:2 
PO1f (minimal) 18.54% 7.66% 18.90% 35.00% 1.39% 
PO1f (High C:N) 18.14% 5.07% 24.14% 41.51% 1.12% 
PO1f-Δmfe1 (High C:N) 11.48% 4.02% 21.31% 45.87% 2.11% 
PO1f-Δpex10 (High C:N) 15.14% 3.94% 21.06% 39.47% 0.59% 
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The Y. lipolytica strains harboring the three episomal Gmlox1 expression 
cassettes, driven by the EXP1, TEF1 and UAS1B16-Leum promoters, were cultured in 
High C:N media for eight days and analyzed for pentane production (Figure 5.4b).  A 
large increase in pentane production was observed for each construct by switching from 
standard media to High C:N media, culminating in a 4.19mg/L pentane yield by the 
highest strength UAS1B16-Leum-Gmlox1 cassette (Figure 5.4b).  Therefore, increasing 
lipid levels (and thus concomitant increases in fatty acid substrate availability) by altering 
growth media formulation was an effective measure to increase alkane product 
formulation.  The increase in n-pentane yield attributable to the 67% increase in overall 
lipid content more than compensated for the slight reduction in linoleic acid 
accumulation.  Thus, we concluded that free linoleic acid substrate availability was a 
major factor limiting alkane production in our system, and could be effectively overcome 
by encouraging general fatty acid and lipid accumulation.   
Figure 5.4: Increasing pentane production by increasing lipid levels   
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Figure 5.4 continued 
 
 
(A) The percentage of lipid and fatty acid dry cell weight (Lipid %DCW) is shown for Y. lipolytica strain PO1f 
cultivated in standard synthetic minimal media or in High C:N media and for strains PO1f-Δmfe1 and PO1f-Δpex10 
cultivated in High C:N media.  Cultivation conditions were identical to those employed for pentane production, and all 
strains harbored plasmid pMCSCen1.  Growth on High C:N media boosts lipid %DCW by 67% in strain PO1f, from 
9.5% to 15.9%.  Deletion of key fatty acid degradation enzymes further increases Lipid %DCW to 20.0% and 18.4% 
for mfe1 and pex10 gene deletions, respectively.  (B) Y. lipolytica PO1f strains harboring TEF, EXP, and UAS1B16-
Leum driven Gmlox1 expression cassettes were cultivated for eight days in standard minimal media or in High C:N 
media.  Cultivation in High C:N media resulted in increased pentane production for all strains, due to a concurrent 
increase in linoleic acid substrate accumulation.  Cultivation of a Y. lipolytica strain harboring the UAS1B16-Leum-
Gmlox1 expression cassette in High C:N media produced 4.19 mg/L pentane.  (C) Y. lipolytica PO1f Δmfe1 and 
Δpex10 strains harboring UAS1B16-Leum driven Gmlox1 expression cassettes were cultivated for eight days in High 
C:N media.  The pex10 gene deletion abolished pentane production.  Deletion of the mfe1 gene increased yields by 
19% to 4.98mg/L pentane, due to a decrease in linoleic acid substrate degradation.   Error bars represent standard 
deviation from biological triplicates. 
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5.3.2.2 Removing β-oxidation 
By altering media composition to shift Y. lipolytica’s metabolism towards fatty 
acid and lipid accumulation, we demonstrated a positive correlation between substrate 
availability and short-chain n-alkane production.  Removal of fatty acid β-oxidation 
capacity in Y. lipolytica represents a well-established alternative method to increase fatty 
acid (including linoleic acid) and lipid accumulation.  The bulk of fatty acid degradation 
occurs inside peroxisomes, specialized organelles prevalent in Y. lipolytica 
164
.  Deletion 
of the six acyl-CoA oxidase enzymes (POX1-6) that catalyze the first step of fatty acid β-
oxidation or of the multifunctional enzyme (MFE1) that catalyzes both the second and 
third step of fatty acid degradation have been shown to increase lipid accumulation in Y. 
lipolytica 
63,158
.  Therefore, we sought to evaluate the impact of two gene deletions on 
pentane production in Y. lipolytica.  We created single knockouts strains of the MFE1 β-
oxidation gene and of the PEX10 gene, a transcription factor necessary for correct 
peroxisomal biogenesis and morphology 
90,91
.  We assayed mfe1 and pex10 gene deletion 
strains for lipid accumulation (Figure 5.4a) and fatty acid content (Table 5.1) when 
cultivated in High C:N media.  The mfe1 gene deletion increased fatty acid and lipid 
accumulation by 25% from 15.9% to 20.0% lipid DCW (Figure 5.4a), while 
simultaneously nearly doubling linoleic acid accumulation from 1.12% to 2.11 % (Table 
5.1).  The pex10 gene deletion also increased lipid accumulation to 18.4% lipid DCW 
(Figure 5.4a), but significantly reduce production of linoleic acid to only 0.59% of total 
fatty acid content (Table 5.1). Once again, organic acid production remained fairly 
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constant, producing 123.4 and 107.6 mg/L citric acid in the mfe1 and pex10 deletion 
strains, respectively.   
We transformed the high strength UAS1B16-Leum-Gmlox1 episomal expression 
cassette into each knockout mutant, and then cultivated these strains in High C:N media.  
The mfe1 gene deletion increased pentane production by 19% to 4.98mg/L, while the 
pex10 gene deletion surprisingly completely abolished pentane production (Figure 5.4c).  
It has been demonstrated that Pex10p controls the composition of intracellular fatty acid 
content, and the pex10 gene deletion has been associated with decreased linoleic acid 
content 
90
.  In this regard, we show that the pex10 deletion specifically reduced linoleic 
acid concentration, despite an overall lipid content improvement.  This once again points 
toward linoleic acid availability as the major rate limiting step in this process.   
Deletion of MFE1 improved pentane production to our highest yield of 4.98mg/L, 
and represented the cumulative effect of three combinatorial strategies to increase alkane 
yield, including optimizing media formulation and removing fatty acid degradation to 
increase substrate availability, and strongly overexpressing the heterologous Gmlox1 
enzyme.   
5.3.3 Investigating the necessity of a hydroperoxide lyase enzyme 
Finally, we sought to evaluate the necessity of a hydroperoxide lyase enzyme in 
the synthetic pentane production pathway.  The lipoxygenase-mediated cleavage of 
linoleic acid to pentane and the 13-oxo-cis-9-trans-11-tridecadienoic acid byproduct 
follows a two-step catalytic pathway (Figure 5.1).  Numerous hydroperoxide enzymes 
have been characterized to cleave long-chain fatty acid hydroperoxides into shorter-chain 
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products (predominantly n-aldehydes) 
152-154
.  Hydroperoxide lyase activity has been 
implicated for n-hexanal production in soybeans, the source of the Gmlox1 lipoxygenase 
enzyme 
165-167
, yet the responsible gene for this is unknown.  Through bioinformatics 
analysis, we found that soybeans contain a protein homolog known as CYP74B15 with 
63% identity to an n-hexanal forming hydroperoxide lyase from green bell pepper 
154,168
.  
We hypothesized that this hydroperoxide lyase homolog could improve pentane 
production when expressed in tandem with the lipoxygenase enzyme if this second step 
of the mechanism was indeed catalyzed by a separate enzyme. 
The soybean hydroperoxide lyase homolog, dubbed Gmhpl1, was codon 
optimized and inserted into a high-strength integrative expression cassette.  As described 
above, consecutive integrations of this cassette and a high strength Gmlox1 expression 
cassette enabled the construction of two stable, markerless strains – for lone Gmlox1 
expression or for simultaneous Gmlox1/Gmhpl1 expression.  We tested each strain for 
pentane production after cultivation on High C:N media, but saw no increase in alkane 
production from Gmhpl1 co-overexpression (Figure 5.5).  Thus, the secondary 
hydroperoxide lyase enzyme had little to no impact towards short-chain n-alkane 
production via lipoxygenase catalyzed cleavage of linoleic acid and was inessential for 
the biochemical reaction mechanism.  In the first enzymatic step (Figure 5.1), the 
lipoxygenase enzyme (Gmlox1) catalyzes the addition of molecular oxygen to linoleic 
acid to form the 13-HPOD intermediate.  The second step of the reaction is either 
spontaneous or catalyzed by the lipoxygenase.  This one-enzyme heterologous pathway is 
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comparably simpler than pathways for higher-chain alkane production previously 
described 
77,169
.    
It is interesting to note that we observed a reduction in pentane production when 
integrating the Gmlox1 expression cassette (comparing Figures 5.4c and 5.5), despite 
that integration should result in a rough doubling of protein expression due to a 
documented ―half on/half off‖ tendency of Y. lipolytica episomal expression cassettes 2.  
We hypothesize that the strongly expressed leucine marker present on our base plasmid 
was influencing and increasing lipid accumulation in these plasmid-borne strains 
170
.  As 
we demonstrated with media modification and gene deletions, an increase in lipid 
accumulation could result in a concurrent increase in linoleic fatty acid substrate 
concentration and downstream pentane production. 
Figure 5.5: Concurrent hydroperoxide lyase expression does not improve pentane 
production.   
 
Y. lipolytica PO1f Gmlox1 and Gmlox1-Gmhpl1 strains harboring only the Gmlox1 (UAS1B16-Leum driven) or both 
the Gmlox1 and the Gmhpl1 integrative expression cassettes, respectively, were cultivated for eight days in High C:N 
media.  Co-expression of the Gmhpl1 hydroperoxide lyase enzyme did not increase pentane yield.   Error bars represent 
standard deviation from biological triplicates. 
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5.4 SUMMARY AND CONCLUSIONS  
The metabolic engineering of Y. lipolytica for short-chain n-alkane production is 
an important step towards enabling microbial replacement of petroleum products.  We 
successfully diverted endogenous fatty acids towards the production of a bio-value added 
product by expressing the soybean lipoxygenase I enzyme.  In this regard, we have 
expanded the chemical palette of cells through the incorporation of a novel heterologous 
metabolic pathway 
11,171
.  Our highest pentane titer must be improved, likely by 
stimulating fatty acid accumulation and lipogenesis to encourage alkane yields.  Strain 
engineering and media optimization increased cellular lipid content more than twofold, 
stimulating a concurrent increase in pentane production.  Thus, we demonstrated that Y. 
lipolytica metabolism can be manipulated to stimulate lipogenesis and that fatty acid 
pools can be diverted to more valuable metabolites such as alkane biofuels.  This 
example serves to demonstrate that short-chain alkane synthesis is conceivable in cellular 
systems and can be improved through further metabolic engineering and protein 
engineering efforts.  In the next chapter, we focus solely on stimulating lipogenesis to 
enable high fatty acid and lipid titers. 
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Chapter 6:  Harnessing Lipogenesis in Yarrowia lipolytica 
6.1 CHAPTER SUMMARY 
Microbial biosynthesis of fuels (such as ethanol and biodiesel) and industrial 
chemical precursors provides a renewable means to reduce dependence on petroleum 
feedstock 
172-176
.  Economic feasibility of these processes hinges upon harnessing either 
native or imported biosynthetic metabolism to achieve high titers and yields in a 
feedstock-independent manner 
10
.  To this end, Yarrowia lipolytica provides an ideal 
platform for oleochemical synthesis due to genetic tractability, broad substrate 
specificity, and native capacity for lipogenesis 
8,59
.  This chapter describes the largest 
engineering effort ever attempted to rewire an oleaginous organism, in which we couple 
combinatorial multiplexing of lipogenesis targets with phenotypic induction, creating a 
strain with unsurpassed lipogenesis capability.  Specifically, tri-level control of Y. 
lipolytica metabolism resulted in saturated cells containing upwards of 90% lipid content 
and titers as high as 25.3 g/L lipids, representing a more than 60-fold improvement over 
parental strain and conditions.  We further demonstrate that these lipids can be easily 
converted into FAMEs suitable for biodiesel.  Through this rewiring effort, we uncover 
several unique, previously unreported facets of lipogenesis, including: (1) that lipogenesis 
is dependent on absolute environmental carbon content, (2) that lipid accumulation 
phenotypes are dependent on leucine biosynthetic capacity, and (3) that rare odd-chain 
fatty acids pathways are naturally activated by high lipogenesis.  Finally, the high titers 
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and carbon-source independent nature of this lipogenesis in Y. lipolytica highlights the 
potential of this organism as a platform for efficient oleochemical and fuels production.   
 
6.2 INTRODUCTION 
 Bio-based production of oils and lipids provides a unique platform for the 
sustainable production of biodiesel and other important oleochemicals 
77,176
.  Most efforts 
for developing such a platform involve either rewiring E. coli or cultivating 
cyanobacteria.  These attempts suffer from low titers (less than 3g/L) and variable lipid 
content (ranging between 10 and 87%), with the highest levels typically occurring in non-
tractable, slow growing hosts cultivated in oil containing media (ex novo lipid 
incorporation instead of de novo  lipogenesis) 
174,176-180
.  As an alternative, several groups 
have explored oleaginous organisms such as the fungus Y. lipolytica, but total oil content 
and titers are still limited 
61,63,92
.  Yet the genetic tractability of this organism 
2,54,69,72,74,181
 
coupled with its modest, innate de novo lipogenesis (~10-15% lipid content in wildtype 
4,63,92
) make Y. lipolytica a potential candidate as a platform organism for superior lipid 
production.  Lipogenesis is generally accepted to be induced by nitrogen starvation 
conditions, in which relative nitrogen content is far less than relative carbon content.  It is 
also assumed that it is the ratio of carbon to nitrogen that is important towards lipid 
accumulation and that adjusting absolute nutrient content has little effect 
59,62,89
.  Lipid 
biosynthesis is primarily initiated by the activity of four enzymes - AMP Deaminase 
(AMPD), ATP-Citrate Lyase (ACL), Malic Enzyme (MAE) and Acetyl-CoA 
Carboxylase (ACC) – that cooperatively divert carbon flux from central carbon 
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metabolism towards fatty acid precursors 
59,61
.  Previous efforts to increase lipid 
accumulation have shown promise but have been limited by their breadth of metabolic 
control and their comprehensiveness of genotypic and phenotypic sampling towards 
complete redirection of metabolic flux towards lipid accumulation 
4,61,63,92
.   
 
6.3 RESULTS AND DISCUSSION 
6.3.1 Genomic engineering to increase lipogenesis 
We performed a combinatorial, multiplexing of targets spanning fatty acid, lipid, 
and central metabolism through the overexpression of five lipogenesis enzymes in four 
genomic backgrounds marked by differential fatty acid catabolic capacity (Table 6.1, 
Figure 6.1a).  Specifically, AMPDp, ACLp, and MAEp overexpressions were 
investigated for their potential to increase acetyl-CoA precursors (ACCp overexpression 
has not been reported to improve lipogenesis and was excluded 
92
) and DGA1p and 
DGA2p (acyl-CoA:diacylglycerol acyltransferases isozymes I and II) were included for 
their potential in catalyzing the ultimate step in triglyceride synthesis 
88
.  These 
overexpression targets were multiplexed with several deletions that served to reduce fatty 
acid catabolism by reducing one or both of β–oxidation (via mfe1 deletion) 61,63 and 
peroxisome biogenesis (via pex10 deletion) 
4,90
 (Table 6.1, Figure 6.1a).  We 
demonstrated in Chapter 5 that restoration of a complete leucine biosynthetic pathway 
potentially increased lipid accumulation more than alleviation of uracil auxotrophy in a 
PO1f base strain 
4
.  Thus, we included the complementing of leucine and uracil 
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biosynthetic capacity both singly and in tandem as targets for this multiplexing.  
Integrated expression cassettes were driven by our high strength synthetic UAS1B16-TEF 
constitutive hybrid promoter, constructed and characterized in Chapter 2 
2
.  Collectively, 
the combinatorial multiplexing of enzyme overexpressions, fatty-acid inhibition 
knockouts, and auxotrophies resulted in 57 distinct genotypes that were analyzed for 
lipogenesis capacity compared to the wild-type strain (Table 6.2).  Initially, a nile red 
based fluorescence assay coupled with flow cytometry 
182
 was used to efficiently 
determine relative lipid content and assess critical genotype synergies.  Across the 
resulting lipogenesis metabolic landscape, we observed a significant range in lipid 
accumulation that spanned a 74-fold improvement in fluorescence over unmodified Y. 
lipolytica PO1f (Figure 6.1b).  By using fluorescence microscopy or by physically lysing 
the cells, it is evident that cells become larger and more saturated with lipid content 
across the resulting lipogenic continuum in this landscape (Figure 6.1c,d).   
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Table 6.1: List of genomic parts used in Chapter 6 
Genomic backgrounds 
Name Genotype  and (function of knockout) 
POlf MatA, leucine
-
, uracil
-
, no extracellular proteases 
pex10 POlf-Δpex10 (prevents peroxisome biogenesis) 
mfe1 POlf-Δmfe1 (prevents β-oxidation) 
pex10 mfe1 
POlf-Δpex10 Δmfe1 (prevents peroxisome biogenesis and β-
oxidation) 
Enzymatic overexpressions 
Name Function 
AMPD Inhibits TCA cycle, increasing citric acid level 
ACLsubunit1 Cleaves citric acid to acetyl-CoA 
ACLsubunit2 Cleaves citric acid to acetyl-CoA 
MEA Increases NADPH cofactor supply 
DGAisozyme1 Catalyzes lipid synthesis step 
DGAisozyme2 Catalyzes lipid synthesis step 
Auxotrophic markers 
Name Utilized for expression 
Leucine
+/-
 Episomally and chromosomally 
Uracil
+/-
 Chromosomally 
AMPD = Adenosine monophosphate deaminase; ACL = ATP-Citrate Lyase; MAE = Malic Enzyme; DGA = acyl-
CoA:diacylglycerol acyltransferases.  ACL is a heterodimeric protein so only dual overexpressions of the ACLsubunit1 
and ACLsubunit2 were constructed and tested. 
Table 6.2: Yarrowia lipolytica strains used and constructed in Chapter 6 
Host Strain Name Genotype 
Reference 
or Source 
Yarrowia lipolytica base strains 
POlf MatA, leucine-, uracil-, xpr2-322, axp1-2 
53
 
pex10 
MatA, leucine-, uracil-, xpr2-322, axp1-2, 
Δmfe1 
4
 
mfe1 
MatA, leucine-, uracil-, xpr2-322, axp1-2, 
Δpex10 
4
 
pex10 mfe1 
MatA, leucine-, uracil-, xpr2-322, axp1-2, 
Δpex10, Δmfe1  
This work 
Yarrowia lipolytica overexpression strains 
Polf background 
POlf uracil
+
 MatA, leucine-, uracil+, xpr2-322, axp1-2 This work 
Polf leucine
+
 MatA, leucine+, uracil-, xpr2-322, axp1-2 This work 
Polf leucine
+
 uracil
+
 MatA, leucine+, uracil+, xpr2-322, axp1-2 This work 
Polf leucine
+ 
Epi MatA, leucine+, uracil-, xpr2-322, axp1-2 This work 
Polf uracil
+
 AMPD 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
AMPD 
This work 
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Table 6.2 continued 
Polf leucine
+
 AMPD 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
AMPD 
This work 
Polf uracil
+
 MEA 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
MEA 
This work 
Polf leucine
+
 MEA 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
MEA 
This work 
Polf leucine
+
 uracil
+
 
AMPD MEA 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
AMPD, MEA 
This work 
Polf leucine
+
 DGA1 
Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
DGA1 
This work 
Polf leucine
+
 DGA2 
Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
DGA2 
This work 
Polf leucine
+
 DGA1 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
DGA1 
This work 
mfe1 background 
mfe1 uracil
+
 MatA, leucine-, uracil+, xpr2-322, axp1-2, 
mfe1 
This work 
mfe1 leucine
+
 MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1 
This work 
mfe1 leucine
+
 uracil
+
 MatA, leucine+, uracil+, xpr2-322, axp1-2, 
mfe1 
This work 
mfe1 uracil
+
 AMPD 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
mfe1, AMPD 
This work 
mfe1 leucine
+
 AMPD 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1, AMPD 
This work 
mfe1 uracil
+
 MEA 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
mfe1, MEA 
This work 
mfe1 leucine
+
 MEA 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1, MEA 
This work 
mfe1 leucine
+
 uracil
+
 
AMPD MEA 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
mfe1, AMPD, MEA 
This work 
mfe1 leucine
+
 uracil
+
 
ACL1 ACL2 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
mfe1, ACL1, ACL2 
This work 
mfe1 leucine
+
 DGA1 
Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1, DGA1 
This work 
mfe1 leucine
+
 DGA2 
Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1, DGA2 
This work 
mfe1 leucine
+
 DGA1 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1, DGA1 
This work 
mfe1 leucine
+
 DGA2 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
mfe1, DGA2 
This work 
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Table 6.2 continued 
pex10 background 
pex10 uracil
+
 MatA, leucine-, uracil+, xpr2-322, axp1-2, 
pex10 
This work 
pex10 leucine
+
 MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10 
This work 
pex10 leucine
+
 uracil
+
 MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10 
This work 
pex10 uracil
+
 AMPD 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
pex10, AMPD 
This work 
pex10 leucine
+
 AMPD 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, AMPD 
This work 
pex10 uracil
+
 MEA 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
pex10, MEA 
This work 
pex10 leucine
+
 MEA 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, MEA 
This work 
pex10 leucine
+
 uracil
+
 
AMPD MEA 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, AMPD, MEA 
This work 
pex10 leucine
+
 DGA1 
Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, DGA1 
This work 
pex10 leucine
+
 DGA2 
Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, DGA2 
This work 
pex10 leucine
+
 DGA1 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, DGA1 
This work 
pex10 mfe1 background 
pex10 mfe1 uracil
+
 MatA, leucine-, uracil+, xpr2-322, axp1-2, 
pex10, mfe1 
This work 
pex10 mfe1 leucine
+
 MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1 
This work 
pex10 mfe1 leucine
+
 
uracil
+
 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1 
This work 
pex10 mfe1 uracil
+
 
AMPD 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, AMPD 
This work 
pex10 mfe1 leucine
+
 
AMPD 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1, AMPD 
This work 
pex10 mfe1 uracil
+
 
MEA 
MatA, leucine-, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, MEA 
This work 
pex10 mfe1 leucine
+
 
MEA 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1, MEA 
This work 
pex10 mfe1 leucine
+
 
uracil
+
 AMPD MEA 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, AMPD, MEA 
This work 
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Table 6.2 continued 
pex10 mfe1 leucine
+
 
uracil
+
 ACL1 ACL2 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, ACL1, ACL2 
This work 
pex10 mfe1 leucine
+
 
DGA1 Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1, DGA1 
This work 
pex10 mfe1 leucine
+
 
DGA2 Epi 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1, DGA2 
This work 
pex10 mfe1 leucine
+
 
uracil
+
 DGA1 Epi 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, DGA1 
This work 
pex10 mfe1 leucine
+
 
DGA1 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1, DGA1 
This work 
pex10 mfe1 uracil
+
 
DGA1 
MatA, leucine+, uracil-, xpr2-322, axp1-2, 
pex10, mfe1, DGA1 
This work 
pex10 mfe1 leucine
+
 
uracil
+
 DGA1 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, DGA1 
This work 
pex10 mfe1 leucine
+
 
uracil
+
 AMPD DGA1 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, AMPD, DGA1 
This work 
pex10 mfe1 leucine
+
 
uracil
+
 MEA DGA1 
MatA, leucine+, uracil+, xpr2-322, axp1-2, 
pex10, mfe1, MEA, DGA1 
This work 
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Figure 6.1: Combinatorial genomic engineering 
 
 
(A) A schematic illustrating how rewiring Y. lipolytica’s metabolism can increase lipid content.  Glucose is converted 
to acetyl-CoA fatty acid substrate through glycolysis and the TCA cycle.  The TCA cycle can be inhibit by AMPD 
activity to increase isocitrate and citrate availability.  Citrate is cleaved by ACL to form acetyl-CoA.  Fatty acid 
synthesis produces acyl-CoA chains that join with a glycerol 3-phospate backbone during lipid synthesis.  Three acyl-
CoA molecules join to a single glycerol 3-phosphate molecule to complete lipid creation, and DGA1 and DGA2 
catalyze the final step of lipogenesis.  During lipolysis, lipases cleave lipids to reform free acyl-CoAs.  Acyl-CoAs are 
degraded during fatty acid β-oxidation, which can be inhibited through pex10 or mfe1 deletion.  Fatty acid and lipid 
synthesis can be manipulated with nutrient signals, including leucine and carbon availability.  AMPD, ACL, MAE, 
DGA, pex10, and mfe1 are described in Table 6.1.  G3P = Glyceraldehyde 3-Phosphate; LPA = lysophosphatidic acid; 
DAG = diacylglceride; TAG = Triacylglceride. 
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Figure 6.1 continued 
 
 
 
(B) Nile red fluorescence analysis of lipid levels of the 57 strains constructed in this study.  Strain names include strain 
background (POlf, pex10, mfe1, pex10 mfe1), auxotrophies relieved (leucine+ or uracil+), and enzymes overexpressed.  
―Epi‖ denotes episomal overexpressions.  The pex10 and pex10 mfe1 backgrounds consistently display improved 
fluorescence levels compared to wildtype PO1f background.  DGA1p overexpression and leucine biosynthetic capacity 
are key effectors of high lipogenesis.  The highest levels of fluorescence were observed when staining the pex10 mfe1 
leucine+ uracil+ DGA1 strain, the strain selected for bioreactor fermentation.  AMPDp and MEAp overexpressions 
improve fluorescence signals in low lipid production strains, but do not enhance fluorescence in the highest production 
strain (far right, and second from right).  Error bars represent standard deviations of biological triplicates.   
  
 100 
Figure 6.1 continued 
 
 
 
 
 
(C) Fluorescence light microscopy images of six strains increasing in lipid content (white) from left (unmodified POlf) 
to right (pex10 mfe1 leucine+ DGA1).  (D)  Image of lysed pex10 mfe1 leucine+ uracil+ DGA1 (left) and POlf control 
(right) cells.  Lipids remain floating after centrifugation at max speed.   
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 Three dominant genetic targets exhibited cooperativity in the lipogenesis 
metabolic landscape—pex10 deletion, DGA1p or DGA2p overexpression, and restoration 
of a complete leucine biosynthetic pathway (leucine
+
 genotype) (Figure 6.1b).  Each of 
these targets improved nile red based fluorescence by more than threefold, and DGA1p 
overexpression outperformed that of DGA2p. Overexpression of the MEA and AMPD 
proteins were positive effectors of lipogenesis, but offered no cooperative advantage 
when combined the pex10 leucine
+
 DGA1 background (Figure 6.1b).  Deletion of the 
mfe1 gene was not seen to alter total nile-red based lipid fluorescence measurements, but 
its removal reduces fatty acid degradation in carbon starvation conditions 
4,61
.  Similarly, 
the uracil
+
 genotype had minimal effect on fluorescence, but improved growth rate and 
permitted cultivation in a pure minimal medium composition.  Thus, the pex10, mfe1, 
leucine
+
, uracil
+
, DGA1p genotype, the strain with the highest lipogenesis potential in 
terms of fluorescence, was selected as our most advantageous strain.  We extracted and 
measured lipid content to confirm nile red-based flow cytometry assessment of lipid 
content (Figures 6.2a,b).  In small scale, test-tube cultivations, the final engineered strain 
outperformed all others, yielding 6.00 g/L lipids with 74% lipid content, a nearly 15-fold 
improvement over control (0.41 g/L lipid and 16.8% lipid content).  
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Figure 6.2: Improvement of lipid production in small-scale cultivation 
 
 
 (A,B) Four strains were assayed for lipid production and for % lipid content (g lipids/g biomass) when cultivated in 
80g/L glucose, 6.7g/L Yeast Nitrogen Base w/o amino acids, and 0.79g/L CSM supplement – POlf, pex10 mfe1 
leucine+ uracil+ AMPD MEA, pex10 mfe1 leucine+ DGA1, and pex10 mfe1 leucine+ uracil+ DGA1.  The pex10 mfe1 
leucine+ uracil+ DGA1 strain yielded the highest lipid production of 6g/L and highest % lipid content (74%), nearly 15-
fold and fourfold improvements, respectively, over POlf control (0.41g/L lipids and 16.8% lipid content).  Without 
uracil biosynthetic capacity, the pex10 mfe1 leucine+ DGA1 strain generated less than 3g/L lipids.   
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6.3.2 Coupling genotypic engineering with phenotypic induction 
 We next sought to understand the complex relationship between de novo lipid 
accumulation and nutrient levels.  It is generally accepted that lipogenesis is highly 
dependent on the ratio of available carbon and nitrogen (C:N ratio) and induction requires 
a nitrogen starvation mechanism 
8,85
.  However, no definitive, quantitative relationship 
between genotype and lipogenesis induction has been determined.  Thus, we analyzed the 
effect of nitrogen starvation and carbon availability on lipogenesis for unmodified Y. 
lipolytica PO1f and eleven engineered strains spanning the lipogenesis landscape (Table 
6.3).  Cultivation of these twelve strains in media formulations containing between 10g/L 
and 160g/L glucose and 0.055g/L and 1.365g/L ammonium revealed that absolute 
glucose level, rather than generally accepted C:N ratio, is crucial towards inducing lipid 
synthesis, and high lipid producers realized optimal accumulation in higher glucose 
media (Table 6.4, Figure 6.3a-l).  In particular, unmodified Y. lipolytica PO1f and other 
low performing strains were most strongly induced by a lower carbon level (20g/L 
glucose and 0.273g/L ammonium), but responded poorly at similar C:N ratios with higher 
glucose and ammonium concentrations (Figure 6.3a-d).  Moderate lipid accumulators 
were highly induced at intermediate glucose levels but again responded poorly at similar 
C:N ratios (Figure 6.3e-i).  The highest accumulators, including the pex10 mfe1 leucine
+
 
DGA1p genotype, were induced most intensely by higher levels of carbon and nitrogen 
(80g/L glucose and 1.365g/L ammonium) (Figure 6.3j-l).  Thus, the current paradigm 
asserting the necessity of nitrogen starvation and that similar C:N ratios beget similar 
induction irrespective of overall carbon and nitrogen levels is incorrect.  Instead, a 
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defined amount of carbon content ultimately controls lipid synthesis, and this favorable 
carbon level increases in strains capable of superior lipogenesis.   
Table 6.3: Twelve strains analyzed to determine dependency of lipid accumulation 
induction on genotype 
PO1f 
mfe1 uracil
+
 leucine
+
 ACL1 ACL2 
pex10 uracil
+
 AMPD 
pex10 mfe1 
mfe1 uracil
+
 leucine
+
 AMPD MEA 
mfe1 uracil
+
 MEA 
pex10 mfe1 uracil
+
 leucine
+
 ACL1 
ACL2 
uracil
+
 leucine
+
 
leucine
+
 DGA1 
pex10 leucine
+
 AMPD 
pex10 leucine
+
  MEA 
pex10 mfe1 leucine
+
 DGA1 
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Table 6.4: Media formulations utilized in lipid accumulation induction-genotype 
dependency assay. 
  
Carbon 
Source Nitrogen Source 
  Glucose 
Ammonium Sulfate 
(Ammonium) 
Media 
Name (g/L) (g/L) 
C20N0.2 20 0.2 (0.055) 
C20N1 20 1.0 (0.273) 
C20N5 
(YSC) 20 5.0 (1.365) 
C40N0.2 40 0.2 (0.055) 
C40N1 40 1.0 (0.273) 
C40N5  40 5.0 (1.365) 
C80N0.2 80 0.2 (0.055) 
C80N1 80 1.0 (0.273) 
C80N5  80 5.0 (1.365) 
C160N0.2 160 0.2 (0.055) 
C160N1 160 1.0 (0.273) 
C160N5  160 5.0 (1.365) 
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Figure 6.3: Dependence of lipid induction phenotype on genotype and environmental 
conditions 
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Figure 6.3 continued 
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Figure 6.3 continued 
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Figure 6.3 continued 
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Figure 6.3 continued 
 
Heat maps of nile red stained lipid fluorescence for the twelve strains listed in Table 6.3 when cultivated in media 
formulations varying glucose between 20g/L and 160g/L and ammonium between 0.055g/L and 1.365g/L.  (A) PO1f: 
Low lipid accumulator; Highest fluorescence values were induced by 20g/L glucose and 0.273g/L ammonium. (B) 
mfe1 leucine+ uracil+ ACL1 ACL2: Low lipid accumulator; Highest fluorescence values were induced by 20g/L 
glucose and 0.273g/L ammonium. (C) pex10 uracil+ AMPD: Low lipid accumulator; Highest fluorescence values were 
induced by 20g/L glucose and 0.273g/L ammonium. (D) pex10 mfe1: Low lipid accumulator; Highest fluorescence 
values were induced by 80g/L glucose and 0.273g/L ammonium. (E) mfe1 leucine+ uracil+ AMPD MEA: Medium lipid 
accumulator; Highest fluorescence values were induced by 40g/L glucose and 0.055g/L ammonium.  This represents 
the only strain of the twelve tested to be induced optimally with 0.055g/L ammonium. (F) mfe1 uracil+ MEA: Medium 
lipid accumulator; Highest fluorescence values were induced by 80g/L glucose and 1.365g/L ammonium. (G) pex10 
mfe1 leucine+ uracil+ ACL1 ACL2: Medium lipid accumulator; Highest fluorescence values were induced by 80g/L 
glucose and 1.365g/L ammonium. (H) PO1f leucine+ uracil+: Medium lipid accumulator; Highest fluorescence values 
were induced by 40g/L glucose and 0.273g/L ammonium. (I) PO1f leucine+ DGA Epi: Medium lipid accumulator; 
Highest fluorescence values were induced by 40g/L glucose and 0.273g/L ammonium. (J) pex10 leucine+ AMPD: High 
lipid accumulator; Highest fluorescence values were induced by 80g/L glucose and 1.365g/L ammonium. (K) pex10 
leucine+ MEA: High lipid accumulator; Highest fluorescence values were induced by 80g/L glucose and 1.365g/L 
ammonium. (L) pex10 mfe1 leucine+ DGA1 Epi: High lipid accumulator; Highest fluorescence values were induced by 
80g/L glucose and 1.365g/L ammonium. 
6.3.3 Optimizing fermentation conditions in a bioreactor 
Taken together, these dominant lipogenesis targets and carbon levels (specifically, 
80 g/L glucose) enabled an optimization of fermentation conditions for the pex10 mfe1 
leucine
+
 uracil
+
 DGA1 strain to maximize lipid accumulation in a bioreactor setting.  We 
cultivated this fully prototrophic strain in an inexpensive minimal media formulation 
consisting of only glucose, ammonium sulfate, and yeast nitrogen base.  By additionally 
controlling pH, temperature, and dissolved oxygen levels, we observed significantly 
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improved lipid titer to 16.1 g/L with cells containing up to 88% lipid cellular content, the 
highest reported yield and content to date (Figure 6.4a-d).  This represents a 5.4 fold 
increase over a POlf leucine
+
 uracil
+
 control and 63% of the theoretical stoichiometric 
yield.  Moreover, this engineered strain exhibit a significantly reduced citric acid 
production rate, and decreased biomass formation (Figure 6.4c,d).  Increasing overall 
glucose availability to (160g/L with double ammonium levels to 2.73g/L) increased titer 
to 25.3 g/L, again the highest reported titer (Figure 6.4a).  As we have observed 
previously, maintaining identical C:N ratio while altering glucose and ammonium 
availability did result in identical lipogenesis.  When cultivating the pex10 mfe1 leucine
+
 
uracil
+
 DGA1 strain in the 160g/L glucose - 2.73g/L ammonium media, we saw lipid 
content reaching only 70% of cell dry weight and reached only 50% of theoretical yield.   
Figure 6.4: Overall increases in lipid content and titer from controlled fermentations 
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Figure 6.4 continued 
 
 
 
(A,B)  Increase in lipid titer and lipid content from POlf to pex10 mfe1 leucine+ uracil+ DGA1 at small scale production 
to pex10 mfe1 leucine+ uracil+ DGA1 fermentation in bioreactor with 80g/L glucose and 1.365 g/L ammonium or 
160g/L glucose and 2.73g/L ammonium.  (C,D)  Fermentation profiles for the pex10 mfe1 leucine+ uracil+ DGA1 (C) 
and POlf leucine+ uracil+ (D) strains cultivated in media containing 80g/L glucose and 1.365 g/L ammonium.  The POlf 
leucine+ uracil+ strain accumulated more than 2g/L citric acid not seen in the engineered strain.  Dissolved oxygen 
levels were held at or above 0.50. 
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6.3.4 Lipogenesis on alternative carbon sources, analysis of lipid content, and 
biodiesel synthesis 
We further tested our pex10 mfe1 leucine
+
 uracil
+
 DGA1 strain and five other 
strains on alternative carbon sources to assay for carbon-source independent lipogenesis.  
We observed that the pex10 mfe1 leucine
+
 uracil
+
 DGA1 strain exhibited superior 
production in nearly all carbon sources, establishing these lipogenesis targets as essential 
in rewiring this organism into an oleochemical platform strain (Figure 6.5a,b).   
Figure 6.5: Lipogenesis on alternative carbon sources 
 
(A) The pex10 mfe1 leucine+ uracil+ DGA1 strain effectively generates lipid content when grown on a variety of sugar 
and carbon sources.  The PO1f base strain is included for comparison.  Error bars represent standard deviations of 
biological triplicates 
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Figure 6.5 continued 
 
(B) We analyzed the ability of unmodified POlf, pex10 uracil+ MEA1p, pex10 leucine+ AMPD, pex10 mfe1 leucine+ 
DGA1 Epi, and pex10 mfe1 leucine+ DGA1 Epi to generate lipids when utilizing glucose, glycerol, xylose, fructose, 
mannose, ribose, or sucrose as their sole carbon source.  Pex10 mfe1 leucine+ DGA1 strains (expressed chromosomally 
or episomally) generated the highest lipid content in all cases, and all engineered strains demonstrated the capacity to 
utilize each carbon source for lipid production.  Glucose and mannose utilization generated the highest nile red stained 
lipid fluorescence, while ribose generated the least.  Error bars represent standard deviations of biological triplicates 
 
 
We analyzed lipid content of several strains with GC and GC-MS and saw 
predominantly C16:0, C16:1, C18:0, C18:1, and C18:2 fatty acids (very similar to a 
soybean-derived biodiesel profile), making these lipid reserves ideal feedstock for 
biodiesel synthesis 
183
.  We also produced 127 mg/L C17 fatty acids, a rare metabolite in 
cells (Figures 6.6a-d).  We hypothesize that extremely active lipogenesis enables less 
favored odd chained synthesis and such high titers permit detection and characterization.  
Finally, a standard methanol transesterification reaction of bioreactor-extracted lipids 
completed de novo biodiesel production (Figure 6.6e,f).   
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Figure 6.6: Analysis of lipid composition and transesterification to biodiesel 
 
 
(A) We performed GC analysis of lipid extract from strains pex10 mfe1 leucine+ uracil+ DGA1 and POlf leucine+ 
uracil+ after 6-day bioreactor batch fermentations to determine fatty acid profile.  We observed predominantly C16 and 
C18 fatty acid content, as expected, with a noticeably amount of C17 accumulation.  We observed C18:2 (linoleic acid) 
production in the pex10 mfe1 leucine+ uracil+ DGA1 but not in the POlf leucine+ uracil+ control.  (B) We performed GC 
and GC-MS analysis of lipid extract from strains POlf, POlf leucine+ uracil+ AMPD MEA, pex10 mfe1 leucine+ uracil+ 
AMPD MEA, pex10 mfe1 leucine+ DGA1, pex10 leucine+ DGA1 Epi, pex10 mfe1 leucine+ DGA1 Epi.  We observed 
predominantly C18:1, C18:0, and C16:0 fatty acid content, and noticed a general tendency towards increasing 
prevalence of C16s, C17s, and desaturated bonds as lipid accumulation capacity increased.   Typical soybean fatty acid 
profile is included for comparison. 
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Figure 6.6 continued 
 
 
 
(C) The C17:0 hexadecanoic acid standard was analyzed with GC (top panel) and GC-MS (bottom panel) and showed 
the major expected peak of 327.  (D) Lipid extract from the pex10 mfe1 leucine+ DGA1 strain was analyzed with GC 
(top panel) and GC-MS (bottom two panels).  Coinciding with the C17:0 standard retention time, C17:0 was present 
between 12.16-12.23, and analysis with GC-MS and showed the major expected peak of 327 (bottom panel).  C17:1 
was present on the GC between 11.79 and 11.86, and analysis with GC-MS (middle panel) revealed the expected major 
peak of 325, which corresponds to C17:0 losing two hydrogen atoms as it is desaturated to C17:1. 
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Figure 6.6 continued 
 
 
(E) We transesterified extracted lipid content from pex10 mfe1 leucine+ uracil+ DGA1p cells fermented in a bioreactor 
with methanol to form FAMEs (biodiesel).  We ran these FAMEs (bottom lane) on a TLC plate next to a mixed 
standard (top lane) containing free fatty acids, lipids, and glycerol and as expected, only FAMEs were present.  (F) A 
picture of ~1500 μl sample of biodiesel is shown in a 15mL Falcon tube against a white backdrop.   
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6.3.5 Understanding lipogenesis in Y. lipolytica  
 In performing these rewiring efforts on Y. lipolytica, we observed and explored 
several previously unreported facets of lipogenesis.  First, we sought to explain the 
benefit bestowed by restoration of the leucine biosynthetic pathway towards lipogenesis 
by comparing leucine supplementation to genetic complementation in leucine
-
 
backgrounds.  We observed that leucine supplementation mimicked genotypic 
complementation in leucine
-
 strains but did not affect leucine
+
 backgrounds (Figure 6.7a-
c).  Neither background responded to isoleucine supplementation, insuring that leucine-
induced lipogenesis is not a result of leucine catabolism (Figure 6.7b,c).  Furthermore, 
we determined that both leucine supplementation and genetic complementation can 
enable a pronounced reduction in steady state nitrogen concentration that correlates with 
lipogenesis in small scale cultivations (Figure 6.7d,e). Thus, we demonstrate that leucine 
acts as an intracellular trigger to enable lipid accumulation and this lipid accumulation 
requires a specific amount of nitrogen availability.  We further determined that extremely 
high lipogenesis levels correlate with a metabolomic shift to sustain steady state 
ammonium level, again revealing the importance of nitrogen availability towards 
lipogenesis (Figure 6.8a-c).  Specifically, we saw that ammonium was fully depleted in 
both the pex10 mfe1 leucine
+
 uracil
+
 DGA1p and PO1f leucine
+
 uracil
+
 fermentations 
after three days, but was replenished in the pex10 mfe1 leucine
+
 uracil
+
 DGA1p 
cultivation (Figure 6.8a,b).  Ammonium replenishment was not solely a result of 
intracellular protein degradation as cellular protein content decreased in both strains as 
the fermentation progressed (Figure 6.8c).     
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Figure 6.7: Understanding lipogenesis by exploring the effects of leucine biosynthesis 
and nitrogen availability 
 
 
(A) We tested if leucine could induce lipid accumulation in POlf leucine- (dark red) to the same levels as seen in POlf 
leucine+ (dark red – far left) and in pex10 mfe1 leucine- DGA1 (light red) to the same levels as seen in pex10 mfe1 
leucine+ DGA1 (light red – far left).  We observed that 0.4g/L leucine supplementation could complement the leucine+ 
phenotype in the unmodified PO1f leucine- strain, while 1.6g/L was necessary for the engineered pex10 mfe1 leucine- 
DGA1 strain.  (B) We tested the ability of leucine and isoleucine supplementation to complement the leucine+ 
phenotype in the pex10 mfe1 leucine- DGA1 background.  Isoleucine had no effect on lipid accumulation.  Error bars 
represent standard deviations of biological triplicates. 
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Figure 6.7 continued 
 
 
(C) We tested the ability of leucine and isoleucine supplementation to complement the leucine+ phenotype in the POlf 
leucine- background.  Isoleucine had no effect on lipid accumulation, while we observed that 0.4g/L leucine 
supplementation could partially complement the leucine+ phenotype in the unmodified PO1f leucine- strain.  Error bars 
represent standard deviations of biological triplicates.  (D) We analyzed steady state ammonium concentration in PO1f 
and in the pex10 mfe1 leucine+ DGA1 Epi background when cultivated in 30 mL media formulated with 80g/L glucose, 
6.7g/L Yeast Nitrogen Base w/o amino acids, and 0.79g/L CSM supplement.  High lipid production strain maintains a 
lower steady state ammonium concentration that POlf. 
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Figure 6.7 continued 
 
(E) We analyzed the effect of leucine supplementation on ammonium concentration in the pex10 mfe1 leucine- uracil+ 
DGA1 and the pex10 mfe1 leucine- uracil+ DGA1 background.   The pex10 mfe1 leucine- uracil+ DGA1 had much 
higher ammonium levels when not supplemented with leucine.  However, supplementation of leucine induced the 
pex10 mfe1 leucine- uracil+ DGA1 strain towards the leucine+ phenotype.  Leucine supplementation had no effect on 
the pex10 mfe1 leucine- uracil+ DGA1 strain.  Error bars represent standard deviations of biological triplicates 
 
Figure 6.8: Ammonium is required for highly active lipogenesis 
 
(A) A time course is shown of ammonium levels in the bioreactor batch fermentation of pex10 mfe1 leucine+ uracil+ 
DGA1 strain in 80g/L glucose, 5g/L ammonium, and 1.7g/L YNB (no amino acids, no ammonium sulfate).  
Ammonium was fully consumed after 72 hours, but surprisingly, ammonium level was replenished to a steady state 
level of ~0.5g/L. 
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Figure 6.8 continued 
 
 
(B) A time course is shown of ammonium levels in the bioreactor batch fermentation of PO1f leucine+ uracil+ strain in 
80g/L glucose, 5g/L ammonium, and 1.7g/L YNB (no amino acids, no ammonium sulfate).  Ammonium was fully 
consumed after 72 hours and was not replenished.  (C) Ammonium concentration (left axis, circles) plummets to zero 
in both the pex10 mfe1 leucine+ uracil+ DGA1 and POlf leucine+ uracil+ fermentations.  However, during pex10 mfe1 
leucine+ uracil+ DGA1 fermentation, ammonium levels are replenished.  We tested if this could be a result of 
intracellular protein degradation by analyzing protein content (right axis, triangles) before, during, and after this dip in 
ammonium concentration.  Cellular protein concentration decreases in both strains cells, so protein degradation is not 
the only mechanism used to replenish ammonium levels. 
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6.4 SUMMARY AND CONCLUSION 
In summary, we have conducted the largest metabolic rewiring of an oleaginous 
organism ever attempted, and we have successfully engineered and enhanced lipid 
accumulation in Y. lipolytica by more than 60-fold.  In doing so, we identified several 
unique features of lipogenesis, determined dominant genotype-phenotype dependencies, 
demonstrated that lipid accumulation approaching 90% of cell mass is possible, and 
demonstrated the feasible conversion of these lipids into FAMEs.  This will serve as a 
stepping stone towards creating a robust, efficient, high production platform for 
ubiquitous conversion of carbon towards value-added oleochemical and biofuels 
products. 
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Chapter 7:  Itaconic Acid Production in Y. lipolytica 
 
7.1 CHAPTER SUMMARY 
During lipogenesis, carbon flux through the citric acid cycle is inhibited resulting 
in a buildup of citric acid and fatty acid precursors.  We efficiently redirected this organic 
acid pool towards lipid accumulation in Chapter 6, but organic acids themselves (like 
citric acid and its derivatives) often represent value-added products 
184
.  Here, we have 
attempted to harness Y. lipolytica’s capacity to accumulate citric acid for the production 
of itaconic acid, a top 12 value-added chemical from biomass according to the United 
States Department of Energy’s 2004 report 184.  Specifically, we utilized our strong 
UAS1B16-TEF promoter to overexpress a heterologous cis-aconitic acid decarboxylase 
enzyme (CAD1) to catalyze the conversion of cis-aconitic acid to itaconic acid.  We 
produced 33mg/L itaconic acid with episomal CAD1 expression in an unmodified Y. 
lipolytica PO1f background, and co-overexpression of the native AMP deaminase 
enzyme (AMPD) increased itaconic acid titers to 141mg/L.  Integration of CAD1 enzyme 
drastically increased titers to 136mg/L and 226mg/L for the unmodified and AMPD 
overexpression backgrounds, respectively.  Utilization of minimal media formulations 
further increased itaconic acid titer to our highest production of 273mg/L, over eightfold 
higher than the starting strain.  Optimization of carbon and nitrogen availability also 
showed promise towards increasing itaconic acid production by enabling high-level 
production of citric acid precursor.  Our work represents the first attempt to use Y. 
lipolytica’s capacity to accumulate organic acids to produce nonnative chemicals. 
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7.2 INTRODUCTION 
 Control of metabolic flux in model hosts can enable efficient production of 
commodity chemicals.  Of particular interest are compounds that serve as renewable 
alternatives for petroleum derived chemicals.  In this regard, itaconic acid is a naturally 
produced versatile monomer with diverse applications as a copolymer in traditionally 
petro-derived plastics and rubbers 
185-187
, and polymerized polyitaconic acid is a 
functional alternative for polyacrylic acid, a high volume commodity petrochemical 
188,189
.  In fact, itaconic acid was named a top 12 value-added chemical from biomass by 
the Department of Energy in 2004 
184
.  The expanding market for itaconic acid derived 
products requires a concurrent decrease in production costs 
187,188
.  Here, we have 
undertaken the metabolic engineering of Yarrowia lipolytica for itaconic acid production.  
Itaconic acid production was first observed in Aspergillus itaconicus in 1932 
190
, 
and current industrial production occurs through fermentation by Aspergillus terreus 
5
.  
Moderate successes towards rationally engineering Aspergillus species for increased 
itaconic acid yield have been described but remain difficult due to a lack of well-defined 
genetic tools 
5,191
.  Media optimization and large-scale mutagenesis approaches have 
proven far more successful towards increasing itaconic acid yield 
192,193
.  While high 
titers of itaconic acid have been realized in A. terreus fermentations, A. terreus growth is 
naturally inhibited in media formulated to induce itaconic acid accumulation, and A. 
terreus is negatively impacted by shear stress, preventing cultivation in standard stirred 
tank bioreactors typically utilized for microorganism fermentations 
5,193,194
.  Metabolic 
profiling of A. terreus demonstrated that itaconic acid production proceeds through the 
decarboxylation of the cis-aconitate TCA cycle intermediate 
83
, and the cis-aconitic acid 
decarboxylase encoding gene (CAD1) was recently isolated and functionally confirmed 
195
.  Thus, the potential to import CAD1 functionality into a model host organism is an 
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ideal possibility towards furthering itaconic acid biosynthetic capacity while avoiding 
difficulties inherent in A. terreus cultivations.   
Lipid accumulation in Y. lipolytica proceeds via accumulation of citric acid cycle 
intermediates, mainly citric acid and isocitric acid 
59
.  Citric acid and isocitric acid are 
interconverted in a two step enzymatic process by the TCA cycle enzyme, cis-aconitase.  
During this interconversion, the cis-aconitic acid intermediate is physically released from 
the cis-aconitase enzyme, allowing its use as a substrate for further catalysis 
196
.  Thus, 
we have attempted to divert Y. lipolytica’s citric and isocitric acid reserves towards the 
production of itaconic acid by expressing the cis-aconitic acid decarboxylase enzyme.  Y. 
lipolytica has a fully developed genetic toolbox to enable rational metabolic engineering 
approaches and is becoming a more standard host for biosynthetic production and 
metabolic engineering 
1,2,4
.  Y. lipolytica offers numerous advantages towards industrial 
fermentations including robust growth in low pH and lower temperatures, high tolerance 
to shear stress, lack of phage-contamination, and ease of separation.  Here, we seek to 
enable heterologous production of itaconic acid by importing cis-aconitic decarboxylase 
activity into Y. lipolytica. 
 
7.3 RESULTS AND DISCUSSION 
7.3.1 Episomal expression of the CAD1 gene in Y. lipolytica 
 Recent characterization of the cis-aconitic acid decarboxylase gene (CAD1) 
enables its utilization for itaconic acid production in microbial hosts.  We inserted the 
CAD1 gene into a high-strength UAS1B16-TEF expression cassette on an episomal 
plasmid to allow for expression in Y. lipolytica, and we observed 33 mg/L itaconic acid 
titer (Figure 7.1).  This is the first time that itaconic acid has been produced by Y. 
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lipolytica and illustrates that CAD1 expression can enable itaconic acid production in Y. 
lipolytica.  We should note that the CAD1 gene had not been codon optimized from its 
original codon usage in Aspergillus terreus.  In fact, use of a CAD1 optimized for S. 
cerevisiae expression resulted in no itaconic acid production in Y. lipolytica.  This 
demonstrates once again the importance of codon usage for heterologous protein 
expression in Y. lipolytica (see Chapter 2 - hrGFP expression) 
2
.   
We attempted to increase itaconic acid production by expressing CAD1 (again 
episomally) in a Y. lipolytica strain with the AMP Deaminase (AMPD) enzyme 
constitutively overexpressed in a UAS1B16-TEF-driven chromosomal expression 
cassette.  Constitutive expression of AMPD should halt the citric acid cycle at the 
isocitric acid intermediate, effectively increasing cis-aconitic acid substrate levels.  We 
observed a nearly fivefold increase in itaconic acid in this AMPD overexpression 
background strain, to 159 mg/L (Figure 7.1).  Thus, AMPD overexpression is an 
effective measure towards increasing itaconic acid production.  This increase is likely 
mediated through inhibition of the TCA cycle to increase organic acid substrate levels.   
Figure 7.1: Itaconic acid production in Y. lipolytica with episomal CAD1 expression 
 
Episomal expression of the CAD1 enzyme, driven by the UAS1B16-TEF promoter, in Y. lipolytica strain PO1f enables 
itaconic acid production at 33mg/L.  Similar expression of CAD1 in a Y. lipolytica strain engineered to constitutively 
express AMPD increased itaconic acid production to 159mg/L.  Strains were cultivated in C20N1.365 media with amino 
acid supplementation (described below).  Error bars represent the standard deviation of biological triplicates. 
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7.3.2 Optimizing C:N ratio for itaconic acid production 
 We have shown that Y. lipolytica’s central carbon metabolism is pliable to 
manipulation by overexpression of the AMPD enzyme for increased itaconic acid 
production.  In Chapter 6, we thoroughly demonstrated that Y. lipolytica’s lipid 
accumulation potential can be drastically manipulated by altering the ratio of carbon 
(glucose) and nitrogen (ammonium) in media formulations (C:N ratio).  Lipid 
accumulation, C:N ratio, and citric acid accumulation (a metabolic precursor for cis-
aconitic acid CAD1 substrate) are all linked in Y. lipolytica 
59,62
.  Increasing C:N ratio 
stimulates lipid accumulation to a certain extent, until further increases shuttle carbon 
directly into citric acid accumulation.  We attempted to increase citric acid accumulation 
and itaconic acid production by increasing C:N ratio.  Specifically, we cultivated 
unmodified Y. lipolytica PO1f and the Y. lipolytica AMPD overexpression background 
(both episomally expressing CAD1) in two new media formulations and assayed for 
itaconic acid production (Figure 7.2a).  Our original media formulation contained 20g/L 
glucose and 1.365g/L ammonium (C20N1.365), and these two new formulations contained 
20g/L glucose and 0.055g/L ammonium (C20N0.055), or 80g/L glucose and 1.365g/L 
ammonium (C80N1.365).  All three formulations also contained yeast nitrogen base and 
CSM-leucine amino acid supplementation.  We observed that increasing C:N ratio 
improved itaconic acid production to more than 100mg/L in the unmodified Y. lipolytica 
background, but had little benefit when the AMPD enzyme was coexpressed, instead 
resulting in drastic citric acid buildup to more than 4g/L (Figure 7.2b).  We concluded 
that both AMPD constitutive expression and high C:N ratios inhibit the TCA cycle to 
increase organic acid levels.  However, when these two methods are employed 
simultaneously, further metabolic rewiring is necessary to draw flux towards itaconic 
acid production.  Only the C20N0.055 media formulation resulted in citric acid 
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accumulation, demonstrating the nitrogen limitation is more important than C:N ratio 
towards TCA cycle inhibition in the PO1f and PO1f AMPD backgrounds (Figure 7.2b).   
Figure 7.2: Altering C:N ration to increase organic acid production 
 
 
(A) Two Y lipolytica strains episomally expressing the CAD1 enzyme, unmodified strain PO1f and a PO1f derivative 
constitutively overexpressing AMPD, were analyzed for itaconic acid production when cultivated in three media 
formulations, C20N1.365, C20N0.055, and C80N1.365, where C and N represent g/L glucose and g/L ammonium, 
respectively.  Increasing C:N ratio, by decreasing nitrogen level or increasing glucose level, effectively increased 
itaconic acid production in PO1f.  No effect on itaconic acid production was seen in the AMPD expression background.  
(B) Interestingly, the C20N0.055 formulation stimulated exceedingly high citric acid production in the AMPD expression 
background.  Other media formulation did not stimulate citric acid accumulation.  Error bars represent standard 
deviations of biological triplicates.  
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7.3.3 Integration of CAD1 to increase itaconic acid production 
We have previously observed increased protein activity using chromosomal 
expression compared to episomal expression in Chapter 1 
2
.  Thus, we integrated the 
CAD1 gene into the PO1f and PO1f AMPD overexpression backgrounds and assayed for 
itaconic acid production (Figure 7.3).  We observed a pronounced increase in itaconic 
acid production, suggesting that CAD1 expression is a limiting factor in our systems.   
Figure 7.3: Chromosomal CAD1 expression increases itaconic acid production 
 
PO1f and POlf AMPD overexpression backgrounds, harboring chromosomal CAD1 expression cassettes, were assayed 
for itaconic acid production after cultivation in standard C20N1.365 media (including CSM amino acid supplementation).  
Chromosomal CAD1 expression increased itaconic acid titers to 136 and 226mg/L for the PO1f and PO1f AMPD 
backgrounds, respectively.  Cultivation in (C20N1.365) media without amino acid supplementation increased itaconic 
acid production to our highest yield of 272mg/L in the AMPD CAD1 chromosomal expression strain.  Error bars 
represent the standard deviation of biological triplicates. 
We have also observed an increase in fatty acid accumulation when cultivating in 
minimal media (media not containing CSM-based amino acid supplementation), 
specifically for bioreactor fermentations described in chapter 6.  Thus, we assayed our 
two chromosomal CAD1 expression strains for itaconic acid when cultivated in minimal 
media (C20N1.365 without CSM).  The PO1f chromosomal CAD1 expression strain 
required additional supplementation with 20mg/L uracil due to an auxotrophy, while 
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uracil auxotrophy had been alleviated in the AMPD overexpression background by 
insertion of the AMPD expression cassette (Figure 7.3).  We observed another 
pronounced increase in itaconic acid production, culminating in 272mg/L produced by 
the AMPD overexpression background.  Thus, reducing amino acid supplementation and 
increasing C:N ratio are important towards increasing itaconic acid production in Y. 
lipolytica. 
 
7.4 SUMMARY AND CONCLUSION 
 Y. lipolytica has the capacity to accumulate lipid content and organic acids 
9
.  
These accumulation mechanisms are interrelated, as fatty acid accumulation requires an 
inhibition and reversal of flux through the TCA cycle to supply acetyl-CoA and malonyl-
CoA fatty acid building blocks.  In Y. lipolytica strains without advanced lipid 
accumulation capabilities, TCA flux is inhibited but is not drawn towards fatty acid 
synthesis.  Instead, organic acid intermediates are accumulated, predominantly as citric 
and isocitric acid.  We have attempted to utilize these organic acid reserves for the 
production of itaconic acid, a value-added chemical monomer with diverse applications.  
Specifically, we enabled the first reported production of itaconic acid in Y. lipolytica 
through the episomal expression of a CAD1 (cis-aconitic acid decarboxylase) enzyme.  
The substrate for the CAD1 enzyme, cis-aconitic acid, is formed during a two-step 
isomerization reaction between citric acid and isocitric acid.  Citric acid, isocitric acid, 
and cis-aconitic acid are present during standard cellular respiration.  We attempted to 
increase cis-aconitic acid availability through the overexpression of an AMP deaminase 
enzyme, an enzyme know to inhibit the TCA cycle at the isocitric acid level.  AMPD 
coexpression successfully increased itaconic acid, as did modulation of C:N content, a 
more thoroughly studied mechanism to inhibit TCA cycle flux.  However, combining 
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these two methods did not increase itaconic acid synthesis, instead resulting in high levels 
of citric acid accumulation.  Future work will be devoted to pulling this citric acid content 
towards itaconic acid production.  We further increased itaconic acid by chromosomally 
expressing the CAD1 gene, a known method to increase gene expression by avoiding a 
document ―half on/ half off‖ phenotype observed in centromeric Y. lipolytica plasmids 2.  
Finally, we utilized a minimal media formulation to increase itaconic acid to our highest 
titer, 272 mg/L, illustrating once again that amino acid supplementation disrupts efficient 
diversion of TCA flux towards a desired product, be it fatty acid production (Chapter 6) 
or itaconic acid production.   
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Chapter 8:  Major Findings and Proposals for Future Work  
8.1 MAJOR FINDINGS 
 The experiments described herein had two major goals.  First, develop and 
generalize the hybrid promoter engineering for widespread application, and second, 
engineer Yarrowia lipolytica to produce short chain alkanes, high lipid titers, and itaconic 
acid.  For our first goal, we successfully employed the hybrid promoter approach to an 
expression limited system, Y. lipolytica, and increased overall promoter strength 
sevenfold.  Our promoter libraries also enabled the first reported capacity for tunable 
gene expression in this organism, spanning a range of more than 400 fold in terms of 
mRNA levels.  We then demonstrated de novo hybrid promoter construction in Y. 
lipolytica and applied the hybrid promoter approach to a second yeast, S. cerevisiae.  In 
S. cerevisiae, we exploited a large collected of well characterized promoter parts to 
increase the expression of the strongest yeast constitutive (PGDP) and inducible (PGAL) 
promoters by 2.5 fold and 15%, respectively.  We also engineered promoter regulation 
and imported synthetic galactose induction to constitutive promoters.  Finally, we created 
a collection of galactose-inducible promoters that span a nearly 50-fold dynamic range of 
induced expression levels.  Our results demonstrated that hybrid promoter engineering 
can efficiently increase expression capacity in two distinct eukaryotic lineages.  
Combination of modular UAS and core promoter elements enabled a predictable gene 
expression and regulation response in resultant hybrid promoters.  Thus, we have opened 
the possibility of creating synthetic designer promoter constructs. 
 For our second goal, we successfully produced short-chain alkanes, itaconic acid, 
and high lipid titers in Y. lipolytica.  Heterologous expression of a soybean lipoxygenase 
enzyme was necessary and sufficient to enable pentane production.  Gene expression, 
media, and strain background improvements increased yield threefold, but pentane 
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production was still too low to consider scale up.  We had much more success enabling 
the heterologous production of itaconic acid, up to 272mg/L with modest flux control and 
media optimization.  Much work can be done to improve this titer, described below. 
 Our greatest success was engineering and enhancing lipid accumulation in Y. 
lipolytica.  We fully sampled the lipogenesis metabolic landscape through AMPDp, 
ACLp, MAEp, DGA1p and DGA2p overexpressions multiplexed with deletions that 
prevent β–oxidation and peroxisome biogenesis.  We determined three dominant genetic 
targets that exhibited cooperativity in the lipogenesis metabolic landscape—pex10 
deletion, DGA1p or DGA2p overexpression, and restoration of a complete leucine 
biosynthetic pathway (leucine
+
 genotype) – to enhance lipid levels nearly 15-fold over 
control to 6.00 g/L in small scale cultivation.  We analyzed the effect of nitrogen 
starvation and carbon availability on lipogenesis to understand the complex relationship 
between de novo lipid accumulation, strain genotype, and nutrient levels.  We realized 
that the current paradigm stating that - (1) nitrogen starvation is necessary for lipogenesis 
and (2) similar C:N ratios beget similar induction - is incorrect.  Instead, a defined 
amount of carbon content ultimately controls lipid synthesis, and this favorable carbon 
level increases in strains capable of superior lipogenesis.  Controlled fermentation of the 
pex10 mfe1 leucine
+
 uracil
+
 DGA1 strain improved lipid titer to up to 25.3 g/L 
(representing a more than 60-fold improvement over parental strain and conditions) and 
produced cells almost fully consisting of lipid content (88% lipid dry cell weight).  These 
represent the highest reported lipid yield and content to date.  Finally, we demonstrated 
production of rare C17 fatty acids, and determined that leucine biosynthetic capacity 
stimulates lipogenesis. 
 Engineering Y. lipolytica’s metabolism for lipid and itaconic acid production 
entailed simultaneous stimulus of phenotypic-induction (through media optimization).  
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Our experience maximizing phenotypic output in this manner allowed use to realize one 
essential point – that genotypic perturbations (even seemingly benign modifications like 
auxotrophy relief) can drastically redistribute intracellular metabolic flux and should be 
followed by a re-optimization of media formulation.  Specifically, we observed how 
altering carbon and nitrogen availability produces different phenotypic responses in a 
strain dependant manner.  Although labor intensive, this property increases the pliability 
of Y. lipolytica’s central carbon metabolism for redirection towards multiple secondary 
metabolites.  
 
8.2 PROPOSALS FOR FUTURE WORK 
 The studies described herein demonstrate how to enable metabolic engineering 
applications in a non-conventional host.  We have described a start to finish protocol to 
improve native biosynthetic capacity in an organism with ill-defined gene expression 
tools.  It would be interesting to see if this protocol would be effective in other poorly 
characterized hosts that have basic recombinant DNA technology (and the native capacity 
to produce an interesting product).  For instance, itaconic acid production in Aspergillus 
species 
187
 or alkane production in algae populations 
197
 may be improved using our 
general techniques of promoter engineering, high-strength heterologous and endogenous 
enzymatic overexpressions, large-scale strain development, and thorough media 
optimization. 
As described above, we developed a generalizable hybrid promoter engineering 
approach to modulate and increase promoter strength in two fungal species.  This method 
should be applied to other industrially relevant hosts to illustrate its utility across 
eukaryotic systems.  In particular, gene expression is a major limiting factor towards 
protein and therapeutic production in mammalian cell lines.  Utilizing a hybrid approach 
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is an ideal method to generate high capacity promoters that efficiently drive gene 
expression regardless of cell line or integration loci.  Suitable UAS and strong core 
promoter elements have been characterized in mammalian systems 
198,199
 and fluorescent 
reporter proteins are available 
200
, enabling immediate mammalian hybrid promoter 
construction. 
Our production of pentane is significant as it represents the first time this 
molecule has been produced synthetically in an organism.  Nevertheless, there is 
considerable strain engineering that must be done to further improve yields and titers.  
Specifically, free linoleic acid availability must be increased.  Efforts to increase free 
fatty acids through expression of thioesterases 
63,88,158,201
 must be used in Y. lipolytica to 
further increase pentane production.  An additional consideration toward improving yield 
is the byproduct formed through the lipoxygenase reaction.  In the case of pentane 
production, 13-HPOD is also converted into 13-oxo-cis-9-trans-11-tridecadienoic acid.  
To increase overall yield, it will be necessary to catabolically recycle this byproduct back 
into linoleic acid.  Finally, we demonstrated that the soybean lipoxygenase enzyme is 
sufficient to produce the short-chain alkane pentane.  It is conceivable that protein 
engineering efforts can be used to alter either the specificity of substrate or the product 
profile from this enzyme.  In fact, our lab recently engineered an E. coli biosensor to be 
highly responsive to pentane and hexane 
202
.  This biosensor can be utilized to isolate 
mutant lipoxygenases that can produce alternative short-chain alkanes.  Finally, we have 
produced a robust, efficient, high production lipid accumulator, the Y. lipolytica PO1f 
pex10 mfe1 leucine
+
 uracil
+
 DGA1 strain.  We should assay this strain for pentane 
production after inserting a heterologous Gmlox1 expression cassette. 
Our Y. lipolytica PO1f pex10 mfe1 leucine
+
 uracil
+
 DGA1 strain accumulates the 
highest lipid levels reported, and we have shown that Y. lipolytica is amenable to further 
 137 
in vivo catalysis of its lipid reserves in Chapter 5 
4
.  Overexpression of fatty acid or lipid 
modifying enzymes can isolate or further alter the carbon backbone.  For instance, 
coexpression of a fatty acyl reductase and an aldehyde decarbonylase could enable long 
chain alkane production by isolating the carbon acyl backbone 
77
.  Expression of wax 
ester synthetases coupled with methanol or ethanol supplementation could enable in vivo 
synthesis of fatty acid methyl esters or fatty acid ethyl esters (biodiesel) 
78
.  Finally, 
expression of additional fatty acid elongases and desaturases can enable production of 
EPA (eicosapentaenoic acid) or DHA (docosahexaenoic acid) omega-3 fatty acids 
91,203,204
. 
We also enabled itaconic acid production in Y. lipolytica PO1f and AMPD 
overexpression strains through heterologous CAD1 (cis-aconitic acid decarboxylase) 
expression.  Itaconic acid yield can invariably be improved through effective engineering 
of central carbon metabolism and control of media formulation.  For instance, we 
observed high level citric acid production in the AMPD overexpression strain when 
cultivated in nitrogen starvation conditions.  Overexpression of the native cis-aconitase 
enzyme can reactivate flux conversion of citric acid to cis-aconitic acid substrate.   
Nitrogen starvations results in the transportation of citric acid out of the 
mitochondria via the citrate-malate shunt 
62
.  Therefore, it may be more beneficial to 
express a cytoplasm-targeted version of the cis-aconitase enzyme.  Cytoplasmic 
detargeting can be accomplished by removal of the mitochondrial localization signal 
(MLS) found in the first ~40 N-terminal amino acids of mitochondrial-localized 
enzymes.  Exact placement of the MLS can be determined through a simple comparison 
of Y. lipolytica and S. cerevisiae cis-aconitase amino acid sequence.  Specifically, MLS 
activity is dependent only on relative hydrophobicity making sequence conservation 
unnecessary, while cis-aconitase sequence is highly conserved.  Thus, removal of 
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nonconserved N-terminal amino acids will enable cytoplasmic detargeting.  It may be 
beneficial to redirect the entire itaconic acid production pathway to the cytoplasm by 
further retargeting of the citrate synthase enzyme.  Alternatively, it may be beneficial to 
target the CAD1 enzyme to the mitochondria through addition of an N-terminal MLS.  In 
the past, mitochondrial targeting and cytoplasmic detargeting have proven equally 
beneficial 
205,206
.   Expression of a unidirectional cis-aconitase enzyme could further 
increase cis-aconitic acid substrate levels 
207
.  Finally, optimization of media formulation 
and fermentation condition could grant large gains in itaconic acid production, similar to 
those we have seen for lipogenesis.   
Collectively, my research has had two main thrusts (1) development of a novel 
promoter engineering technique to enable high strength gene expression for metabolic 
engineering applications and (2) utilization of these promoters to enable short-chain 
alkane, lipid and itaconic acid production in Y. lipolytica.  In particular, I was able to 
employ large-scale strain and media optimization to generate, analyze, and characterize 
the most efficient lipid producer ever created. 
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Chapter 9:  Materials and Methods 
9.1 COMMON MATERIALS AND METHODS 
9.1.1 Common E. coli and yeast growth conditions 
E. coli strain DH10B was used for all cloning and plasmid propagation.  DH10B 
was grown at 37
o
C with constant shaking in Luria-Bertani (LB) Broth (Teknova) 
supplemented with 50μg/ml ampicillin for plasmid propagation.  Yarrowia lipolytica 
strain PO1f (ATCC # MYA-2613), a leucine and uracil auxotroph devoid of any secreted 
protease activity 
53
 was used as the starting point for all strain construction Y. lipolytica 
studies.  YSC media consisted of 20g/L glucose (Fisher Scientific), 0.79g/L CSM 
supplement (MP Biomedicals), and 6.7g/L Yeast Nitrogen Base w/o amino acids 
(Becton, Dickinson, and Company).  YSC-URA, YSC-LEU, and YSC-LEU-URA media 
contained 0.77g/L CSM-Uracil, 0.69g/L CSM-Leucine, or .67g/L CSM-Leucine-Uracil 
in place of CSM, respectively.  YPD media contained 10g/L yeast extract (Fisher 
Scientific), 20g/L peptone (Fisher Scientific) and 20g/L glucose, and was supplemented 
with 300μg/ml Hygromycin B (Invitrogen) for Y. lipolytica knockout selection. 
9.1.2 Cloning and transformation procedures.    
All restriction enzymes were purchased from New England Biolabs and all 
digestions were performed according to standard protocols.  PCR reactions were set up 
with recommended conditions using Phusion high fidelity DNA polymerase (Finnzymes), 
or LongAmp Taq DNA polymerase (New England Biolabs).  Ligation reactions were 
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performed overnight at room temperature using T4 DNA Ligase (Fermentas).  Gel 
extractions were performed using the Fermentas GeneJET extraction kit purchased from 
Fisher ThermoScientific.  Purification of small DNA fragments (<200 bp) generated 
during plasmid construction were performed using the MERmaid Spin Kit (Qbiogene).  
E. coli minipreps were performed using the Zyppy Plasmid Miniprep Kit (Zymo 
Research Corporation). Y. lipolytica minipreps were performed using Zymoprep Yeast 
Plasmid Miniprep II kit (Zymo Research Corporation).  E. coli maxipreps were 
performed using the Qiagen HiSpeed Plasmid Maxi Kit.  Transformation of E. coli 
strains was performed using standard electroporator protocols (Sambrook and Russell, 
2001).  Large amounts of linearized DNA (>20μg), necessary for Y. lipolytica PO1f 
transformation were cleaned and precipitated using a standard phenol:chloroform 
extraction followed by an ethanol precipitation. 
Genomic DNA (gDNA) was extracted from Y. lipolytica or S. cerevisiae using the 
Wizard Genomic DNA Purification kit (Promega).  Transformation of Y. lipolytica and S. 
cerevisiae with episomal expression plasmids was performed using the Zymogen Frozen 
EZ Yeast Transformation Kit II (Zymo Research Corporation), with plating on 
appropriate selection plates.  Transformation of Y. lipolytica PO1f with linearized 
cassettes was performed as described previously 
4
.  Briefly, PO1f was inoculated from 
glycerol stock directly into 10mL YPD media, grown overnight, and harvested at an 
OD600 between 9 and 15 by centrifugation at 1000 x g for 5 minutes.  Cells were washed 
in 8.0mL TE buffer (10mM Tris, 1mM EDTA, pH = 7.5), spun down, and resuspended in 
8.0mL TE buffer.  10
8
 cells were dispensed into separate microcentrifuge tubes for each 
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transformation, spun down, and resuspended in 1.0mL LiOAc buffer (100mM LiOAc, 
adjusted to pH = 6.0 with 2M acetic acid).  Cells were incubated with shaking at 30
o
C for 
60 minutes, spun down, resuspended in 90μL LiOAc buffer, and placed on ice.   1-5μg of 
linearized DNA was added to each transformation mixture in a total volume of 10μL, 
followed by 25μL of 50mg/mL boiled salmon sperm DNA (Sigma-Aldrich).   Cells were 
incubated at 30
o
C for 15 minutes with shaking, before adding 720μL PEG buffer (50% 
PEG8000, 100mM LiOAc, pH = 6.0) and 45μL 2M Dithiothreitol.  Cells were incubated 
at 30
o
C with shaking at 225rpm for 60 minutes, heat shocked for 10 minutes in a 39
o
C 
water bath, spun down and resuspended in 1mL LiOAc buffer.  200μL of cells were 
plated on appropriate selection plates.    
9.1.3 Citric acid and itaconic acid quantification 
A 1-2 mL culture sample was pelleted down for 5 minutes at 3000 x g, and the 
supernatant was filtered using a 0.2 mm syringe filter (Corning Incorporated).  Filtered 
supernatant was analyzed with a HPLC Ultimate 3000 (Dionex) and a Zorbax SB-Aq 
column (Agilent Technologies).  A 2.0 μL injection volume was used in a mobile phase 
composed of a 99.5:0.5 ratio of 25 mM potassium phosphate buffer (pH=2.0) to 
acetonitrile with a flow rate of 1.25 mL/min.  The column temperature was maintained at 
30
o
C and UV–Vis absorption was measured at 210 nm. Citric acid and itaconic acid 
standards (Sigma-Aldrich) were used to detect and quantify organic acid production. 
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9.2 MATERIALS AND METHODS FOR CHAPTER 2 
9.2.1 Calculation of codon adaptation index.   
Codon Adaption Indices were calculated for the hrGFP, mStrawberry, EGFP, and 
yECitrine genes using the CAIcal server 
208
 and the codon usage table for Y. lipolytica 
available on the Codon Usage Database 
209
.   
9.2.2 Plasmid construction.    
9.2.2.1 Construction of endogenous promoter fluorescence cassettes (Figure 9.1a) 
A table of primer sequences can be found in Table 9.1.  All plasmids employed 
for gene expression in Y. lipolytica were centromeric, replicative vectors based off 
plasmid pSl16-Cen1-1(227) 
98
, which was initially modified to include a new 
multicloning site and redubbed pMCSCen1.  The cyc1 terminator (cyc1t) was amplified 
from p416-TEF-yECitrine 
30,210
 and inserted into pMCSCen1 with an EcoNI/BlpI 
digestion to form pMCScyc1t.  Endogenous promoters as defined previously 
102
 EXP1 
(JB096/97), GPAT (JB094/95), GPD (JB088/89), TEF (JB104/105), YAT1 (JB090/91), 
XPR2 (JB275/276), and XPR2fus (JB277/276) (Table 2.1) were amplified from 
Yarrowia lipolytica PO1f genomic DNA and ligated into pMCScyc1t using XmaI/AscI 
for FBA and BstBI/AscI for the rest to form pMCS-Promoter serial constructs.  Reporter 
genes including yECitine 
30
 (JB083/084), mStrawberry (pmstrawberry, Clonetech) 
(JB153/155), EGFP 
211
 (JB156/158), hrGFP (pIRES-hrGFP, Agilent) (JB160/161) and 
lacZ 
212
 (JB312/313) were amplified using the indicated primers pairs and inserted into 
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appropriate pMCS-Promoter constructs to form different pMCS-Promoter-Reporter 
constructs.  Additionally, hrGFP and lacZ were inserted into pMCS-cyc1t to form 
plasmids pMCS-hrGFP and pMCS-lacZ.   
9.2.2.2 Constructions of UAS1B1-Leum through UAS1B32-Leum expression cassettes 
(Figure 9.1b)  
Primers JB162/163 amplified a 140bp minimal leucine promoter, Leum (Table 
2.1) from plasmid pMCSCen1 that was inserted into pUC19 with SphI/HindIII to form 
pUC-Leum.  Additionally, Leum was amplified using primers LQ19/20 and inserted into 
pMCS-HrGFP with BstBI/AscI to form plasmid pLeum-hrGFP.   
Template for UAS1B was created by annealing primers JB177/178.  Primers 
JB164/165 amplified a UAS1B oligo that was inserted into pUC-Leum with SalI-
HF/SphI-HF to form pUC-UAS1B1-Leum-No5’3’.  Additionally, Primers JB174/165 
amplified a UAS1B oligo that was inserted into pUC-Leum with SacI/SphI to form 
pUChp1dins.  pUC-1dins contained only EcoRI and SacI sites 5’ of the UAS1B to allow 
for future insertion of four tandem UAS1B sequences. 
Primers JB167/168 amplified a UAS1B oligo for BamHI-HF/SalI-HF insertion 
into pUC-UAS1B1-Leum-No5’3’ to form pUC-UAS1B2-Leum-No5’3’, while primers 
JB174/168 were used to create plasmid pUC-2dins from pUC-UAS1B1-Leum-No5’3’.  
Primers JB169/170 amplified a third UAS1B for XbaI/BamHI-HF insertion into pUC-
UAS1B2-Leum-No5’3’ to create pUC-UAS1B3-Leum-No5’3’, while primers JB174/170 
were used to create plasmid pUC-3dins from pUC-UAS1B2-Leum-No5’3’.  Primers 
JB171/172 amplified a fourth UAS1B for XbaI/SacI-HF insertion into pUC-UAS1B3-
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Leum-No5’3’ to create pUC-UAS1B4-Leum-No5’3’, while primers JB173/172 were used 
to form pUC-4d5’ins from pUC-UAS1B3-Leum-No5’3’.  pUC-4d5’ins was edited with a 
SalI/SpHI mediated UAS1B replacement (from primers JB163/166) to form pUC-4dins. 
Plasmid pUC-4dins was digested with EcoRI/SacI to extract a 444bp fragment 
containing four sequential UAS1Bs that was ligated into digests of pUC-1dins, pUC-
2dins, pUC-3dins, and pUC-UAS1B4-Leum-No5’3’ to form plasmids pUC-UAS1B5-
Leum-No5’3’ through pUC-UAS1B8-Leum-No5’3’.  An AscI restriction enzyme site was 
added 3’ of leum in these eight plasmid with primers JB251/252 and an BstBI-PstI-KpnI 
sequence was added 5’ to the EcoRI site of the AscI altered plasmids using primers 
JB249/250 to form plasmids pUC-UAS1B1-Leum through pUC-UAS1B8-Leum.  pUC-
UAS1B8-Leum-No5’3’ was modified to include a 5’ (of EcoRI) PstI site and a 3’ (of 
leum) KpnI site using primer pairs JB253/249 and JB254/252 respectively to create 
plasmid pUC-8dins.  pUC-8dins was PstI/KpnI digested to extract a 902bp fragment 
containing eight UAS1Bs that was inserted into pUC-UAS1B1-Leum through pUC-
UAS1B8-Leum to create plasmids pUC-UAS1B9-Leum through pUC-UAS1B16-Leum. 
Plasmid pUC16dblank was created by annealing together primers JB289/290, and 
inserting this 74bp oligo into pUC19 with NdeI/HindIII.  Plasmid pUC-UAS1B8-leum 
was digested with KpnI and then SphI-HF, and a 895bp fragment containing ―KpnI-
EcoRI-UAS1B8-SphI‖ was extracted and inserted into pUC16dblank to form 
pUC16d8dins.  pUC-UAS1B8-leum was digested with EcoRI-HF, and a 901bp UAS1B8 
fragment was extracted and inserted into pUC16d8ins to create pUC16dins.  A 1808bp 
UAS1B16 fragment was BstBI/PstI gel extracted from pUC16dins and inserted into 
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vectors pUC-UAS1B1-Leum through pUC-UAS1B16-Leum to form plasmids pUC-
UAS1B17-Leum through pUC-UAS1B32-Leum. 
UAS1Bn-Leum promoter elements were cut out using BstBI/AscI and inserted 5’ 
of hrGFP and lacZ reporter genes in pMCS-hrGFP or pMCS-lacZ constructs in which the 
hrGFP and lacZ genes lacked their native ATG start site.    
9.2.2.3 Construction of TEF-based promoters and expression cassettes (Figure 9.1c) 
The 1004bp region upstream and including the TEF promoter was amplified from 
PO1f gDNA using primers LQ13 and JB105 and inserted into a pMCS-HrGFP 
expression cassette in which the hrGFP gene included its native ATG start site using 
BstBI/AscI to form plasmid pMCS-TEF(1004)-HrGFP.  Promoters TEF(804) (LQ12), 
TEF(604) (LQ10), TEF(504) (LQ9), TEF(272) (LQ16), TEF(203) (LQ15), and TEF(136) 
(LQ14) were amplified from plasmid pMCS-TEF(1004)-HrGFP using the indicated 
primer and JB105.  These seven promoters replaced TEF(1004) in pMCS-TEF(1004)-
HrGFP to form the pMCS-TEF(n)-HrGFP core TEF promoter series (Table 2.1).   
Plasmid pUC19-8d was formed by the insertion of a BstBI/HindIII digested, gel 
extracted UAS1B8 fragment from pUC16d8dins in place of UAS1B16-Leum in digested 
pUC-UAS1B16-Leum vector.  Plasmid pUC19-16d was formed by the insertion of a 
BstBI/HindIII gel extracted UAS1B16 sequence from pUC16dins in place of UAS1B16-
Leum in digested pUC-UAS1B16-Leum vector.  The TEF series of promoters was 
reamplified using primers as follows: TEF(1004) (LQ29/17), TEF(804) (LQ28/17), 
TEF(604) (LQ26/17), TEF(504) (LQ25/17), TEF (LQ18/17), TEF(272) (LQ32/17), 
TEF(203) (LQ31/17), and TEF(136) (LQ30/17) and inserted into plasmids pUC19-16d 
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and pUC19-8d using a HindIII/AscI digest to form pUC-UAS1B8/16-TEF(n) vectors.  
UAS1B8/16-TEF(n) promoters were cut out with BstBI/AscI and inserted in place of 
TEF(136) in the pMCS-TEF(136)-hrGFP vector to form pMCS-UAS1B8/16-TEF(n)-
hrGFP vectors.     
Table 9.1: Primers used in Chapter 2 
Primer                                          Sequence (5’-3’) 
JB085          CGGGATCCCCCCCGGGAATTCGAATTGGCGC 
                     GCCCCTTAATTAAGGCACGTGCCTAAAAAAGGCGGACCGG 
                     GCTTAGCTTGTTTAAACAACTGCAGTTTT 
JB088          GGTTCGAAGACGCAGTAGGATGTCCTGCA  
JB089          TTGGCGCGCCGTTGATGTGTGTTTAATTCAAGAATGA 
JB090          GG TTCGAAATAAGTTTGCAAAAAGATCGTATTATAGT 
JB091          TTGGCGCGCCTTGTGAATTAGGGTGGTGAGA  
JB092          TCCCCCCGGGTAAACAGTGTACGCAGTACTATAGA 
JB093          TTGGCGCGCCGGAGAGCTGGGTTAGTTTGT 
JB094          GG TTCGAACAACTTTTCTTGTCGACCTGAGAT  
JB095          TTGGCGCGCCTTAGCGTGTCGTGTTTTTGTTGT  
JB096          GGTTCGAAGGAGTTTGGCGCCCGTTTTT  
JB097          TTGGCGCGCCTGCTGTAGATATGTCTTGTGTGTAAGGG 
JB099           AAAACTGCAGTTGTTTAAACAAGCTAAGCCCGGTC 
                     CGCCTTTTTTAGGCACGTGCCTTAATTAAGGGGCGCGCCAAT 
                     TCGAATTCCCGGGCCGGATCCCG 
JB102          GGCCTAAAAAAGGATCGATACCGTCGACCTCGAG  
JB103           GGGCTTAGCCGAGCGTCCCAAAACCTTCTC 
JB153          TTGGCGCGCCATGGTGAGCAAGGGCGAGGA 
JB155          CCTTAATTAACTACTTGTACAGCTCGTCCATGCC 
JB156          TTGGCGCGCCATGTCTAAAGGTGAAGAATTATTCA 
JB158          CCTTAATTAATTATTTGTACAATTCATCCATACCA  
JB160          TTGGCGCGCCATGGTGAGCAAGCAGATCCTGAAG  
JB161          CCTTAATTAATTACACCCACTCGTGCAGGC 
JB162          ACATGTGCATGCACTGATCACGGGCAAAAGTGCGTATATAT 
JB163          CAACCCAAGCTTTTAGTTTCGGGTTCCATTGTGG 
JB164          GACACGCGTCGACCTGAGGTGTCTCACAAGTGC 
JB165          GACACATGCATGCCCGGATCGAGGTGGGCGGG 
JB166          GACACATGCATGCGAGCTCCCGGATCGAGGTGGGCGGG   
JB167          CGCGGATCCCTGAGGTGTCTCACAAGTGCC  
JB168          GACACGCGTCGACCCGGATCGAGGTGGGCGGG  
JB169          CACACACGAGCTCCTAGTCTAGACTGAGGTGTCTCACAAGTGCC  
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Table 9.1 continued 
 
JB170          CGCGGATCCCCGGATCGAGGTGGGCGGG  
JB171          CACACACGAGCTCCTGAGGTGTCTCACAAGTGCC 
JB172          CTAGTCTAGACCGGATCGAGGTGGGCGGG 
JB173          CCGGAATTCCTGAGGTGTCTCACAAGTGCC  
JB174          CACACACGAGCTCCTGAGGTGTCTCACAAGTGC  
JB177           CTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCAC 
                     TTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAG 
                     ACCGTTGTTCCCGCCCACCTCGATCCGG 
JB178           CCGGATCGAGGTGGGCGGGAACAACGGTCTCGATAATG 
                     TACGTACACTACACACAAAGAGAAGCAAGTGGGGGCGG 
                     GACTGCACGGCACTTGT GAGACACCTCAG         
JB249          CATATGCGGTGTGAAATACCGC 
JB250          GGAATTCGGGTACCAACTGCAGTTCGAAACT 
                     GGCCGTCGTTTTACAAC  
JB251          AAGCTTCAGGCGCGCCATCATGGTCATAGCTGTTTCCTG 
JB252          CCCACATGTTCTTTCCTGCGTTATCC 
JB253          GGAATTCAACTGCAGACTGGCCGTCGTTTTACAAC 
JB254          ACATACATGCATGCGGTACCCGGGCAAAAGTGCGTATAT 
                     ATACAA 
JB289          GGAATTCCATATGTGTAAAACGACGGCCAGTTT 
                     CGAAGGTACCAAGGAAGCATGCCTGCAG 
                     AAGCTTGGGAAGA 
JB290           TCTTCCCAAGCTTCTGCAGGCATGCTTCCTTGGTA 
                   CCTTCGAAACTGGCCGTCGTTTTACACATATGGAATTC 
JB311           TTGGCGCGCCATGACCATGATTACGGATTCACTG 
JB312           ACTGTTGGCGCGCCACCATGATTACGGATTCACTGGC 
JB313          CCTTAATTAATTATTTTTGACACCAGACCAACTGG 
LQ9              CCAATTGGTTCGAAATGTCCCAACTTGCCAAATT 
LQ10            CCAATTGGTTCGAAATTGCACCCCAGCCAGACCG 
LQ12            CCAATTGGTTCGAATTGCGTTTCGCTCCCACAC 
LQ13            CCAATTGGTTCGAATCTGTAAAAAGTCTCTACAAG 
LQ14            CCAATTGGTTCGAATTGTGGTTGGGACTTTAG 
LQ15            CCAATTGGTTCGAATTTCTTTGTCTGGCCATC 
LQ16            CCAATTGGTTCGAACCCACACTTGCCGTTAAG 
LQ17            TTAAAGCTTAGAGACCGGGTTGGCG 
LQ18            TATAAGCTTGGCGCGCCTCATTTTGAATGATTCTTATAC 
LQ19            CCAATTGGTTCGAACGGGCAAAAGTGCGTAT 
LQ20            TTGGCGCGCCTGAAGCTTTTAGTTTCG 
LQ25            CCAATTGGAAGCTTATGTCCCAACTTGCCAAATT 
LQ26            CCAATTGGAAGCTTATTGCACCCCAGCCAGACCG 
LQ28            CCAATTGGAAGCTTTTGCGTTTCGCTCCCACAC 
LQ29            CCAATTGGAAGCTTTCTGTAAAAAGTCTCTACAAG 
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LQ30            CCAATTGGAAGCTTTTGTGGTTGGGACTTTAG 
LQ31            CCAATTGGAAGCTTTTTCTTTGTCTGGCCATC 
LQ32            CCAATTGGAAGCTTCCCACACTTGCCGTTAAG 
   
Figure 9.1: Construction of plasmids used in Chapter 2 
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Figure 9.1 continued 
 
 
(A) A simplified schematic picture is provided detailing the construction of endogenous promoter fluorescence 
cassettes (B) and the construction of UAS1B1-Leum through UAS1B32-Leum expression cassettes. (C) and the 
construction of TEF based promoters and expression cassettes. 
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9.2.3 Promoter characterization with flow cytometry 
Y. lipolytica PO1f strains, transformed with different plasmids, were inoculated 
directly from glycerol stock (in biological duplicate or triplicate) in YSC-LEU media for 
48 hours at 30
o
C with shaking, and then normalized to an OD600 of 0.03 in 2ml fresh 
YSC-LEU and incubated for another 48 hours at 30
o
C in a rotary drum (CT-7, New 
Brunswick Scientific) at speed seven.  A time course of fluorescence values showed 48 
hours to be an optimal incubation time for high expression levels from native and hybrid 
promoters (data not shown).  To harvest, the cultures were spun down at 500g for five 
minutes, washed in cold water, and resuspended in 5ml ice cold water before testing with 
a FACSCalibur (BD Biosciences) using 488nm excitation; FL1 detector; and 10,000 cell 
count for hrGFP detection.  Standard, optimized protocols were used for other reporter 
proteins tested in this study.  The samples were kept on ice during the test and the data 
was analyzed using FlowJo software (Tree Star Inc., Ashland, OR) to compute mean 
fluorescence values.  Day-to-day variability was mitigated by analyzing all comparable 
strains on the same day.  An average fluorescence and standard deviation was calculated 
from the mean values of biological replicates. 
9.2.4 Promoter characterization with β–galactosidase assay 
Y. lipolytica PO1f strains, transformed with different plasmids, were inoculated 
directly from glycerol stock (in biological triplicate) in YSC-LEU media for 48 hours at 
30
o
C in a rotary drum (CT-7, New Brunswick Scientific) at speed seven, and then 
normalized to an OD600 of 0.03 in 2ml fresh YSC-LEU and incubated for another 48 
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hours in the same conditions.  The cultures were washed twice in 1ml Z buffer , 
resuspended in 1 ml of Z buffer, and their OD600 readings were recorded 
106,107.  β-
galactosidase assays were performed as described by Miller 
106
 using 10μl of chloroform-
permeabilized cells, with a reaction length of 17 minutes.  
9.2.5 Promoter characterization with qRT-PCR  
Y. lipolytica PO1f strains, transformed with different plasmids, were inoculated 
directly from glycerol stock (in biological triplicate) in YSC-LEU media for 48 hours at 
30
o
C with shaking, and normalized to an OD600 = 0.03 in 2ml fresh YSC-LEU media and 
incubated for another 48 hours at 30
o
C in a rotary drum (CT-7, New Brunswick 
Scientific) at speed seven.  The cells were pelleted and total RNA was extracted using the 
RiboPureTM-Yeast Kit (Ambion).  1000ng of RNA from each sample was used for a 
reverse transcription reaction with the High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems).  A 1.2μl sample from each reaction was used to set up a qPCR 
reaction (in triplicate) with FastStart SYBR Green Master (Roche) using primers  
5’-TCAGCGACTTCTTCATCCAGAGCTTC-3’  
and 5’-ACACGAACATCTCCTCGATCAGGTTG-3’ as described in the manual 
with a non-template control.  The reactions were run with Applied Biosystems 7900HT 
Fast Real-Time PCR System (Applied Biosystems) using fast 96 well plates (Applied 
Biosystems). The data was analyzed with ABI 7900HTsequence detection systems 
(version 2.4; Applied Biosystems). 
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9.2.6 Plasmid stability test 
Y. lipolytica PO1f strains containing plasmids pUAS1B12-Leum-hrGFP or 
pUAS1B16-Leum-hrGFP were grown for 48 hours from glycerol stock and thereafter 
subcultured in fresh YSC-LEU media at an OD600=0.01 every 48 hours.  After a total 
continuous culture time of 192 hours, corresponding to 36 cell doublings, yeast cells were 
miniprepped to extract the plasmid.  Individual plasmids were isolated by transformation 
into E. coli, and sequencing and restriction enzymes digests of isolated plasmids were 
used to confirm the stability of the UAS1B12-Leum and UAS1B16-Leum promoters over 
this timeframe.   
 
9.3 MATERIALS AND METHODS FOR CHAPTER 3 
9.3.1 Media 
When testing on alternative carbon sources, glucose was replaced within the YSC 
media formulation by 20g/L sucrose (Acros Organics), 20g/L glycerol (Fisher Scientific), 
or 30g/L oleic acid (Sigma Aldrich)  
9.3.2 Plasmid construction 
Primer sequences can be found in Table 9.2.  All Y. lipolytica plasmids were 
centromeric, replicative vectors derived from  plasmid pSl16-Cen1-1(227) 
98
, which was 
modified to include a multi-cloning site, a hrGFP green fluorescent reporter gene 
(pIRES-hrGFP, Agilent), and a cyc1 terminator 
210
 to create plasmid pMCS-hrGFP.  A 
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TEF promoter 
45,203
 was added to pMCS-hrGFP to form pMCS-TEF-hrGFP.  Vectors 
pMCS-HrGFP, pMCS-TEF-HrGFP, pUC-UAS1B16-TEF, pUC-UAS1B8-TEF, pMCS-
TEF(136)-hrGFP, pMCS-TEF-LacZ, and pUC-UAS1B2-Leum have been described 
previously 
2
.  Unless stated otherwise, all PCRs utilized pMCS-TEF-hrGFP as template.  
All plasmids were sequenced confirmed. 
9.3.2.1 Construction of UASTEF(n)-TEF and UASTEF(n)-Leum hrGFP expression 
cassettes (Figure 9.2a) 
A UASTEF fragment amplified by primers JB438/439 was SphI/HindIII digested 
and inserted in place of the UAS1B16 fragment in pUC-UAS1B16-TEF to form pUC-
UASTEF(1)-TEF.  A second UASTEF fragment (primers JB440/437) was inserted into pUC-
UASTEF(1)-TEF with BstBI/SphI to form pUC-UASTEF(2)-TEF.  UASTEF(1)-TEF and 
UASTEF(2)-TEF promoters were gel extracted and inserted into pMCS-hrGFP with 
BstBI/AscI to create pMCS-UASTEF(1)-TEF-hrGFP and pMCS-UASTEF(2)-TEF-hrGFP, 
respectively.  A final UASTEF fragment (primers JB442/443) was inserted into pMCS-
UASTEF(2)-TEF-hrGFP with XmaI/BstBI to form pMCS-UASTEF(3)-TEF-hrGFP, 
completing UASTEF(n)-TEF expression cassette construction.   
An EcoRI/SphI digested UASTEF fragment amplified by primers JB436/437 was 
inserted in place of the UAS1B2 fragment in plasmid pUC-UAS1B2-Leum to create 
plasmid pUC-UASTEF(1)-Leum.  A BstB1/EcoRI digested UASTEF fragment (primers 
JB440/441) was inserted into pUC-UASTEF(1)-Leum to create pUC-UASTEF(2)-Leum.  
UASTEF(1)-Leum and UASTEF(2)-Leum promoters were inserted into pMCS-hrGFP with 
BstB1/AscI to create pMCS-UASTEF(1)-Leum-hrGFP and pMCS-UASTEF(2)-Leum-hrGFP, 
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respectively.  A final UASTEF fragment (primers JB442/443) was inserted into pMCS-
UASTEF(2)-Leum-hrGFP with XmaI/BstBI to form pMCS-UASTEF(3)-Leum-hrGFP, 
completing UASTEF(n)-Leum expression cassette construction.   
9.3.2.2 Construction of the UASTEF(2)-UAS1B8-TEF-hrGFP expression cassette 
(Figure 9.2b) 
A  BstBI/EcoRI digested UASTEF fragment amplified with primers JB440/441 
was inserted 5’ of the UAS1B8 region of pUC-UAS1B8-TEF to form pUC-UASTEF-
UAS1B8-TEF.  Promoter UASTEF-UAS1B8-TEF was extracted with BstBI/AscI and 
inserted into pMCS-hrGFP, and a final 5’ UASTEF fragment was added with XmaI/BstBI 
to create pMCS-UASTEF(2)-UAS1B8-TEF-hrGFP. 
9.3.2.3 Dissection of the TEF upstream region 
Twenty two overlapping fragments spanning the UASTEF region were inserted 5’ 
of the TEF(136) minimal promoter in plasmid pMCS-TEF(136)-hrGFP with XmaI/BstBI 
digests to form plasmids pMCS-UASTEF#1-TEF(136)-hrGFP through pMCS-
UASTEF#22-TEF(136)-hrGFP.  Primer pairs JB442/443, JB442/508, JB442/509, 
JB442/510, and JB442/511 amplified fragments UASTEF#1through UASTEF#5.  
JB503/443, JB503/507, JB503/508, JB503/510, and JB503/511 amplified fragments 
UASTEF#6 through UASTEF#10.  JB504/443, JB504/509, and JB504/511 amplified 
fragments UASTEF#11 through UASTEF#13.  JB505/507, JB505/508, JB505/510, and 
JB505/511 amplified fragments UASTEF#14 through UASTEF#17.  Finally, JB506/443, 
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JB506/507, JB506/508, JB506/510, and JB506/511 amplified fragments UASTEF#18 
through UASTEF#22.   
9.3.2.4 Construction of library of UASTEF#2(n)-TEF(136) hrGFP expression cassettes 
(Figure 9.2c) 
An initial UASTEF#2 region amplified by primers JB544/537 was inserted into 
plasmid pUC-UAS1B8-TEF(136) in place of UAS1B8 with EcoRI/HindIII to form 
plasmid pUC-UASTEF#2(1)-TEF(136).  Second (primers JB546/539) and third UASTEF#2 
(JB548/541) elements were inserted into pUC-UASTEF#2(1)-TEF(136) with EcoRI/BamHI 
and then EcoRI/XbaI digests to create pUC-UASTEF#2(2)-TEF(136) and then pUC-
UASTEF#2(3)-TEF(136), respectively.  To enable plasmid construction, a multicloning site 
annealed together from JB630/631 was inserted into p416-MCS-yECitrine 
3
 to created 
plasmid pTMCS.  A 737bp fragment containing three tandem UASTEF#2 elements in 
series amplified from pUC-UASTEF#2(3)-TEF(136) plasmid DNA with primers 
JB620/621 was inserted twice sequentially into pTMCS, first using SalI-HF/HindIII then 
SphI-HF/EcoRI-HF to create plasmids pTMCS-UASTEF#2(3) and pTMCS-UASTEF#2(6).   
This same 737bp fragment, digested with SphI/EcoRI, was inserted into the three pUC-
UASTEF#2(1, 2, and 3)-TEF(136) plasmids to create plasmids pUC-UASTEF#2(4, 5, and 6)-
TEF(136).  The six promoters - UASTEF#2(1)-TEF(136) through UASTEF#2(6)-TEF(136) - 
were BstBI/AscI extracted and inserted into pMCS-hrGFP to create pMCS-UASTEF#2(1)-
TEF(136)-hrGFP through pMCS-UASTEF#2(6)-TEF(136)-hrGFP.  Three or six UASTEF#2 
tandem repeats were BstBI/XmaI extracted from pTMCS-UASTEF#2(3) or pTMCS-
UASTEF#2(6) and inserted into pMCS-UASTEF#2(6)-hrGFP to create pMCS-UASTEF#2(9)-
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TEF(136)-hrGFP and pMCS-UASTEF#2(12)-TEF(136)-hrGFP, completing UASTEF#2(n)-
TEF(136)-hrGFP library construction.   
9.3.2.5 Construction of the lacZ expression cassettes 
The β-galactosidase gene encoded by E. coli lacZ 213 was gel extracted from 
pMCS-TEF-lacZ with AscI/PacI and inserted in place of hrGFP in certain pMCS- hrGFP-
based plasmid series to generate lacZ expression cassettes. 
9.3.2.6 Construction of mutant UASTEF#2 elements 
Utilizing plasmid pUC-UASTEF#2(1)-TEF(136) as DNA template for the 
Stratagene Quikchange mutagenesis kit, three putative transcription factor binding sites 
(TFBSs) were removed from UASTEF#2.  Primers JB682/683 deleted a ―tgtgt‖ motif to 
abrogate a putative NDT80p TFBS.  Primers JB680/681 deleted a ―ttaag‖ motif to 
remove a putative MCM1 TFBS, and primers JB684/685 deleted a ―gccatc‖ motif to 
remove a GCRp putative TFBS.  Sequential mutagenesis reactions created all 
combinations of NDT80p, MCM1p, and GCR1p TFBS deletion mutants in the pUC-
UASTEF#2(1)-TEF(136) background.  These seven mutants were BstB1/AscI extracted 
and inserted into pMCS-hrGFP to complete mutant UASTEF#2 expression cassette 
construction.   
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Table 9.2: Primers used in Chapter 3 
Primer 
Name 
Primer Sequence (5'-3') 
JB436 CGGAATTCAGAGACCGGGTTGGCGGC 
JB437 GTCGACATGCATGCTCAGTAGTCTATTTTGCGTCCGGC 
JB438 GTCGACATGCATGCAGAGACCGGGTTGGCGGC 
JB439 TAGGTCCCAAGCTTTCAGTAGTCTATTTTGCGTCCGGC 
JB440 CACTGGTTCGAAAGAGACCGGGTTGGCGGC 
JB441 CGGAATTCTCAGTAGTCTATTTTGCGTCCGGC 
JB442 TCCCAACCCGGGAGAGACCGGGTTGGCGGC 
JB443 CACTGGTTCGAATCAGTAGTCTATTTTGCGTCCGGC 
JB503 TCCCAACCCGGGATTTGTGTCCCAAAAAACAGCC 
JB504 TCCCAACCCGGGCCCCAATTGCCCCAATTGA 
JB505 TCCCAACCCGGGCCCAAATTGACCCAGTAGCG 
JB506 TCCCAACCCGGGGGCCCAACCCCGGCGAG 
JB507 CACTGGTTCGAATCTATTTTGCGTCCGGCATG 
JB508 CACTGGTTCGAAGGTTACCCGGATGGCCAGA 
JB509 CACTGGTTCGAAAAAGAAACTAGTACAAAGTCTGAAC 
JB510 CACTGGTTCGAATGAACAAGCGTAGATTCCAGAC 
JB511 CACTGGTTCGAAACTGCAGTACCCTACGCCC 
JB537 AGTCAGAAGCTTGGTTACCCGGATGGCCAGA 
JB539 CTGACGGATCCGGTTACCCGGATGGCCAGA 
JB541 CTGACTCTAGAGGTTACCCGGATGGCCAGA 
JB544 TAGTCGAATTCCTGACGGATCCAGAGACCGGGTTGGCGGC 
JB546 TAGTCGAATTCCTGACTCTAGAAGAGACCGGGTTGGCGGC 
JB548 TAGTCGAATTCCTGACGTCGACAGAGACCGGGTTGGCGGC 
JB620 GACTGGTGCATGCCTGACGTCGACAGAGACC 
JB621 GCGACTCGAATTCCCACAAAAGCTTGGTTACC 
JB630 
CGCGGTACCCGGGCATGCGCCAGGAATTCGTCGACC 
GCACAAGCTTCGAAGGCGCGCCAA 
JB631 
TTGGCGCGCCTTCGAAGCTTGTGCGGTCGACGAATTC 
CTGGCGCATGCCCGGGTACCGCG 
JB680 CCCACACTTGCCGGGCGTAGGGTACT 
JB681 AGTACCCTACGCCCGGCAAGTGTGGG 
JB682 AGACCGGGTTGGCGGCGTATTCCCAAAAAAC 
JB683 GTTTTTTGGGAATACGCCGCCAACCCGGTCT 
JB684 GTACTAGTTTCTTTGTCTGCGGGTAACCAAGCTTTTGT 
JB685 ACAAAAGCTTGGTTACCCGCAGACAAAGAAACTAGTAC 
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Figure 9.2: Construction of plasmids used in Chapter 3 
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Figure 9.2 continued 
 
(A) A  schematic picture is provided detailing the construction of UASTEF(n)-TEF and UASTEF(n)-Leum promoter hrGFP 
fluorescence cassettes (B) and the construction of the UASTEF(2)-UAS1B8-TEF-hrGFP expression cassette, (C) and the 
construction of a library of UASTEF#2 hrGFP expression cassettes.  Restriction enzymes utilized are abbreviated as 
follows: A – AscI, Ba – BamHI, B – BstBI, E – EcoRI, H – HindIII, Sa – SalI, S – SphI, Xb – XbaI, X – XmaI 
9.3.3 Promoter characterization by flow cytometry 
The hrGFP green fluorescent protein has been validated as an ideal tool to assess 
promoter strength in Y. lipolytica at the single cell level 
2
, and thus was employed to 
assess relative promoter activity for the majority of results generated in this study.  Y. 
lipolytica PO1f strains, transformed with different plasmids, were inoculated directly 
from glycerol stock (in biological triplicate) in YSC-LEU media for 48 hours at 30
o
C 
with shaking, and then normalized to an OD600 of 0.01 in 2ml fresh YSC-LEU and 
incubated for another 48 hours (unless otherwise stated) at 30
o
C in a rotary drum (CT-7, 
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New Brunswick Scientific) at speed seven.  A time course of fluorescence values showed 
48 hours to be an optimal incubation time for high expression levels from native and 
hybrid promoters 
2
.  To harvest, the cultures were spun down at 4
o
C at 1000g for five 
minutes, washed, and resuspended in 1ml ice cold water before testing with a FACS 
Fortessa (BD Biosciences) using the GFP fluorochrome, a voltage of 319, and a 10,000 
cell count for hrGFP detection.  Samples were kept on ice during the test and the data was 
analyzed using FlowJo software (Tree Star Inc., Ashland, OR) to compute mean 
fluorescence values. Day-to-day variability was mitigated by analyzing all comparable 
strains on the same day.  An average fluorescence and standard deviation were calculated 
from the mean values of biological replicates. 
9.3.4 Promoter characterization with β–galactosidase assay 
Y. lipolytica PO1f strains, transformed with different plasmids, were inoculated 
directly from glycerol stock (in biological triplicate) in YSC-LEU media for 48 hours at 
30
o
C in a rotary drum (CT-7, New Brunswick Scientific) at speed seven, and then 
normalized to an OD600 of 0.01 in 2ml fresh YSC-LEU and incubated for another 48 
hours in the same conditions.  The cultures were washed twice and resuspended in 1ml Z 
buffer, and their OD600 readings were recorded 
106,107.  β-galactosidase assays were 
performed as described by Miller 
106
 using 25μl of chloroform-permeabilized cells, with a 
reaction time of 17 minutes. 
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9.3.5 Kinetic analysis of promoters 
Y. lipolytica PO1f strains, transformed with different plasmids, were inoculated 
directly from glycerol stock (in biological triplicate) in YSC-LEU media for 48 hours at 
30
o
C in a rotary drum (CT-7, New Brunswick Scientific) at speed seven, and then 
normalized to an OD600 of 0.01 in 2ml fresh YSC-LEU and incubated for either 24, 48, 
72, or 96 hours in the same conditions.  Cultures were inoculated such that all cultures 
(for the 24, 48, 72, and 96 hour time points) were harvested and tested via flow cytometry 
at the same time. 
 
9.4 MATERIALS AND METHODS FOR CHAPTER 4 
9.4.1 Strains and media 
The majority of yeast experiments were carried out in S. cerevisiae BY4741 
(MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0) obtained from EUROSCARF, Frankfurt, 
Germany, excluding a single test assaying hybrid promoter strength in a ura3- mutant of 
Kyokai 7 Sake Yeast (NCYC479). Yeast strains were cultivated at 30
o
C with constant 
agitation in either YSC-URA or YSC(gal)-URA media.  YSC(gal)-URA utilized 20g/L 
galactose purchased from Fisher Scientific instead of glucose.   
9.4.2 Plasmid construction 
All plasmids containing expression cassettes were sequenced confirmed before 
transformation into S. cerevisiae.  Table 9.3 contains all primer sequences, and Figure 
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4.1 in the text of Chapter 4 illustrates the construction process for each promoter library, 
and a full description of plasmid construction follows.  The CEN/ARS plasmid p416-
TEF-yECitrine 
30
, containing the native PTEF promoter from S. cerevisiae, the CYC1 
terminator, the URA3 selectable marker, and the yellow fluorescent protein, yECitrine, 
was used as the basis for plasmid construction.  Primers JB374 and JB375 were annealed 
together, digested with SacI-HF and XbaI, and inserted in place of the PTEF promoter in a 
similarly digested p416-TEF-yECitrine plasmid to form plasmid p416-MCS-yECitrine, a 
plasmid containing the yECitrine reporter gene 3’ of a multicloning site to enable plasmid 
construction. 
9.4.2.1 Isolation of UAS elements and construction of plasmid expression cassettes 
containing core promoter regions 
Four well-characterized S. cerevisiae endogenous promoters were isolated from 
plasmids described by Mumberg et al. 
126,214
, including promoters PGPD, PTEF, PCYC, and 
PGAL.  These four promoters were amplified using primer pairs JB427/428, JB429/430, 
JB431/432, and JB512/513, respectively.  A125 nucleotide minimal truncation of the 
LEU2 promoter, called PLEUM, was amplified from plasmid p415-TEF using primers 
JB376/377 
38
.  A 158 nucleotide truncation of the PCYC promoter, called PCYC158, was 
amplified using primers JB379/80.  PCR amplicons of promoters PGPD, PTEF, PCYC, PGAL, 
PLEUM, and PCYC158 were PmeI/XbaI digested and ligated into a similarly digested p416-
MCS-yECitrine plasmid to create plasmids p416-MCS-Gpd, p416-MCS-Tef, p416-MCS-
Cyc, p416-MCS-Gal, and p416-MCS-Leum, and p416-MCS- CYC158. 
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Three previously described upstream activating sequences and one novel UAS 
were utilized for expression enhancement in this study (Table 1 in the main text).   The 
240 basepair UASCLB 
133
, the 275 basepair UASCIT 
134
, and the 309 basepair UASGAL 
29
, 
have been described previously and were originally amplified from S. cerevisiae BY4741 
genomic DNA using primer pairs JB417/418, JB395/396 and JB514/515, respectively.  
The novel UASTEF, containing 203 nucleotides between 198 and 401 basepairs upstream 
of the TEF1 start codon, was amplified from plasmid p416-TEF-yECitrine using primer 
pair JB520/521.  PCR amplicons of UASCLB, UASCIT, UASGAL, and UASTEF, were 
HindIII/PmeI digested and inserted into a similarly digested plasmid p416-MCS-Leum to 
create plasmids p416-UASCLB-Leum, p416-UASCIT-Leum, p416-UASGAL-Leum, and 
p416-UASTEF-Leum.  After sequence confirmation, these four plasmids were used for 
PCR template DNA for their corresponding UAS element. 
9.4.2.2 Construction of LEUM-based and CYC158-based UAS-enhanced promoter 
libraries   
A second UASCIT PCR fragment generated using primers JB415/416 was inserted 
into p416-UASCIT-Leum to create plasmid p416-UASCIT(2x)-Leum with a PacI/HindIII 
digest.  A third UASCIT fragment generated using primers JB419/420 was inserted into 
p416-UASCIT(2x)-Leum with a PacI/AscI digest to create plasmid p416-UASCIT(3x)-Leum.  
An additional UASCLB fragment generated with primers JB425/426 was inserted into 
p416-UASCIT(3x)-Leum with a BamHI-HF/AscI digest to create plasmid p416-UASCLB-
UASCIT(3x)-Leum.  Following a similar construction process, two UASCLB fragments and 
one UASCIT fragment were amplified using primer pairs JB397/398, JB421/422, and 
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JB423/424, respectively, and then inserted one by one into plasmid p416-UASCLB-Leum 
to create plasmids p416-UASCLB(2x)-Leum, p416-UASCLB(3x)-Leum, and p416-UASCIT-
UASCLB(3x)-Leum.  Construction of the CYC158-based hybrid promoter library followed 
the construction process of the LEUM-based library exactly, and generated plasmids 
p416-UASCIT-CYC158, p416-UASCIT(2x)-CYC158, p416-UASCIT(3x)-CYC158, p416-
UASCLB-UASCIT(3x)-CYC158, p416-UASCLB-CYC158, p416-UASCLB(2x)-CYC158, p416-
UASCLB(3x)-CYC158, and p416-UASCIT-UASCLB(3x)-CYC158. 
9.4.2.3 Construction of hybrid promoters with GPD1, TEF1, CYC1, or GAL1 core 
promoters 
 The following UAS constructs were gel extracted from p416-LEUM-based 
hybrid promoter plasmids using a BamHI-HF/PmeI Digest: UASCLB, UASCLB(2x), 
UASCLB(3x), UASCIT(3x).  These four enhancer constructs were inserted into BamHI-
HF/PmeI digested p416-MCS-Gpd, p416-MCS-Tef, p416-MCS-Cyc, and p416-MCS-Gal 
vectors to form vectors p416-UASCLB-Gpd, p416-UASCLB(2x)-Gpd, p416-UASCLB(3x)-
Gpd, p416-UASCIT(3x)-Gpd, p416-UASCLB-Tef, p416-UASCLB(2x)-Tef, p416-UASCLB(3x)-
Tef, p416-UASCIT(3x)-Tef, p416-UASCLB-Cyc, p416-UASCLB(2x)-Cyc, p416-UASCLB(3x)-
Cyc, p416-UASCIT(3x)-Cyc, p416-UASCLB-Gal, p416-UASCLB(2x)-Gal, p416-UASCLB(3x)-
Gal, and p416-UASCIT(3x)-Gal. 
The enhancer elements UASGAL and UASTEF were gel extracted from vectors 
p416-UASGAL-Leum and p416-UASTEF-Leum with a PacI/PmeI digest and inserted into 
similarly digested p416-MCS-Gpd, p416-MCS-Tef, p416-MCS-Cyc, and p416-MCS-Gal 
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vectors to create plasmids p416-UASGAL-Gpd, p416-UASGAL-Tef, p416-UASGAL-Cyc, 
and p416-UASGAL-Gal. 
A HindIII/PmeI UASGAL digested fragment was gel extracted from vector p416-
UASGAL-Gpd and inserted in place of the UASCLB fragment proximal to the LEUM core 
promoter in plasmid p416-UASCLB(3x)-Leum to form plasmid p416-UASCLB(2x)-UASGAL-
Leum.  A UASGAL element was PCR amplified using primers JB516 and JB517, digested 
with PacI/HindIII and inserted in place of the middle UASCLB element in plasmid p416-
UASCLB(3x)-Leum to form plasmid p416-UASCLB-UASGAL-UASCLB-Leum.  This same 
amplicon was inserted into a PacI/HindIII digest p416-MCS-Leum to form plasmid p416-
UASGAL-A-Leum that had unused HindIII/Pme sites between the UASGAL sequence and 
the Leum promoter.  A UASGAL element was PCR amplified using primers JB518 and 
JB519, digested with AscI/PacI and inserted in place of the UASCLB element furthest 
from the LEUM core promoter in plasmid p416-UASCLB(3x)-Leum to form plasmid p416-
UASGAL-UASCLB(2x)-Leum. 
A PacI/HindIII UASCIT digested fragment was gel extracted from vector p416-
UASCIT(2x)-Leum and inserted into a similarly digested p416-UASCLB-Gpd vector to 
create plasmid p416-UASCIT-UASCLB-Gpd.  A UASTEF fragment was PCR amplified 
using primers JB524 and JB525, digested with AscI/PacI, and inserted into a similarly 
digested p416-UASCIT-UASCLB-Gpd vector to create plasmid p416-UASTEF-UASCIT-
UASCLB-Gpd.  A UASTEF-UASCIT-UASCLB fragment was AscI/PmeI digested and gel 
extracted from plasmid p416-UASTEF-UASCIT-UASCLB-Gpd and inserted into an 
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AscI/PmeI digested p416-Leum plasmid to create plasmid p416-UASTEF-UASCIT-
UASCLB-Leum. 
Primers JB480C and JB481C were annealed together, BssHII digested, and 
inserted into a similarly digested p415TEF (insert mumberg reference) vector to form 
plasmid p415-MCS.  Primers JB618 and JB619 were annealed, BamHI-HF/SacI-HF 
digested, and inserted into digested p415-MCS vector to form plasmid p415-6XMCS.  
AscI/PmeI digested fragments of UASTEF-UASCIT-UASCLB and UASCLB(3x) were 
extracted from their respective p416-Leum based plasmids and inserted into digest p415-
6XMCS to form plasmids p415-6XMCS-UASTEF-UASCIT-UASCLB and p415-6XMCS-
UASCLB(3x), respectively.  BamHI-HF/SacI-HF fragments of UASTEF-UASCIT-UASCLB 
and UASCLB(3x) were extracted from their respective p415-6XMCS based plasmids.  The 
UASTEF-UASCIT-UASCLB fragment was inserted into plasmids p416-UASTEF-UASCIT-
UASCLB-Gpd and p416-UASTEF-UASCIT-UASCLB-Leum to create plasmids p416-
(UASTEF-UASCIT-UASCLB)2x-Gpd and p416-(UASTEF-UASCIT-UASCLB)2x-Leum, 
respectively, while the UASCLB(3x) fragment was inserted into plasmids p416-UASCLB(3x)-
Gpd to create plasmid p416-UASCLB(6x)-Gpd. 
9.4.2.4 Construction of a library for tunable galactose-induced gene expression 
A dissection of the key 54bp element within UASGAL was performed by inserting 
DNA products created using the following primer pairs behind the Leum promoter in 
plasmid p416-MCS-Leum with a HindIII/PmeI digest.  G4BS1-4 was PCR amplified 
with primers JB585/586 from p416-MCS-GAL plasmid DNA and inserted as described 
to form plasmid p416-G4BS1-4-Leum.  Primer pairs JB587/588, JB589/590, JB591/592, 
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JB593/594, JB595/596, JB597/598, JB599/600, and JB601/602 were annealed together 
and similarly inserted to form plasmids p416-G4BS13-Leum, p416-G4BS12-Leum, 
p416-G4BS34-Leum, p416-G4BS24-Leum, p416-G4BS1-Leum, p416-G4BS2-Leum, 
p416-G4BS3-Leum, and p416-G4BS4-Leum.   Primer pair JB606/607 was annealed and 
inserted into plasmid p416-UASGAL-A-Leum with a HindIII/PmeI digest to form plasmid 
p416-UASGAL-A9-Leum.  Fragments of the 5’ region of PCYC1 generated with primer 
pairs JB603/604 and JB603/605 were inserted into the same backbone to create plasmids 
p416-UASGAL-CU1-Leum and p416-UASGAL-CU2-Leum, respectively. 
Table 9.3: Primers used in Chapter 4 
Primer Sequence 
JB374  gacacatgagctccgggatccttggcgcgccccttaattaacggaagcttcctgtttaaactagttctagactag 
JB375 
 
ctagtctagaactagtttaaacaggaagcttccgttaattaaggggcgcgccaaggatcccggagctcatgtgtc 
JB376  agctttgtttaaaccaatattatttaaggacctattgttt 
JB377  ctagtctagatagaatggtatatccttgaaatatatat 
JB379  ctagtctagattagtgtgtgtatttgtgtttgcg 
JB380  agctttgtttaaactgcgacgacacatgatcatat 
JB395  gcagctcaagctttagagattactacatattccaacaag 
JB396  agctttgtttaaacagggattgcgatcctcca 
JB397  ccttaattaaagtggaattattagaatgaccactac 
JB398  gcagctcaagcttggacaggcaccgaagttc 
JB415  ccttaattaatagagattactacatattccaacaag 
JB416  gcagctcaagcttagggattgcgatcctcca 
JB417  gcagctcaagcttagtggaattattagaatgaccactac 
JB418  agctttgtttaaacggacaggcaccgaagttc 
JB419  ttggcgcgcctagagattactacatattccaacaag 
JB420  ccttaattaaagggattgcgatcctcca 
JB421  ttggcgcgccagtggaattattagaatgaccactac 
JB422  ccttaattaaggacaggcaccgaagttc 
JB423  cgggatcctagagattactacatattccaacaag 
JB424  ttggcgcgccagggattgcgatcctcca 
JB425  cgggatccagtggaattattagaatgaccactac 
JB426  ttggcgcgccggacaggcaccgaagttc 
JB427  agctttgtttaaacagtttatcattatcaatactcgccattt 
JB428  ctagtctagaatccgtcgaaactaagtt 
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Table 9.3 continued 
 
JB429  agctttgtttaaacatagcttcaaaatgtttctactcctt 
JB430  ctagtctagaaaacttagattagattgctatgc 
JB431  agctttgtttaaacatttggcgagcgttggttg 
JB432  ctagtctagattagtgtgtgtatttgtgtttgc 
JB480
C 
tgactgactgactgcgcgcgtcgacgtcagtcgagctcaatctagaggggatccttcccgggaacggccgagcgcgcagtgactgagtt
g 
JB481
C 
caactcagtcactgcgcgctcggccgttcccgggaaggatcccctctagattgagctcgactgacgtcgacgcgcgcagtcagtcagtc
a 
JB512  agctttgtttaaactagtacggattagaagccgc 
JB513  ctctagtctagaatccggggttttttct 
JB514  gcagctcaagctttagtacggattagaagccgc 
JB515  agctttgtttaaacctgttaatagatcaaaaatcatcgct 
JB520  gcagctcaagcttatagcttcaaaatgtttctactcct 
JB521  agctttgtttaaacgcctttttcgacgaagaaaaag 
JB522  ccttaattaaatagcttcaaaatgtttctactcct 
JB523  gcagctcaagcttgcctttttcgacgaagaaaaag 
JB524  ttggcgcgccatagcttcaaaatgtttctactcct 
JB525  ccttaattaagcctttttcgacgaagaaaaag 
JB585  gctggtcaagcttcggattagaagccgccgag 
JB586  agctttgtttaaaccggaggagagtcttccgtcg 
JB587  ctgtcaagcttcggattagaagccgccgagcgggcgacagccctccggtttaaacaaagc 
JB588  gctttgtttaaaccggagggctgtcgcccgctcggcggcttctaatccgaagcttgacag 
JB589  gctggtcaagcttcggattagaagccgccgagggcgacagccgtttaaacacagtc 
JB590  gactgtgtttaaacggctgtcgccctcggcggcttctaatccgaagcttgaccagc 
JB591  gctgtcaagcttcgggcgacagccctccgacggaagactctcctccggtttaaacacctc 
JB592  gaggtgtttaaaccggaggagagtcttccgtcggagggctgtcgcccgaagcttgacagc 
JB593  gcagctgaagcttggcgacagccacggaagactctcctccggtttaaacacagtc 
JB594  gactgtgtttaaaccggaggagagtcttccgtggctgtcgccaagcttcagctgc 
JB595  gctggtcaagcttcggattagaagccgccggtttaaacacagtc 
JB596  gactgtgtttaaaccggcggcttctaatccgaagcttgaccagc 
JB597  gcagctgaagcttggcgacagccgtttaaacacagtc 
JB598  gactgtgtttaaacggctgtcgccaagcttcagctgc 
JB599  gctggtcaagcttcgggcgacagccctccggtttaaacacagtc 
JB600  gactgtgtttaaaccggagggctgtcgcccgaagcttgaccagc 
JB601  gctggtcaagcttcggaagactctcctccggtttaaacacagtc 
JB602  gactgtgtttaaaccggaggagagtcttccgaagcttgaccagc 
JB603  ccaaccaacgctcgccaaataagcttgaccagc 
JB604  gactgtgtttaaactgcctgtatgtgtcagcactaaa 
JB605  gactgtgtttaaaccatacagagcacatgcatgcca 
JB606  gctggtcaagcttcatgtacttacccaattaggaaatttacatggtttaaacacagtc 
JB607  gactgtgtttaaaccatgtaaatttcctaattgggtaagtacatgaagcttgaccagc 
JB618  gtcagtgagagctcaggcgcgccgctagacatagtttaaacgggatcccatgcatg 
JB619  catgcatgggatcccgtttaaactatgtctagcggcgcgcctgagctctcactgac 
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9.4.3 Promoter characterization with flow cytometry 
S. cerevisiae strains, transformed with different plasmids, were inoculated directly 
from glycerol stock (in biological triplicate) in YSC-URA media for 48 hours at 30
o
C 
with shaking, and then normalized to an OD600 of 0.01 in  2ml fresh YSC-URA or 2mls 
fresh YSC(gal)-URA.  Strains reinoculated in YSC-URA were incubated for another 15 
hours at 30
o
C with shaking, while strains reinoculated in YSC(gal)-URA were given 24 
hours before harvesting.  To harvest, cultures were spun down at 4
o
C at 1000g for five 
minutes, resuspended in 2ml ice cold water, and kept on ice until testing with a FACS 
Fortessa (BD Biosciences) using the YFP fluorochrome, a voltage of 308, and a 10,000 
cell count for yECitrine detection.  Data was analyzed using FlowJo software (Tree Star 
Inc., Ashland, OR) to compute mean fluorescence values. Day-to-day variability was 
mitigated by analyzing all comparable strains on the same day.  An average fluorescence 
and standard deviation was calculated from the mean values of biological replicates.  
9.4.4 Promoter characterization with β–galactosidase assay 
S. cerevisiae BY4741 strains, transformed with different plasmids, were 
inoculated directly from glycerol stock (in biological triplicate) in YSC-URA media for 
48 hours at 30
o
C with shaking, and then normalized to an OD600 of 0.01 in  2ml fresh 
YSC-URA or 2mls fresh YSC(gal)-URA.  Strains reinoculated in YSC-URA were 
incubated for another 15 hours at 30
o
C with shaking, while strains reinoculated in 
YSC(gal)-URA were grown 24 hours before harvesting.  Cultures were cooled in an ice 
bath for 30 minutes, washed twice in 1ml Z buffer, resuspended in 1ml Z buffer, and 
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measured for OD600 absorbance 
106.  β-galactosidase assays were performed as described 
by Miller 
106
 using 50μl of chloroform-permeabilized cells, and a reaction length of 12.5 
minutes.  Average activity and standard deviation were calculated from biological 
replicates. 
9.4.5 Promoter characterization with qRT-PCR 
S. cerevisiae BY4741 strains, transformed with different plasmids, were 
inoculated directly from glycerol stock in YSC-URA media for 48 hours at 30
o
C with 
shaking, and then normalized to an OD600 of 0.01 in  2ml fresh YSC-URA or 2mls fresh 
YSC(gal)-URA.  Strains reinoculated in YSC-URA were incubated for another 15 hours 
at 30
o
C with shaking, while strains reinoculated in YSC(gal)-URA were grown 24 hours 
before harvesting.  The cells were pelleted and total RNA was extracted using the 
RiboPureTM-Yeast Kit (Ambion).  500ng of RNA from each sample was used as 
template for the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems).  
A 3μl sample from each cDNA reaction was used to set up a qPCR reaction (in triplicate) 
with FastStart SYBR Green Master (Roche) using primers  
5’- TTCTGTCTCCGGTGAAGGTGAA -3’  
and 5’- TAAGGTTGGCCATGGAACTGGCAA-3’ as described in the manual 
with a non-template control.  The reactions were run with the ViiA™ 7 Real-Time PCR 
System using fast 96 well plates (Applied Biosystems). The data was analyzed with 
ViiA
TM
 7 Software (v. 1.0). 
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9.5 MATERIALS AND METHODS FOR CHAPTER 5 
9.5.1 Cultivation and media 
Y. lipolytica was cultivated at 30
o
C with constant agitation at 180rpm for all 
experiments.  Fatty acid accumulation was promoted by cultivation in media with a high 
carbon to nitrogen ratio, called High C:N media, containing 160g/L glucose, CSM (-
leucine, -uracil, or complete) supplement, 0.17g/L Yeast Nitrogen Base w/o amino acid 
and w/o (NH4)2SO4 (Becton, Dickinson, and Company), and 0.2 g/L (NH4)2SO4 (Fisher 
Scientific).  Solid media for E. coli and Yarrowia lipolytica was prepared by adding 
20g/L agar (Teknova) to liquid media formulations. 
9.5.2 Plasmid construction 
9.5.2.1 Construction of episomal Gmlox1 expression cassettes 
 A table of primer sequences can be found in Table 9.4.  Plasmids pMCSCen1, 
pMCS-TEF-hrGFP, pMCS-EXP-hrGFP, pMCS-UAS1B16-TEF-hrGFP, and pMCS-
UAS1B16-Leum-hrGFP have been described previously 
2
.  A codon optimized soybean 
lipoxygenase 1 gene 
156
, Gmlox1, was synthesized by Blue Heron and then amplified 
with primers JB408/JB409 and inserted into pMCSCen1, pMCS-TEF-hrGFP, and pMCS-
EXP-hrGFP in place of hrGFP with an AscI/PacI digest to form pMCS-Gmlox1, pMCS-
TEF-Gmlox1, and pMCS-EXP-Gmlox1, respectively.  Gmlox1 was similarly inserted 
into pMCS-UAS1B16-Leum-hrGFP after amplification by primers JB410/JB409 to create 
plasmid pMCS-UAS1B16-Leum-Gmlox1. 
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9.5.2.2 Construction of integrative expression cassettes 
Primers JB316/317 amplified a 149 basepair minimal terminator region from the 
XPR2 gene (xpr2tmin) from Y. lipolytica PO1f gDNA and flanked it with a 5’ BamHI 
restriction enzyme site and 3’ PmeI, RsrII, AvrII, SgfI, SalI sites.  Xpr2tmin was digested 
with BamHI-HF/SalI-HF and inserted into pUC19 to form plasmid, pUC-xpr2tmin.  
Primers JB320/321 amplified a 578 basepair region of Y. lipolytica 26S rDNA 
76
 from the 
PO1f genome, flanked by 5’ SacI and NotI restriction enzyme sites and 3’ KpnI and 
XmaI sites
76
.  This DNA fragment was inserted into pUC-xpr2tmin with a SacI-HF/XmaI 
digest to form plasmid pUCrDNA5’.  Primers JB324/325 amplified a 822 basepair region 
of Y. lipolytica 26S rDNA 
76
 from the PO1f genome flanked by 5’ SbfI and 3’ NotI and 
HindIII sites.  This fragment was inserted into pUCrDNA5’ with a SbfI/HindIII digest to 
form plasmid pUCrDNA.  Primers JB326/328 amplified the Ura3d1 allele 
75
 from Y. 
lipolytica strain IFO1659 
215
 flanked by 5’ KpnI and 3’ BstBI, AscI, PacI and BamHI 
sites.  The Ura3d1 fragment was inserted into pUCrDNA with a KpnI/BamHI-HF digest 
to form plasmid pUC-S1-nolox.  To allow for marker retrieval, the Ura3d1 gene was 
replaced by an identical Ura3d1 gene flanked by lox sites using primers JB572/574 and a 
SacII/BstBI digest, forming plasmid pUC-S1.  The strong UAS1B16-Leum promoter 
2
 
was then inserted into plasmid pUC-S1 with a BstBI/AscI digest to create plasmid pUC-
S1-UAS1B16-Leum.  The UAS1B16-TEF promoter 
2
 was similarly inserted into plasmid 
pUC-S1 to create plasmid pUC-S1-UAS1B16-TEF.  The Gmlox1 gene was gel extracted 
from plasmid pMCS-UAS1B16-Leum-Gmlox1 and inserted into pUC-S1-UAS1B16-Leum 
with AscI/PacI to form plasmid pUC-S1-UAS1B16-Leum-Gmlox1.  Primers JB608/609 
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amplified a Blue Heron codon optimized soybean hydroperoxide lyase gene 
165-167
, 
Gmhpl1, for insertion into pUC-S1-UAS1B16-TEF with AscI/PacI to form plasmid pUC-
S1-UAS1B16-TEF-Gmhpl1. 
9.5.2.3 Construction of knockout cassettes 
Primers JB124/125 amplified a cyc1 terminator from plasmid p416-TEF-
yECitrine 
30,210
 for insertion into plasmid pUC19 with XbaI/PstI to create plasmid 
pUCcyc1t.  Primers JB126a/127 amplified a hygromycin resistance gene (Hph) from 
plasmid pAG34 
216
 for insertion into plasmid pUCcyc1t to create plasmid pUCHphcyc1t.  
Primers JB138/146 amplified a EXP promoter regions from plasmid pMCS-EXP1-hrGFP 
2
 for insertion into plasmid pUCHphcyc1t to create plasmid pUCEXPHphcyc1t.   
Primers JB199/200 were annealed together and inserted into pUC19 with an 
EcoRI-HF/SacI-HF digest to create plasmid pUC5’lox.  Primers JB201a/202a were 
annealed together and inserted into pUC5’lox with a XbaI/HindIII digest to create 
plasmid pUC5’3’lox.   Primers JB203a/204a amplified an EXP1-Hph-cyc1t hygromycin 
resistance cassette from plasmid pUCEXPHphcyc1t for insertion into plasmid 
pUC5’3’lox to create plasmid pKO.  Primers JB347/348 amplified 3000 basepairs of 
genomic DNA 5’ of the MFE1 gene (YALI0E15378g) using PO1f gDNA as template, 
while primers JB349/350 amplified genomic DNA 3’ of the MFE1 gene.  These 
fragments were inserted sequentially into plasmid pKO with an AscI/NotI-HF and a 
FseI/PmeI digest, respectively, to form plasmid pKOMFE1.  Similarly, primers pairs 
JB564/565 and JB566/567 amplified 5’ and 3’ genomic DNA relative to the PEX10 gene 
(YALI0C01023g) to enable the construction of pKOPEX10. 
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9.5.2.4 Construction of cre-recombinase expressing plasmid 
A cyc1 terminator regions was amplified from plasmid pUCcyc1t by primers 
JB151/152 for insertion into plasmid pMCSCen1 
2
 to create plasmid pMCScyc1t.  Then, 
the UAS1B16-TEF promoter was gel extracted from plasmid pMCS-UAS1B16-TEF-
hrGFP 
2
 with a XmaI/AscI digested and inserted into plasmid pMCScyc1t to form 
plasmid pMCS-UAS1B16-TEF.  Primers JB149/150 amplified the Cre Recombinase gene 
from plasmid pSH47 
217
 for insertion into pMCS-UAS1B16-TEF with AscI/PacI to create 
plasmid pMCS-UAS1B16-TEF-Cre. 
Table 9.4: Primers used in Chapter 5: 
Primer  Sequence (5’  3’) 
JB124 gctctagaatcgataccgtcgacctcgag 
JB125 aaaactgcagttgtttaaacaagctaagcccgagcgtcccaaaaccttctc 
JB126
a cgggatccttggcgcgccccttaattaaatgggtaaaaagcctgaactcacc 
JB127 gctctagattattcctttgccctcggacgag 
JB138 ttggcgcgccggagtttggcgcccgttttt 
JB146 ccttaattaatgctgtagatatgtcttgtgtgtaagg 
JB149 ttggcgcgccatgtccaatttactgaccgtacac 
JB150 ccttaattaactaatcgccatcttccagcag 
JB151 ccttaattaatcatgtaattagttatgtcacgctt 
JB152 ccggcgcgccgtttaaaccgagcgtcccaaaaccttctc 
JB201
a 
tgctctagagtataacttcgtataatgtatgctatacgaagttattgggccggccagctttgtttaaacaagcttggga
ctag 
JB202
a 
ctagtcccaagcttgtttaaacaaagctggccggcccaataacttcgtatagcatacattatacgaagttatactcta
gagca 
JB199 
cggaattcggcgcgccaagcggccgcaacctgcagggtataacttcgtataatgtatgctatacgaagttattgga
gctcgagtat 
JB200 
atactcgagctccaataacttcgtatagcatacattatacgaagttataccctgcaggttgcggccgcttggcgcgc
cgaattccg 
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Table 9.4 continued 
 
JB203a cggggtaccggagtttggcgcccgttttt 
JB204a cgcggatcccgagcgtcccaaaaccttctc 
JB316 cgcggatccgcaattaacagatagtttgccggtg 
JB317 accacgcgtcgacttgcgatcgcttcctaggttcggaccgtttgtttaaaccgaacaaagacgggattttgcc 
JB320 actactacgagctcagcggccgcagatcttggtggtagtagcaaa 
JB321 cccaacccgggaggtaccccgcgggtccggctgcca 
JB324 gtcgctcgcctgcaggcagacactgcgtcgctccg 
JB325 cccaagcttttgcggccgctgcttcggtatgataggaagagcc 
JB326 ggggtaccctgcagactaaatttatttcagtctcc 
JB328 cgcggatccttaattaattggttggcgcgccttggttttcgaactaacagttaatcttctggtaagcctc 
JB347 ttggcgcgcctaagaattgccaaaacgtatctctt 
JB348 aaggaaaaaagcggccgctgtgtgtgtgtgttgaataaataga 
JB349 agtcagtcggccggccgctattatctgaccaagtgatacga 
JB350 agctttgtttaaacgctgaggaggaaaaatccgta 
JB408 ttggcgcgccatgttttccgcaggccacaa 
JB409 ccttaattaattagatggagattgaattagggataccg 
JB410 ttggcgcgccttttccgcaggccacaaaat 
JB572 ccaccgcggataacttcgtataatgtatgctatacgaagttatctgcagactaaatttatttcagtctcc 
JB574 cggttcgaaataacttcgtatagcatacattatacgaagttatctaacagttaatcttctggtaagcct 
JB564 gataggcgcgccaggtcgtgggaaagacagatt 
JB565 agcaaggttctgcggccgcgacgaagattccgaggggata 
JB566 gagctagcaggccggccgatggaaggactagtcagcga 
JB567 cagctcagtttaaacaagaagttctcacacagcagc 
JB608 ttggcgcgccatgtctctccccccaccctc 
JB609 ccttaattaattactttgttttctgaagagcagtg 
 
9.5.3 Strain construction 
Plasmids pUC-S1-UAS1B16-Leum-Gmlox1 and pUC-S1-UAS1B16-TEF-Gmhpl1 
were digested with Not1-HF to create linear expression cassettes, devoid of E. coli DNA 
and surrounded by Y. lipolytica rDNA for targeted integrations.  Y. lipolytica PO1f was 
transformed with these linearized expression cassettes individually and plated on YSC-
URA dropout media to isolate strains PO1f-Gmlox1 and PO1f-Gmhpl1.  The Ura3d1 
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marker was subsequently removed by transformation with plasmid pMCS-UAS1B16-
TEF-Cre followed by replica plating for selection of uracil auxotrophs, and then growth 
on permissive media to lose plasmid pMCS-UAS1B16-TEF-Cre.  Strain PO1f-Gmlox1 
was further transformed with the S1-UAS1B16-Leum-Gmlox1 cassette, followed by loss 
of the Ura3d1 marker as described above to yield strain PO1f-Gmlox1-Gmhpl1. 
  Knockout cassettes that targeted the MFE1 gene and PEX10 gene were 
amplified from plasmids pKOMFE1 and pKOPEX10 using primers JB347/350 and 
JB546/567, respectively. Y. lipolytica PO1f was transformed with these knockout 
cassettes, with selection on YPD-hygromycin plates, followed by loss of the hygromycin 
resistance cassette marker to yield strains PO1f ΔMFE1 and PO1f ΔPEX10.  All strains 
were confirmed through gDNA extraction and five distinct PCR confirmations. 
9.5.4 Cultivation conditions and quantification of pentane yield 
Y. lipolytica strains were inoculated directly from glycerol stock in biological 
triplicate in appropriate media (YSC-LEU for strains containing plasmid, and YSC for 
strains not containing plasmid) for 48 hours at 30
o
C in a rotary drum (CT-7, New 
Brunswick Scientific) at speed seven.  These strains were reinoculated at an OD600 of 
0.01 in 100mL of fresh media (composition varies and is specified in text) and incubated 
for up to 192 hours in 1000mL Kimax* GL 45 glass media/storage bottles (Fisher 
Scientific), sealed with open top GL-45 Caps with 34mm apertures (Chemglass Life 
Sciences) fitted with PTFE seals (Chemglass Life Sciences).  The cultures were grown 
inside 1L glass bottles sealed with PTFE septa to prevent loss of pentane product and to 
allow for headspace sampling of the product.   
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Pentane production was quantified by injecting 100μL headspace from the 100mL 
cultures into a GC-FID (Agilent Technologies 6890 Network GC System) equipped with 
an Agilent HP-5 column (5% phenyl-95% methylsiloxane - product number 19091J-413) 
and measuring the peak area at 3.34 minutes.  Briefly, the following settings were used: 
Detector Temp = 250
o
C, He Flow = 45.0 mL/min, Oven Initial Temp = 50
o
C, Oven Final 
Temp = 140
o
C, Ramp = 20
o
C/min.  Standards were used to detect and quantify n-pentane 
(Fisher scientific) and hexanal (Acros Organics) production.   
9.5.5 Lipid quantification and fatty acid profile analysis 
Y. lipolytica strains were cultivated as described above for eight days in 1L glass 
bottles.  Lipids from ~20-30 OD equivalents were extracted following the procedure 
described by 
218
 and modified for yeast 
219
.  Dried lipids were transesterified with N-tert-
Butyldimethylsilyl-N-methyltrifluoroacetamide (Sigma-Aldrich) following the procedure 
of 
220, and 2 μL samples were injected into a GC-FID (Agilent Technologies 6890 
Network GC System) equipped with an Agilent HP-5 column (5% phenyl-95% 
methylsiloxane - product number 19091J-413) to analyze fatty acid fractions.  Briefly, the 
following settings were used: Detector Temp = 300
o
C, He Flow = 1.0 mL/min, Oven 
Temp = 80°C for 2 min, increased at 30°C/min to 200 °C, increased at 2°C/min to 229 
°C, increased at 1°C/min to 232°C, increased at 50°C/min to 325°C.  Fatty acid standards 
for C16:0 palmitic acid, C16:1(n-7) palmitoleic acid, C18:0 stearic acid, C18:1 (n-9) 
oleic acid, and C18:2 (n-6) linoleic acid were purchased from Sigma-Aldrich, 
transesterified, and analyzed by GC to identify fatty acid peaks.   
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9.6 MATERIALS AND METHODS FOR CHAPTER 6 
9.6.1 Strains and media 
Yarrowia lipolytica strain PO1f (ATCC # MYA-2613), a leucine and uracil 
auxotroph devoid of any secreted protease activity (Madzak et al., 2000), was used as the 
base strain for all studies.  Table 6.2 contains a complete list of PO1f derivatives 
produced and used in Chapter 6.  Y. lipolytica was cultivated at 30
o
C with constant 
agitation.  2mL cultures of Y. lipolytica used in large-scale screens were grown in a rotary 
drum (CT-7, New Brunswick Scientific) at speed seven, and larger culture volumes were 
shaken in flasks at 225rpm or fermented in a bioreactor. 
Lipid accumulation response towards media formulation was investigated by 
cultivation in varying concentrations of glucose and nitrogen.   These media formulations 
contained .79g/L CSM, 1.7g/L Yeast Nitrogen Base w/o amino acid and w/o (NH4)2SO4 
(Becton, Dickinson, and Company), between 20g/L and 160g/L glucose, and between 
0.2g/L and 5g/L ammonium sulfate - (NH4)2SO4 (Fisher Scientific) – which corresponds 
to between 0.055g/L and 1.365g/L ammonium.  Minimal media formulations utilized for 
bioreactor fermentations typically contained 80g/L glucose and 6.7g/L Yeast Nitrogen 
Base w/o amino acids (1.7g/L YNB and 5g/L (NH4)2SO4).  When utilizing alternative 
carbon sources, glucose was replaced by 80g/L arabinose (Fisher Scientific), 80g/L 
fructose (Alfa Aesar), 80g/L galactose (Fisher Scientific), 80g/L glycerol (Fisher 
Scientific), 80g/L mannose (Alfa Aesar), 80g/L maltose (Acros Organics),  80g/L ribose 
(MP Biomedicals), 80g/L sucrose (Acros Organics), or 80g/L Xylose (Acros Organics).   
Solid media for E. coli and Yarrowia lipolytica was prepared by adding 20g/L agar 
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(Teknova) to liquid media formulations.  Leucine (MP Biomedicals) and isoleucine 
(Sigma Aldrich) supplementation was used to analyze the effect of leucine biosynthetic 
capacity.  Leucine was added at a concentration of 0.8g/L or 1.6g/L, while isoleucine was 
added at concentration of 1.6g/L.  Inhibition of the TOR protein was caused by 
supplementation with 200ng/mL rapamycin (LC Laboratories).   
9.6.2 Plasmid construction 
Primer sequences can be found in the Table 9.5.  All Y. lipolytica episomal 
plasmids were centromeric, replicative vectors derived from  plasmid pSl16-Cen1-1(227) 
98
 after it had been modified to include a multi-cloning site, a hrGFP green fluorescent 
reporter gene (pIRES-hrGFP, Agilent) driven by the strong UAS1B16-TEF promoter 
2
, 
and a cyc1 terminator 
210
 to create plasmid pMCS-UAS1B16-TEF-hrGFP.  Integrative 
plasmids were derived from plasmids pUC-S1-UAS1B16-Leum or  pUC-S1-UAS1B16-
TEF 
4
 that contained 5’ and 3’ rDNA integrative sequences surrounding the following 
elements - (from 5’ to 3’) a uracil section marker surrounded by LoxP sites for marker 
retrieval, the strong UAS1B16-Leum or UAS1B16-TEF promoter, AscI and PacI 
restriction enzyme sites for gene insertion, and a XPR2 minimal terminator.  These 
integrative plasmids were also designed to contain two identical NotI restriction enzyme 
sites directly outside of the rDNA regions so that plasmid linearization would 
simultaneously remove E. coli pUC19-based DNA.  All plasmids containing expression 
cassettes were sequenced confirmed before transformation into Y. lipolytica.  All 
auxotrophic or antibiotic selection markers used for chromosomal integrations were 
 180 
flanked with LoxP sites to allow for retrieval of integrated markers with the pMCS-
UAS1B16-TEF-Cre replicative vector 
4
.   
9.6.2.1 Construction of episomal expression cassettes 
The following genes were PCR amplified from Y. lipolytica PO1f gDNA and 
inserted into vector pMCS-UAS1B16-TEF-hrGFP in place of hrGFP with an AscI/PacI 
digest: AMPD, ACL subunit 1 (ACL1), ACL subunit 2 (ACL2), MEA1, DGA1, and 
DGA2 with primers JB387/388, JB402/404, JB405/407, AH020/021, JB911/912, and 
JB913/914, respectively.  This formed plasmids pMCS-UAS1B16-TEF-AMPD, pMCS-
UAS1B16-TEF-ACL1, pMCS-UAS1B16-TEF-ACL2, pMCS-UAS1B16-TEF-MEA, 
pMCS-UAS1B16-TEF-DGA1, and pMCS-UAS1B16-TEF-DGA2. 
A leucine marker containing plasmid expressing the Cre-Recombinase gene, 
pMCS-UAS1B16-TEF-Cre, has been described previously 
4
. 
9.6.2.2 Construction of integrative expression cassettes 
The following genes were gel extracted from the previously constructed episomal 
expression vectors and inserted into vector pUC-S1-UAS1B16-TEF with an AscI/PacI 
digest: AMPD, ACL subunit 1 (ACL1), ACL subunit 2 (ACL2), MEA1, DGA1, and 
DGA2.  This formed plasmids pUC-S1-UAS1B16-TEF-AMPD, pUC-S1-UAS1B16-TEF-
ACL1, pUC-S1-UAS1B16-TEF-ACL2, pUC-S1-UAS1B16-TEF-MEA1, and pUC-S1-
UAS1B16-TEF-DGA1, and pUC-S1-UAS1B16-TEF-DGA2.  The loxP-surrounded uracil 
marker of these integrative plasmids was replaced with a loxP-surrounded leucine marker 
created by amplification of pMCSCen1 template with primers JB862/863 followed by 
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insertion using a BstBI/SacII digest.  These plasmids enabled integrative selection with 
leucine auxotrophy and co-expression of two enzymes without marker retrieval.  These 
leucine marker integrative plasmids were dubbed plasmids pUC-S2-UAS1B16-TEF-
AMPD, pUC-S2-UAS1B16-TEF-ACL1, pUC-S2-UAS1B16-TEF-ACL2, pUC-S2-
UAS1B16-TEF-MEA1, and pUC-S2-UAS1B16-TEF-DGA1, and pUC-S2-UAS1B16-TEF-
DGA2.   
ACL1 and ACL2 were similarly inserted into pUC-S1-UAS1B16-Leum with 
primers JB403/404 and JB406/407, respectively, to form plasmids pUC-S1-UAS1B16-
Leum-ACL1 and pUC-S1-UAS1B16-Leum-ACL2.   
9.6.3 Strain construction 
All strains were confirmed through gDNA extraction and PCR confirmation and 
are listed in Table 6.2.  We previously constructed two markerless single-gene deletion 
strains in the Y. lipolytica PO1f background, PO1f-Δmfe1 and PO1f-Δpex10, deficient in 
their β-oxidation and peroxisomal biogenesis capacity, respectively 4.  Following our 
previous protocol, the PEX10 gene was deleted from strain PO1f-Δmfe1 to form the 
markerless double mutant PO1f-Δmfe1-Δpex10.  These four strains, referred to as PO1f, 
pex10, mfe1, and pex10 mfe1 were utilized as backgrounds for single and double 
overexpression of the AMPD, ACL1, ACL2, MEA, DGA1, and DGA2 proteins, 
including variation in selective marker utilized, i.e., leucine (chromosomal or episomal 
expression cassette) vs. uracil (chromosomal expression cassette).  Integrative cassettes 
were linearized, transformed into the four background strains, and selected for on 
appropriate dropout plates.  Integrative vectors without open reading frames to express, 
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pUC-S1-UAS1B16-TEF and pUC-S2-UAS1B16-TEF, were utilized to create strains with 
leucine, uracil, or both leucine and uracil prototrophies, but without enzyme 
overexpression (Table 6.2). 
Table 9.5: Primers used in Chapter 6 
JB387 TTGGCGCGCCatgccgcagcaagcaatgg 
JB388 CCTTAATTAAttaaccatgcagccgctcaaac 
JB402 TTGGCGCGCCatgtctgccaacgagaacat 
JB403 TTGGCGCGCCtctgccaacgagaacatctc 
JB404 CCTTAATTAActatgatcgagtcttggccttg 
JB405 TTGGCGCGCCATGTCAGCGAAATCCATTCACG 
JB406 TTGGCGCGCCTCAGCGAAATCCATTCACGAG 
JB407 CCTTAATTAATTAAACTCCGAGAGGAGTGGAA 
JB862 CCAccgcggataacttcgtataatgtatgctatacgaagttatgagtctttattggtgatgggaaga 
JB863 CGGTTCGAAataacttcgtatagcatacattatacgaagttatcagtcgccagcttaaagatatcta 
JB911 cattcaaaGGCGCGCCatgactatcgactcacaatactaca 
JB912 gcGGATCCTTAATTAAttactcaatcattcggaactctgg 
JB913 cattcaaaGGCGCGCCATGGAAGTCCGACGACGAAA 
JB914 gcGGATCCTTAATTAACTACTGGTTCTGCTTGTAGTTGT 
AH020 GACTGGCGCGCCATGTTACGACTACGAACCATGC 
AH021 GTCCTTAATTAACTAGTCGTAATCCCGCACATG 
9.6.4 Fatty acid characterization by nile red staining coupled with flow cytometry or 
fluorescence microscopy:  
Nile Red (MP Biomedicals) is commonly utilized to stain oleaginous cellular 
material and can be coupled with fluorescence flow cytometry to gauge relative lipid 
content 
182
.  Y. lipolytica strains were routinely inoculated from glycerol stock in 
biological triplicate in appropriate media for 72 hours at 30
o
C with shaking.  Cell 
concentrations were normalized to a specific OD600 for reinoculation in fresh media and 
further incubation.  For assays in which the effect of media formulation was not being 
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investigated, this media contained .79g/L CSM, 1.7g/L Yeast Nitrogen Base w/o amino 
acid and w/o (NH4)2SO4, 80g/L carbon source, and 5g/L ammonium sulfate, as this 
formulation was shown to strongly induce lipid accumulation in the highest lipid 
producing strains.  For large experiments, 2mL cultures were utilized to test large number 
of cultures and were inoculated to an OD600 =2.5, and larger volume cultures were 
inoculated to an OD600 = 0.1.  Cultures were incubated for two to eight days at 30
o
C with 
constant agitation.  2mL cultures were incubated in a rotary drum (CT-7, New Brunswick 
Scientific) at speed seven.  Flasks were shaken at 225rpm in a standing incubator, and 
bioreactors were agitated by rotor at no less that 225rpm and no more than 800rpm.  To 
harvest, one OD600 unit of culture was spun down at 1000g for three minutes and 
resuspended in 500 μL Phosphate Buffered Saline solution (PBS) (Sigma Aldrich).  6μL 
of 1mM Nile Red (dissolved in DMSO) was added, and then cells were incubated in the 
dark at room temperature for 15 minutes.  Cells were spun down at 1000g for three 
minutes, resuspended in 800μL ice cold water, spun down again, and resuspended again 
in 800μL ice cold water.  300μL of stained cells was added to 1ml ice cold water and 
tested with a FACS Fortessa (BD Biosciences), a voltage of 350, a 10,000 cell count, a 
forward scatter of 125, a side scatter of 125, and the 535LP and 585/42BP filters for 
fluorescence detection using the GFP fluorochrome.  Samples were kept on ice and in the 
dark during the test and fluorescence data was analyzed using FlowJo software (Tree Star 
Inc., Ashland, OR) to compute mean fluorescence values. Day-to-day variability was 
mitigated by analyzing all comparable strains on the same day.  An average fluorescence 
and standard deviation were calculated from the mean values of biological replicates.  
 184 
Stained cells were routinely examined with fluorescence microscopy under a 100X oil 
immersion objective using the FITC channel on an Axiovert 200M microscope (Zeiss). 
9.6.5 Lipid quantification and fatty acid profile analysis 
Lipids from 500μL culture were extracted following the procedure described by 
218
 and modified for yeast 
219
.  Dried lipids were transesterified with N-tert-
Butyldimethylsilyl-N-methyltrifluoroacetamide (Sigma-Aldrich) following the procedure 
of (Paik et al., 2009), and 2 μL samples were injected into a GC-FID (Agilent 
Technologies 6890 Network GC System) equipped with an Agilent HP-5 column (5% 
phenyl-95% methylsiloxane - product number 19091J-413) to analyze fatty acid 
fractions.  Briefly, the following settings were used: Detector Temp = 300
o
C, He Flow = 
1.0 mL/min, Oven Temp = 80°C for 2 min, increased at 30°C/min to 200 °C, increased at 
2°C/min to 229 °C, increased at 1°C/min to 232°C, increased at 50°C/min to 325°C.  
Fatty acid standards for C16:0 palmitic acid, C16:1(n-7) palmitoleic acid, C17:0 
heptadecanoic acid, C18:0 stearic acid, C18:1 (n-9) oleic acid, and C18:2 (n-6) linoleic 
acid were purchased from Sigma-Aldrich, transesterified, and analyzed by GC to identify 
fatty acid peaks.  Similarly, C16:1(n-9) palmitoleic acid was purchased from Cayman 
Chemical and used a standard.  GC-MS confirmation of fatty acid type was performed 
with a Thermo Scientific TSQ Quantum Triple Quad using chemical ionization and a 
1.5mL/minute flow rate.  
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9.6.6 Ammonium quantification 
1 mL of culture was heated to 80
o
C for 15 minutes, and then centrifuged at 17,900 
x g for 3 minutes.  Supernatant was stored at 4
o
C for less than 1 week, and ammonium 
concentration was determined using the R-Biopharma Ammonium Assay kit following 
the manufacturer’s instructions.  Ammonium Assay kit accuracy was assessed by 
measuring ammonium concentration in solutions with varying concentrations of Yeast 
Nitrogen Base w/o amino acids.  Minor necessary adjustments were made using the 
resulting standard curve.   
9.6.7 Bioreactor fermentations 
Typically, bioreactor fermentations were run in minimal media (described above) 
as batch processes.  However, one fermentation included a spike of an additional 80g/L 
glucose at the 72 hour timepoint, and another had a doubled media formulation that 
contained 160g/L glucose and 13.4g/L YNB w/o amino acids.  All fermentations were 
inoculated to an initial OD600 = 0.1 in 1.5L of media.  Dissolved oxygen was maintained 
at 50% of maximum by varying rotor speed between 250rpm and 800rpm with a constant 
air input flow rate of 2.5v/v/m (3.75v/m).  PH was maintained at 3.5 or above with 1M 
NaOH, and temperature was maintained at 28
o
C.  10-15 mL samples were taken every 
twelve hours, and fermentations lasted 6-7 days.  We ran several fermentations with 
suboptimal conditions before settling on the above parameters.   
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9.6.8 Transesterification 
Y. lipolytica lipid reserves were transesterified using acid-promoted direct 
methanolysis of cellular biomass 
221
.  1L of pex10 mfe1 leucine
+
 uracil
+
 DGA1p 
fermented in a bioreactor for seven days as described above was washed twice in 400mL 
water.   Cells were dried on a hotplate at 140
o
C for 3 hours.  The dried cell mass was 
transesterified with 2% w/v H2SO4 in 200mL methanol at a fast boil with reflux and 
constant agitation for 72 hours.  The reaction mixture was centrifuged to remove cellular 
debris.  FAMEs (fatty acid methyl esters) were extracted from the supernatant by adding 
0.2 volumes water, mixing, centrifuging, and removing the polar phase.  Additional 
FAMEs were extracted in the polar phase with a second extraction using 0.4 volume of 
water.  FAMEs were washed in 1 volume of water and analyzed with TLC and GC.    
9.6.9 Thin layer chromatography 
A thin layer chromatography of transesterified lipid product was run on a silica 
gel 60 TLC plate with hexane (Fischer Scientific) - diethyl ether (Sigma Aldrich) - acetic 
acid (Mallinckrodt Baker, Inc) at 40:10:1 using 6μl of 1.25 μg/μl standard mixture and 
6μl of 1 μg/μl sample and then stained with vanillin (Sigma Aldrich).   
9.6.10 Protein extraction 
Protein content from 0.5 to 1.0 mL of culture was extracted using the Pierce BCA 
Protein Assay Kit following the manufacturer’s instructions.  Protein concentration 
(mg/mL) was normalized per mL of culture and per culture OD600 to normalize to the 
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individual cellular level.  PO1f leucine
+
 uracil
+
 and pex10 mfe1 leucine
+
 uracil
+
 DGA1p 
strains were analyzed in this manner after fermentation in a bioreactor. 
9.6.11 Glucose quantification 
Supernatant was diluted 1:10 and glucose concentration was quanitified using a 
YSI Life Sciences Bioanalyzer 7100MBS. 
 
9.7 MATERIALS AND METHODS FOR CHAPTER 7 
9.7.1 Media 
Cultivation for itaconic acid production entailed the following: Yarrowia 
lipolytica strains were cultivated for two days at 30
o
C with constant agitation in 2mL 
cultures and then reinoculated to an OD600 = 0.005 in 15mL media in flasks and shaken 
for three days at 30
o
C at 225rpm. 
Itaconic acid accumulation response towards media formulation was investigated 
by cultivation in varying concentrations of glucose and nitrogen.   These media 
formulations contained .79g/L CSM, 1.7g/L Yeast Nitrogen Base w/o amino acid and 
w/o (NH4)2SO4 (Becton, Dickinson, and Company), and the following concentrations of 
glucose and ammonium sulfate - 20g/L and 5g/L ammonium sulfate, 20g/L glucose and 
0.2g/L ammonium sulfate, 80g/L and 5g/L ammonium sulfate.  Minimal media 
formulations utilized 20g/L glucose, 6.7g/L Yeast Nitrogen Base w/o amino acids (1.7g/L 
YNB and 5g/L (NH4)2SO4), and uracil supplementation at .02g/L if necessary.   
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9.7.2 Plasmid construction 
Primer sequences can be found in Table 9.6.  Four gBlocks gene fragments 
(Integrated DNA Technologies) were designed to encompass the intronless CAD1 gene 
sequence from Aspergillus terreus with at least 50 nucleotide overlap between each 
gBlock and with the p416-UASTEF-UASCIT-UASCLB-PGPD vector backbone 
3
.  Primers 
JB931/932, JB933/934, JB935/936, and JB937/938 were used to PCR amplify the four 
gBlocks.  Amplified gBlock DNA fragments and linearized p416-UASTEF-UASCIT-
UASCLB-PGPD vector backbone were transformed into S. cerevisiae BY4741 following 
Hegemann’s yeast transformation protocol 217 to enable homologous recombination 
mediated gene assembly 
222
.  Plasmid p416-UASTEF-UASCIT-UASCLB-PGPD–AtCAD1 was 
isolated from transformed BY4741 with a yeast miniprep, transformed into E. coli, 
miniprepped, and sequence confirmed. 
Primers JB1050 JB1051 were used to amplify the CAD1 gene from plasmid 
p416-UASTEF-UASCIT-UASCLB-PGPD–AtCAD1 and insert it into the pUC-S2-UAS1B16-
TEF and pMCS-UAS1B16-TEF chromosomal and episomal expression vectors 
(respectively) with an AscI/PacI digest to form plasmids pUC-S2-UAS1B16-TEF-CAD1 
and pMCS-UAS1B16-TEF-CAD1. 
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Table 9.6: Primers used in Chapter 7 
Primers Sequence (5'--> 3') 
JB931 gtattgattgtaattctgtaaatctatttc 
JB932 cttgctgcaaagaccgcaggaaggacaatgcttgcagagtgtaggggggcttcgctgtgg 
JB933 tttcatacaggctacggagcttgacgactaccacagcgaagcccccctacactctgcaag 
JB934 gaggctctctgccgttgccc 
JB935 ttcttgggggactgttggcc 
JB936 agatgaagtaaccttcctggccagatc 
JB937 ccgtccagctggtcgaccag 
JB938 ctccttccttttcggttagagcggatgtggggggagggcgtgaatgtaa 
JB1050 gagtggcgcgccatgaccaaacaatctgcgg 
JB1051 gcacttaattaattataccagtggcgatttca 
9.7.3 Strain construction 
All strains were confirmed through gDNA extraction and PCR confirmation.  We 
previously constructed and AMPD chromosomal expression strain utilizing the uracil 
auxotrophic marker (Table 9.5), referred to in Chapter 7 as PO1f AMPD.  Episomal 
(pMCS-UAS1B16-TEF-CAD1) and chromosomal (NotI-HF linearized pUC-S2-
UAS1B16-TEF-CAD1) expression cassettes were transformed in Y. lipolytica PO1f and 
PO1f AMPD to form four strains: PO1f CAD (episomal and chromosomal) and PO1f 
AMPD CAD (episomal and chromosomal).    
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